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S u m m a r y
A. Effects of the hypoxanthine-xanthine oxidase system and
homocysteine on endothelial barrier function
1. Endothelial barrier function was assessed by use of an in vitro model 
in which the transfer of trypan blue-labelled albumin was measured 
across monolayers of bovine aortic endothelial cells (BAEC) grown 
on polycarbonate membranes.
2. Addition of either hypoxanthine (0.2 mM) or xanthine oxidase 
(20 mU ml“l)  alone to BAEC monolayers during a 90 minute 
incubation period was found to have no effect on the level of albumin 
transfer obtained, but a combination of both was found to significantly 
increase transfer.
3. The increase in albumin transfer induced by hypoxanthine and 
xanthine oxidase was abolished by catalase (3 U ml-1), significantly 
reduced by allopurinol (4 mM), but unaffected by superoxide 
dismutase (6000 U m l'l), the hydroxyl radical scavengers, mannitol 
(15 mM), dimethylthiourea (10 mM) and N-(2-mercaptopropionyl)- 
glycine (1 mM), overnight pretreatment with the iron chelator, 
deferoxamine (0.5 mM), ferric chloride (50 /iM), an inhibitor of nitric 
oxide synthase, N03-nitro-L-arginine (l-NOARG), or the antioxidant, 
dithiothreitol (3 mM).
4. Addition of xanthine (0.2 mM) in combination with xanthine oxidase 
(20 mU ml“l)  generated a similar increase in albumin transfer across 
BAEC monolayers to that obtained using hypoxanthine in combination
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with xanthine oxidase. The increase induced by xanthine and 
xanthine oxidase was similarly abolished by catalase (3 U ml-1).
5. Hydrogen peroxide (0.1-30 mM) itself induced an increase in albumin 
transfer across m onolayers of BAEC, exhibiting a biphasic 
concentration-response curve with peaks at around 0.1-0.3 mM and 
10-30 mM. The increase in albumin transfer induced by 0.1 mM was 
abolished by 0.3 U ml-! catalase, whilst that induced by 10 mM 
hydrogen peroxide was abolished by 3000 U ml-1 catalase.
6. Homocysteine (0.5 and 1.5 mM) was found to have no effect on the 
level of albumin transfer across BAEC monolayers which was obtained 
w hen it was added alone. However, w hen it was added in 
combination with copper sulphate (5 and 50 /iM) which catalyses its 
oxidation to homcystine, a significant increase in albumin transfer 
was observed.
7. The increase in albumin transfer induced by the combination of 
homocysteine (1.5 mM) and copper sulphate (50 j j M )  was abolished 
by catalase (1 U ml-!), but was unaffected by superoxide dismutase 
(6000 U ml-!), mannitol (15 mM), dimethylthiourea (1 mM) or 
overnight pretreatment with deferoxamine (0.5 mM).
8. The data suggest that the endothelial barrier dysfunction induced by 
the combination of hypoxanthine and xanthine oxidase is likely 
mediated solely by the actions of hydrogen peroxide and not by 
superoxide anion, hydroxyl radical, peroxynitrite anion, nitric oxide 
or hypochlorous acid. Also, it was shown that xanthine and 
hypoxanthine may both equally well be used as substrates for 
xanthine oxidase in order to induce endothelial barrier dysfunction.
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These findings further indicate that the endothelial barrier dysfunction 
which is associated with ischaemia-reperfusion injury could well be 
mediated by the hypoxanthine-xanthine oxidase system which is 
known to be activated in this condition.
9. The data also indicate that endothelial barrier dysfunction is induced 
by the copper-catalysed oxidation of homocysteine, rather than by 
a direct action of homocysteine itself. This dysfunction is also likely 
mediated solely by hydrogen peroxide and not by superoxide anion 
or hydroxyl radical. This ability of homocysteine to induce endothelial 
barrier dysfunction in the presence of copper may contribute to the 
atherogenic actions of homocysteine observed in sufferers of 
homocystinuria.
B. Effects of lipopolysaccharide (LPS) on endothelial barrier 
function
10. Following 24 hours’ incubation, after which the transfer of albumin 
across monolayers of BAEC was measured, LPS (0.1-1000 ng ml-!) 
was found to induce a concentration-dependent increase in albumin 
transfer.
11. The increase in albumin transfer induced by LPS (30 ng ml-!) was 
found to develop with a biphasic time-course. An early, transient 
peak was observed which was maximal at around 2 hours. The level 
of albumin transfer then declined back towards basal levels before 
rising again, nearing a second maximum by 24 hours.
12. The increase in albumin transfer induced following 24 hours’ 
incubation with LPS (30 ng ml-!) was abolished by polymixin B
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(10 /ig ml-1), enhanced by the nitric oxide synthase inhibitor, L-NMMA 
(2 mM), but unaffected by the nitric oxide synthase inhibitors, 
l-NOARG (100 /iM) and l-NAME (500 /iM), the cyclo-oxygenase 
inhibitor, flurbiprofen (30 /iM), catalase (1000 U ml-1) or by a 20 
hour pretreatment with the glucocorticoid, dexamethasone (1 /iM).
13. The increase in albumin transfer induced following 2 hours’ 
incubation with LPS (30 ng m l'1) was abolished by polymixin B 
(10 /ig ml-1), enhanced by l-NMMA (2 mM), but unaffected by 
L-NAME (500 /iM) or by a 20 hour pretreatment with dexamethasone 
(1 /iM).
14. Following 24 hours’ incubation, human recombinant interferon-y 
(IFN-y) (0.75-75 U ml-1) was found to have no effect on the level of 
albumin transfer obtained across monolayers of BAEC.
15. The data show that LPS can induce endothelial barrier dysfunction 
through a direct action on the endothelium which develops with a 
biphasic time-course. Neither the increase induced by LPS after 
2 hours’ incubation, nor that obtained after 24 hours’ incubation, is 
mediated by production of nitric oxide. Additionally, the increase 
induced by LPS after 24 hours’ incubation is also not mediated by 
a cyclo-oxygenase product or hydrogen peroxide, and is unlikely to 
be mediated by IFN-y. These findings may be of relevance to the 
profound vascular leakage observed in septic shock of which LPS is 
a common cause.
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C h a p t e r  I
I. I The vascular endothelium
he vascular endothelium comprises a single layer of cells, resting on
a basement membrane, which lines the luminal side of every blood 
vessel within the body, as well as the chambers of the heart. It forms an 
interface between the blood and the underlying interstitium, thereby exerting 
a regulatory effect on both these components as well as controlling the 
passage of solutes, fluids and cells from the blood into the interstitial
The tone of the vascular smooth muscle is regulated by a number of 
vasoactive agents which are either released from cells into the bloodstream, 
from nerve terminals in the vessel wall or are secreted by the endothelium. 
Included in this last category are two vasodilator substances, prostacyclin 
(Moncada et al., 1976) and endothelium-derived relaxing factor (EDRF) 
(Furchgott & Zawadzki, 1980), and the endothelins, a group of vaso­
constrictor peptides (Yanagisawa et al., 1988).
The endothelium also provides a non-thrombogenic lining to the blood 
vessel both due to the nature of the endothelial cell surface and through 
the release of EDRF and prostacyclin which inhibit platelet aggregation 
(Moncada et al., 1976; Azuma et al., 1986; Furlong et al., 1987; Radomski 
et al., 1987a). Additionally, EDRF has been shown to inhibit platelet adhesion 
(Radomski et al., 1987b), whilst prostacyclin has been shown to inhibit the 
adhesion only of activated platelets (Fry et al., 1980). Under certain 
circumstances, such as in response to tissue injury, the endothelium may 
also promote platelet adhesion and aggregation through the production of
space.
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collagen (Sage et al., 1979), thrombospondin (Mosher et al., 1982), 
fibronectin (Jaffe & Mosher, 1978) and von Willebrand factor (Jaffe et al., 
1973).
I. I. I Endothelium-derived relaxing factor (EDRF)
EDRF was first described by Furchgott & Zawadzki (1980) who observed that acetylcholine-induced relaxation of pre-constricted rabbit aortic 
strips was dependent on the presence of the endothelium. They also 
showed using a “sandwich” preparation in which an endothelium-denuded 
transverse aortic strip was co-mounted with an endothelium-containing 
longitudinal strip (which due to its orientation contributed only negligibly 
to the contraction recorded), that following pre-constriction with 
phenylephrine, acetylcholine induced the release of a relaxant from the 
endothelium of the longitudinal strip which could relax the transverse 
strip. From these observations it was postulated that the endothelial cells 
were releasing a factor, in response to stimulation with acetylcholine, 
which can relax vascular smooth muscle. This factor was termed EDRF.
Subsequent research has shown that EDRF release may be induced by a 
wide variety of stimuli including bradykinin, ATP, thrombin, histamine, 
substance P and the calcium ionophore, A23187 (Furchgott, 1984). 
Endothelium-dependent relaxation of vascular smooth muscle has also 
been shown to be induced by hypoxia, increased blood flow and electrical 
stimulation (see Moncada et al., 1988 for review).
Following on from the “sandwich” preparation described by Furchgott & 
Zawadzki (1980), cascade bioassay techniques have been used to confirm 
the humoral nature of EDRF. For instance, Griffith et al. (1984) showed 
that the perfusate passing through pre-constricted endothelium-containing
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aortic segments stimulated with acetylcholine or A23187 could subsequently 
relax segments of endothelium-denuded coronary artery. This study also 
revealed that EDRF had a biological half-life of around 6 seconds.
EDRF has also been shown to be an inhibitor of platelet aggregation 
(Azuma et a l, 1986) and adhesion (Radomski et a l, 1987b), and a rise in 
cellular levels of cyclic GMP following stimulation of soluble guanylate 
cyclase is associated with both endothelium-dependent inhibition of platelet 
aggregation and endothelium-dependent vascular relaxation (Rapoport & 
Murad, 1983; Busse, 1987). Moreover, selective inhibitors of cyclic GMP 
phosphodiesterase, such as M&B 22948 (Zaprinast) and MY 5445, have 
been shown to potentiate endothelium-dependent relaxation (Martin et a l, 
1986a), as well as the actions of EDRF on smooth muscle (Kukovetz et a l, 
1982) and platelets (Radomski et a l, 1987b).
The breakdown of EDRF has been shown to be inhibited by superoxide 
dismutase (Gryglewski et a l, 1986) thus suggesting that it is destroyed by 
superoxide anion (-02'). Superoxide dismutase also prevents the action of 
various EDRF inhibitors, such as pyrogallol, dithiothreitol and hydroquinone, 
suggesting that these act by generating -02 ' (Moncada et a l, 1986). Other 
inhibitors of EDRF include haemoglobin, which acts by binding the EDRF 
molecule (Martin et a l, 1986b), and methylene blue which inhibits soluble 
guanylate cyclase (Gruetter et a l, 1981).
1.1.2 The L-arginine-nitric oxide pathway
In 1986, both Furchgott and Ignarro independently suggested that EDRF might be nitric oxide or a nitric oxide-like substance (see Furchgott, 
1988; Ignarro et a l, 1988). Evidence that this is in fact the case was 
subsequently provided by Palmer et a l  (1987). Using a cascade bioassay,
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they showed that addition of exogenous nitric oxide mimicked the ability 
of EDRF, released from porcine aortic endothelial cells grown on 
microcarrier beads, to relax spiral strips of endothelium-denuded rabbit 
aorta. Both nitric oxide and EDRF were found, using this system, to have 
similar biological half-lives of around 3 seconds, and, like EDRF, nitric 
oxide was found to be inactivated by -02". The most compelling evidence, 
however, was obtained using a chemiluminescence assay which directly 
demonstrated that bradykinin induced the release of nitric oxide from 
cultured endothelial cells in quantities similar to those required to cause 
a relaxation using the cascade bioassay. Other work, using spectro­
photometry to measure the formation of nitric oxide-bound haemoglobin 
from deoxyhaemoglobin (Ignarro et al., 1987b) or the diazotisation of 
sulphanilic acid (Ignarro et al., 1987a), confirmed the identification of 
EDRF as either nitric oxide or a labile nitroso compound.
Further work, using mass spectrometry, revealed that the nitric oxide 
produced by both macrophages (Iyengar et al., 1987) and endothelial cells 
(Palmer et al., 1988a) originates from one of the two terminal guanadino 
nitrogen atoms of L-arginine with L-citrulline being formed as a co-product 
(see Figure 1.1). Also, the formation of L-citrulline from L-arginine in 
macrophages (Hibbs, Jr. et al., 1987), and of nitric oxide from L-arginine 
in cultured endothelium (Palmer et al., 1988b), was found to be inhibited 
by the L-arginine analogue, N®-monomethyl-L-arginine (l-NMMA).
The enzyme, nitric oxide synthase, which synthesises nitric oxide from 
L-arginine in endothelial cells, was subsequently studied using endothelial 
homogenates and characterised (Palmer & Moncada, 1989). It was found 
to be both NADPH- and Ca2+-dependent (Mayer et al., 1989; Miilsch 
et al., 1989). Also, its activity was shown to be inhibited by calmodulin-
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Figure 1.1 The nitric oxide synthase-catalysed formation of nitric oxide 
and L-citrulline from L-arginine.
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binding peptides and antagonists suggesting that its Ca2+-dependence is 
mediated by calmodulin (Busse & Miilsch, 1990a).
In addition to l-NMMA, other analogues of L-arginine have been shown to 
inhibit the synthesis of nitric oxide in endothelial cells including N^-nitro- 
L-arginine (l-NOARG), its more soluble, methyl ester form, N^-nitro- 
L-arginine methyl ester (l-NAME), and N®-iminoethyl-L-arginine (l-NIO) 
(Moore et al., 1990; Rees et al., 1990).
1.1.3 Nitric oxide synthase isoforms
In addition to vascular endothelial cells, nitric oxide synthases have been found to be present in a variety of cell types. Based on their mechanisms 
of regulation, two main isoforms have been shown to exist—termed 
constitutive and inducible, respectively. The constitutive enzyme binds 
calmodulin in a reversible, Ca2+-dependent manner and therefore may be 
activated by agonists which elevate intracellular Ca2+ levels. The inducible 
enzyme was originally believed to be both Ca2 +- and calmodulin- 
independent but has recently been shown to bind calmodulin so tightly as 
to effectively be irreversibly bound (Cho et al., 1992). Thus, its activity is 
unaffected by exogenous levels of both Ca2 + and calmodulin, and instead 
has been shown to be regulated by the induction of transcription (Xie 
et a l, 1992) and the availability of co-factors. For instance, it has been 
shown that induction of an inducible nitric oxide synthase may be 
accompanied by induction of GTP cyclohydrolase, an enzyme required for 
the formation of tetrahydrobiopterin, a necessary co-factor for nitric oxide 
synthesis (Hattori & Gross, 1993).
In addition to tetrahydrobiopterin and Ca2+/calmodulin, binding sites for 
various cofactors required for nitric oxide synthesis have been identified
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in both constitutive and inducible nitric oxide synthases, including NADPH, 
FAD, FMN and iron protoporphyrin IX (a haeme-containing group) (see 
Marietta, 1993 for review). The conversion of L-arginine to nitric oxide and 
L-citrulline involves a 5-electron oxidation and it is thought that NADPH, 
FAD, FMN and iron protoporphyrin IX are involved in the electron transfer 
process. Calcium and calmodulin play a regulatory role, whilst tetrahydro­
biopterin is thought to be involved in stabilising the enzyme.
Constitutive nitric oxide synthases have now been shown to be present in 
a variety of cell types including endothelial cells, certain central neurones, 
certain peripheral non-adrenergic, non-cholinergic (NANC) neurones, blood 
neutrophils, mast cells, platelets, adrenal medullary cells, pancreatic P cells 
and astrocytes. Inducible nitric oxide synthases have been shown to be 
p resen t following im m unological stim ulation in, am ongst others, 
macrophages, Kupffer cells, hepatocytes, vascular smooth muscle cells, 
endothelial cells, inflammatory neutrophils, fibroblasts, astrocytes and 
mesangial cells (see Nathan, 1992 for review).
The constitutive enzyme has been purified in both brain (Bredt & Snyder, 
1990; Mayer et al., 1990; Schmidt & Murad, 1991) and vascular endothelial 
cells (Pollock et al., 1991), whilst the inducible enzyme has been purified 
in macrophages (Stuehr et al., 1991; Hevel et al., 1991). Both the constitutive 
nitric oxide synthase found in brain and the inducible nitric oxide synthase 
found in macrophages have been shown to be cytosolic enzymes, whilst 
the constitutive enzyme purified from vascular endothelium was found to 
be membrane-bound.
At present, therefore, there would appear to be at least three distinct 
isoforms of nitric oxide synthase—two constitutive and one inducible. 
Additionally, at least three nitric oxide synthase genes have so far been
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identified (Nathan, 1992), with at least one of these giving rise to enzyme 
isoforms of different molecular weights through alternative splicing.
1.2 Endothelial barrier function
he vascular endothelium acts as an important barrier between the
components of the blood and the underlying tissues, thereby fulfilling 
a key homeostatic role within the body. The ability of molecules to cross 
this barrier is determined both by their molecular size and charge. Smaller, 
non-polar molecules are more easily able to cross than either charged 
molecules or those of high molecular weight.
Classically, the endothelium was regarded to have a fixed hydraulic 
conductivity. Only physical properties such as mass and charge were 
believed to affect its permeability to different molecules, with the 
endothelium itself playing a passive role (Starling, 1896). A pore theory 
was subsequently put forward which suggested that passive pores existed 
in the endothelium to allow molecules to cross (Pappenheimer, 1953). 
These pores existed either running across the endothelial cells themselves 
or passing through the junctions between them. Additionally, there were 
believed to be two distinct sizes of pore—termed small and large pores 
respectively—with there being substantially greater numbers of small pores 
thus explaining why small molecules could more easily cross than large 
molecules (Grotte, 1956).
This classical view likened the endothelial barrier to that of a semi-permeable 
membrane and, indeed, filtrates of plasma through artificial semi-permeable 
membranes with pores of a certain size have been found to be comparable 
to capillary filtrates (Grega, 1986a). This model, however, cannot take
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account of the significantly increased protein efflux, across the endothelial 
barrier from the blood to the interstitium, which is observed in inflammation.
Evidence that the endothelial cells themselves could influence permeability 
followed primarily from observations that the presence of various mediators 
could enhance the transport of macromolecules across the endothelial 
barrier as compared to that obtained under basal conditions (Grega, 1986b). 
These findings conflicted with the idea of the endothelial barrier as being 
one which was passive and not under physiological regulation and 
suggested that the endothelial cells were, in fact, active functional units 
which were involved in the regulation of endothelial permeability.
Two possible routes exist by which molecules can cross the endothelial 
barrier— intracellular (through the cells) and paracellular (between the 
cells)—with evidence having been shown for the existence of both routes. 
Debate, however, still surrounds the mechanism by which macromolecules 
cross the endothelium with some groups arguing that an extensive 
intracellular system of vesicular transport is the most important (Simionescu 
et al., 1 9 8 7 ), whilst others argue that such transport occurs mainly by a 
paracellular route through pores between endothelial cells (Rippe & 
Haraldsen, 1987).
1.2.1 Intracellular routes of transendothelial passage
Intracellular routes across the endothelial barrier have been shown to exist in various forms. Several studies using tracer molecules have 
revealed numerous plasmalemmal vesicles within the endothelial cell and 
it has been hypothesised that such vesicles form the basis of transport 
mechanisms across the endothelial barrier. However, since these studies 
are based on the use of electron microscopy, they only reveal the state of
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the endothelium at any one fixed moment in time and hence three different 
hypotheses have been put forward as to exactly how these vesicles may 
contribute to transendothelial passage (shown diagrammatically in Figure 
1.2).
The first hypothesis to be put forward has been referred to as the “shuttle” 
hypothesis (Palade, I960). According to this hypothesis, vesicles containing 
molecules to be transported bud off from the plasmalemma on one side 
of the endothelial cell, traverse the cell cytoplasm and then fuse with the 
plasmalemma on the opposite side of the cell to release their contents. 
These vesicles may either form de novo, when required, by plasmalemmal 
invagination or, alternatively, may be more permanent structures which 
maintain a stable presence on fusing with the plasmalemma and can again 
bud off to become free cytoplasmic vesicles.
The second hypothesis of transendothelial vesicular transport has been 
referred to as a fusion-flssion process (Clough & Michel, 1981). According 
to this hypothesis, vesicles do not traverse fully across the endothelial cell, 
but instead only move a short distance to fuse with neighbouring vesicles. 
This enables each vesicle to transfer its contents into its neighbour which 
subsequently buds off from it to fuse with another vesicle. This process 
continues until the plasmalemma on the opposite side of the endothelial 
cell is reached, whereupon any molecules which had entered the original 
vesicle are released. In a variant of this hypothesis, groups of vesicles may 
be fused together forming clusters that are separated from each other by 
diaphragms. These diaphragms form and reform on a cyclical basis, allowing 
molecules to progress across the cell in stages as they progress from one 
cluster to the next.
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Figure 1.2 Diagrammatic representation of the three proposed hypotheses 
of transendothelial vesicular transport mechanisms. Reproduced from Michel, 
1992. a) the “shuttle” hypothesis, b ) the “fusion-fission” hypothesis, 
c) transendothelial vesicular channels.
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In the third hypothesis, vesicles form fused structures which create channels 
across the endothelium, running from the luminal surface through to the 
abluminal surface (Simionescu et al., 1975). Thus, molecules can easily 
traverse the endothelium from one side to the other by passing along these 
channels. These channels may be permanent or, alternatively, may be 
transient in their existence, but with their numbers at any one time in a 
given area remaining constant.
1.2.2 Paracellular routes of transendothelial passage
he first evidence for a paracellular route of transendothelial passage
was provided by Majno & Palade (1961) from electron microscopic 
studies of rat cremaster muscle. Using tracer molecules of colloidal HgS 
given by intravenous injection, they observed the formation of intercellular 
gaps on subsequent administration of the inflammatory mediators, histamine 
and 5-HT. Further investigation revealed that these intercellular gaps were 
confined to the venous side of the circulation and occurred predominately 
at the post-capillary venule (Majno et al., 1961). Later work showed that 
the formation of intercellular gaps was accompanied by deformations in 
the endothelial cell nuclei and this was regarded as a sign of cell contraction 
(Majno et al., 1969). This lead to the hypothesis that inflammatory mediators 
induce an increase in endothelial permeability by causing the contraction 
of individual endothelial cells away from each other, thereby leading to 
intercellular gap formation.
Studies of the effects of mediators on endothelial permeability have also 
been shown using hamster cheek pouch preparations (Duling, 1973; Svensjo 
et al., 1978). In this model, fluorescein-isothiocyanate-labelled dextran 
(FITC-dextran) is injected intravenously into hamsters prior to the 
administration of mediators. Intravital light microscopy is then used to
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identify sites of vascular leakage, shown by the leakage of the fluorescent 
FITC-dextran, which form at post-capillary venules in the cheek pouch. 
Using such a model, Svensjo & Grega (1986) demonstrated the ability of 
various inflammatory mediators, including leukotrienes (C4 , D4 , E4  and 
B4 ), bradykinin, histamine, 5-HT, substance P, complement 3a, complement 
5a, PAF and prostaglandins (Ei, E2  and F2a)> to increase permeability at 
the post-capillary venule through the formation of intercellular gaps.
Venular endothelial cells have been found to possess receptors for a wide 
variety of inflammatory mediators (Buonassisi & Venter, 1976). For instance, 
histamine H i receptors are found in large numbers in venular endothelial 
cells where they are localised in close proximity both to cell junctions and 
to contractile proteins (Heltianu et al., 1982). Also, it has been shown that 
vascular leakage may be stimulated by selective H i agonists, whilst 
histamine-induced vascular leakage may be blocked by H i antagonists 
(Guth & Hirabayashi, 1983) confirming that the actions of histamine on 
endothelial barrier function are receptor-mediated.
1.2.3 Role of contractile proteins in intercellular gap formation
he hypothesis that inflammatory mediators cause the formation of
intercellular gaps through cell contraction was lent further weight by 
the identification of contractile proteins, such as actin, myosin, tropomyosin, 
a-actinin and vinculin, within endothelial cells (Becker & Nachman, 1973; 
Drenckhahn, 1983; Gabbiani et al., 1983; Drenckhahn & Wagner, 1986). 
Although the presence of contractile proteins does not necessarily indicate 
a contractile function, the distribution of contractile proteins within venular 
endothelial cells was found to be different from that found in arterial 
endothelial cells and this is therefore consistent with the fact that 
inflammatory mediators only increase permeability on the venular side of
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the circulation (Grega, 1986a). This lack of activity may, however, also be 
due to a lack of receptors for inflammatory mediators in arterial endothelial 
cells.
Further confirmation that endothelial cell contractile proteins are involved 
in the development of an increase in permeability was shown by Shasby 
et al. (1982). In their study using porcine pulmonary artery endothelial 
cells, two microfilament disrupting agents, cytochalasin B and cytochalasin 
D, were shown to induce an increase in endothelial monolayer permeability 
to albumin. Microscopic studies confirmed that these agents were causing 
a disruption of microfilament bundles and revealed a retraction of the cell 
cytoplasm consistent with cell contraction. Furthermore, on addition of 
histamine to monolayers of human umbilical vein endothelial cells, Rotrosen 
& Gallin (1986) have reported a decrease in cytoplasmic F-actin content. 
More recently, using an in vitro model of endothelial permeability utilising 
monolayers of calf pulmonary artery endothelial cells, Phillips et al. (1989) 
demonstrated that thrombin-induced increases in permeability were inhibited 
in the presence of phallacidin, an actin-stabilising agent which prevents its 
activation.
1.2.4 Role of calcium (Ca2+) in intercellular gap formation
Many studies have suggested a requirement for Ca^+ to facilitate endothelial cell contraction in intercellular gap formation. The first 
evidence was shown by Liddell & Simpson (1980) who found that histamine- 
induced gap formation between venular endothelial cells was abolished 
w hen EDTA was used to remove Ca2+ from the extracellular fluid. It has 
also been shown that the increase in venular permeability induced by 
histamine in the hamster cheek pouch can be blocked by the calcium 
channel blocker, verapamil (Mayhan & Joyner, 1984). Furthermore, using
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the fluorescent Ca2+ probe, quin 2, Rotrosen & Gallin (1986) demonstrated 
that histamine causes both mobilisation of intracellular Ca2 + and influx of 
extracellular Ca^+ in human umbilical vein endothelial cells and this occurs 
over a similar concentration range to the histamine-induced permeability 
increase which can be observed using monolayers of these cells in vitro.
Evidence for Ca2+-dependence has also been shown in thrombin-induced 
permeability increases. For instance, Lum et al. (1989) demonstrated both 
that thrombin induced an influx of Ca2 + into bovine pulmonary artery 
endothelial cells and induced an increase in albumin permeability across 
monolayers of these cells which was calcium-dependent. Evidence for this 
Ca2+-dependence was that LaCl3 , which competes with Ca2+ for entry 
into cells, caused a reduction in the thrombin-induced permeability increase 
and, additionally, preloading the cells with quin 2 to buffer intracellular 
Ca2 +, induced a concentration-dependent inhibition.
Further evidence for a role of Ca2+ in mediating increases in endothelial 
permeability has been shown in various studies using the Ca2 + ionophore, 
A23187 which facilitates Ca2+ entry into endothelial cells. In vivo, A23187 
has been shown to increase endothelial permeability in cerebral venules 
(Olesen & Crone, 1986; Olesen, 1987) whilst using in vitro models, it has 
been shown to increase permeability of monolayers of porcine pulmonary 
artery (Shasby & Shasby, 1986), porcine aortic (Gudgeon & Martin, 1989) 
and human umbilical vein (Yamada et al., 1990a) endothelial cells.
In contrast to these findings, research in this laboratory has suggested a 
dissociation of the effects thrombin on endothelial permeability from its 
effects on cytosolic calcium levels (Buchan & Martin, 1992). In this study, 
thrombin was found to induce similar increases in intracellular calcium 
levels in both bovine pulmonary artery and bovine aortic endothelial cells.
Page 37
M odulation o f  Endothelial Barrier Function Chapter 1
However, thrombin was only found to be able to cause an increase in 
albumin permeability across monolayers of pulmonary artery endothelial 
cells, having no effect on the permeability of monolayers of aortic endothelial 
cells. Moreover, the permeability increase induced by thrombin was found 
to be inhibited by atriopeptin II and 8  bromo cyclic GMP, which had no 
effect on intracellular calcium levels, and also by forskolin which in fact 
enhanced these levels. Buchan & Martin therefore proposed that the effects 
of thrombin on endothelial barrier function are not mediated by Ca2 + and 
may instead be mediated by other second messengers such as cyclic 
nucleotides and protein kinase C.
1.2.5 Role of protein kinase C in the regulation of endothelial barrier 
function
arious studies have indicated a role for protein kinase C in regulating
endothelial barrier function. The phorbol ester, phorbol myristate 
acetate (PMA) which activates protein kinase C has been shown in vivo to 
increase the endothelial permeability of cerebral venules (Olesen, 1987) 
whilst in vitro it has been shown to increase the permeability of monolayers 
of porcine aortic (Gudgeon & Martin, 1989), porcine pulmonary artery 
(Shasby et al., 1983), bovine aortic (Oliver, 1990; Buchan & Martin, 1992) 
and bovine pulmonary artery (Lynch et al., 1990; Buchan & Martin, 1992) 
endothelial cells. Buchan & Martin (1992) additionally showed that these 
permeability increases induced by PMA occurred without an accompanying 
increase in intracellular Ca^+ levels thereby providing further evidence for 
a dissociation of Ca2 + from a role as a necessary mediator of permeability 
increases.
In contrast, using human umbilical vein endothelial cells, Yamada et al. 
(1990a) found that both PMA and another phorbol ester which activates
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protein kinase C, oleoyl acetyl glycerol (OAG), caused a decrease in basal 
monolayer permeability, whilst Morel et al. (1990) showed that PMA 
prevented endothelial cell contraction induced by angiotensin II in cultured 
bovine pulmonary microvessel endothelial cells.
Evidence however exists that protein kinase C mediates the permeability 
increases induced by various agents. Lynch et al. (1990) showed that H7, 
a protein kinase C inhibitor, prevented the increases in albumin permeability 
of bovine pulmonary artery endothelial cell monolayers induced by PMA, 
thrombin and phospholipase C which is believed to activate protein kinase 
C through the formation of diacylglycerol (DAG).
1.2.6 Role of cyclic nucleotides in the regulation of endothelial 
barrier function
yclic AMP has been shown to have a regulatory effect on the
permeability of epithelium in which it has been demonstrated to 
enhance tight junction integrity (Duffey et al., 1981). Additionally, (3- 
adrenoceptors agonists, which stimulate adenylate cyclase causing cyclic 
AMP production, have been shown in vivo to inhibit the endothelial 
permeability increases induced by various inflammatory mediators in the 
hamster cheek pouch (Svensjo et al., 1979; Svensjo & Grega, 1986). Also, 
P-adrenoceptors agonists have been shown in intro to inhibit both the 
PAF- (Grigorian & Ryan, 1987) and thrombin- (Minnear et al., 1989) induced 
permeability increases in monolayers of bovine pulmonary artery endothelial 
cells, to inhibit the PMA-induced permeability increase in monolayers of 
porcine aortic endothelial cells (Gudgeon & Martin, 1989) and to cause the 
relaxation of bovine pulmonary microvessel endothelial cells (Morel et al.,
1990).
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More direct evidence for a role of cyclic AMP in inhibiting increases in 
endothelial permeability has been obtained both using forskolin, which 
directly activates adenylate cyclase, and from the effects of addition of 
stable analogues of cyclic AMP, such as dibutyryl cyclic AMP and 8  bromo 
cyclic AMP. Forskolin has been shown to inhibit the permeability increase 
induced by PMA in monolayers of porcine aortic (Gudgeon & Martin, 
1989), as well as bovine pulmonary artery and bovine aortic (Buchan & 
Martin, 1992) endothelial cells, and also to inhibit the permeability increase 
induced by thrombin in monolayers of bovine pulmonary artery endothelial 
cells (Buchan & Martin, 1992). Additionally, it has been shown, in itself, 
to decrease the permeability of monolayers of bovine pulmonary artery 
(Stelzner et al., 1989) and human umbilical vein (Yamada et al., 1990a) 
endothelial cells.
Dibutyryl cyclic AMP has also been shown to decrease the basal permeability 
of monolayers of bovine pulmonary artery (Stelzner et al., 1989) and 
human umbilical vein (Yamada et al., 1990a) endothelial cells and to 
inhibit the permeability increase induced by PMA in monolayers of porcine 
aortic endothelial cells (Gudgeon & Martin, 1989). In addition, 8  bromo 
cyclic AMP has been shown to decrease the basal permeability of 
monolayers of bovine aortic endothelial cells (Oliver, 1990).
Cyclic GMP has also been shown to exhibit a regulatory effect on endothelial 
permeability. The membrane-permeant cyclic GMP analogues, 8  bromo 
cyclic GMP and dibutyryl cyclic GMP, were found to decrease basal 
permeability in monolayers of human umbilical vein endothelial cells 
(Yamada et al., 1990a) and, additionally, 8  bromo cyclic GMP was found 
to inhibit the thrombin-induced permeability increase in monolayers of 
bovine pulmonary artery cells (Buchan & Martin, 1992). In contrast to 
agents which elevate cell cyclic AMP levels, however, 8  bromo cyclic GMP
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was found to have no effect on the permeability increases induced by PMA 
in monolayers of porcine aortic endothelial cells (Gudgeon & Martin, 1989), 
or in monolayers of either bovine aortic or bovine pulmonary artery 
endothelial cells (Buchan & Martin, 1992).
1.2.7 Role of endothelial barrier function in the inflammatory
decrease in endothelial barrier function is a fundamental aspect of
the inflammatory process, the mechanism by which the body responds 
both to microbial infection and to cell or tissue injury. This decrease is 
important since it facilitates the entry, to a site of injury, of cells and 
mediators produced by the body to fight infection and to deal with tissue
The first observable effects of the inflammatory process are those of 
haemodynamic changes which result initially in a substantial increase in 
blood flow to a site of injury. This is followed by a reduction in blood 
flow, a decrease in endothelial barrier function and the exudation of fluid 
to produce oedema. The initial increase in blood flow is brought about by 
the release of vasodilators some of which have also been shown to increase 
oedema formation, including histamine (Marciniak et a l, 1978), prostacyclin 
(Rampart & Williams, 1986), prostaglandin E2  and PAF (Svensjo & Grega,
1 9 8 6 ), and these may therefore initiate the decrease in endothelial barrier 
function. Histamine and PAF, as well as leukotriene B4 , have also been 
shown to contribute towards the attraction, migration and activation of 
neutrophils and these contribute to the later, more sustained phase of 
decreased endothelial barrier function (Kubes, 1993).
process
injury.
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The decrease in endothelial barrier function at the site of inflammation 
enables a variety of mediators to enter the interstitial space from the 
bloodstream. These include components of the complement, coagulation, 
fibrinolytic and kinin systems. Many of these mediators themselves 
contribute to the decrease in barrier function including bradykinin, which 
can act directly on the endothelium (Svensjo et al., 1979), as well as 
complement 3a and complement 5a. Both of these complement components 
act indirectly to decrease barrier function through the release of histamine, 
whilst complement 5 a additionally does so by acting as a chemoattractant 
for leucocytes including neutrophils.
Many cell types which are normally only present in the blood gain access 
to tissues during inflammation as a result of the decrease in endothelial 
barrier function. Polymorphonuclear leucocytes, including neutrophils, 
eosinophils and basophils, are the first leucocytes to appear at the site of 
inflammation from the bloodstream. Neutrophils and eosinophils attack 
invading organisms, which they can engulf and digest, and neutrophils can 
also release damaging reactive oxygen species (Martin, 1984; Ward et al., 
1983) which can further impair endothelial barrier function (Shasby et al.,
1983). Monocytes/macrophages enter the area of inflammation several hours 
later. They can also engulf micro-organisms as well as dead cells and 
tissue debris, and play a role in the repair process. As well as enzymes, 
they can secrete complement components, eicosanoids and also cytokines 
such as interleukin- 1 and interferon-y, both of which have also been shown 
to impair endothelial barrier function (Campbell et al., 1992; Burke-Gaffney 
& Keenan, 1993b; Burke-Gaffney & Keenan, 1993a).
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1.2.8 In vitro techniques for the assessment of endothelial barrier 
function
ver the last 1 0 - 1 5  years, various in vitro models have been developed
to determine the effects of exogenously added agents on endothelial 
barrier function. Such in vitro techniques afford many advantages over 
in vivo techniques. For instance, they enable the effects of agents to be 
tested directly on endothelial cells themselves, whilst eliminating any 
potentially conflicting and com plicating effects these agents may 
simultaneously be having on other cell types. Also, other physiological 
effects of the agents being studied which may indirectly affect endothelial 
barrier function, such as those on blood pressure and blood flow, are 
circumvented, thereby ensuring only direct actions on barrier function are 
observed.
In vitro techniques also enable the employment of more precise control 
over drug concentrations used and allow hydrostatic gradients across the 
endothelial barrier to be more carefully regulated, thereby facilitating a 
greater degree of reproducibility in experimental conditions than that 
afforded by in vivo models. Potentially, in vitro models also allow a more 
rapid throughput of experimental testing and may, through the use of cell 
culture, reduce the cost in animal life required.
The first in intro models employing monolayers of cultured endothelium 
were established to investigate the migration of other cell types through 
these monolayers. Using a model system previously established to investigate 
the adherence of granulocytes (Beesley et al., 1978), the migration of 
granulocytes through monolayers of porcine endothelial cells isolated from 
the post-caval vein, was studied (Beesley et al., 1979). Granulocytes were 
added in suspension to endothelial monolayers cultured both on glass
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coverslips and in plastic wells. After an incubation period involving 
continuous agitation, the cell preparations were appropriately stained and 
both light and electron microscopy were then used to visualise the extent 
to which granulocytes had migrated across the monolayers.
In 1981, Taylor et al. demonstrated the use of a two-chamber system both 
to study the migration of neutrophils across monolayers of bovine aortic 
endothelial cells and to measure the permeability of these monolayers to 
albumin. Cell monolayers were first grown on polycarbonate micropore 
filters. Each polycarbonate filter was placed on top of a nitrocellulose filter 
to which it was sealed using a silicone ring, and a chamber was constructed 
around these filters to yield an upper compartment above the cell 
monolayers and a lower compartment below, these representing the luminal 
and abluminal sides of the endothelium in vivo, respectively. Either 51cr- 
labelled neutrophils or 125i-labelled albumin was placed above the 
monolayer which was then incubated at 37°C. After an appropriate 
incubation period, samples were removed from each upper and lower 
chamber and counted for radioactivity to assess the extent to which the 
neutrophils or albumin had crossed the endothelial monolayer. Using this 
model, endothelial monolayers were found to restrict the passage of both 
albumin and neutrophils compared to that obtained in the absence of 
monolayers, and it was found that addition of the chemoattractant F-met- 
leu-phe to the lower chamber could stimulate neutrophil migration. Thus, 
the model was concluded to be a useful one for studying both neutrophil 
migration and the transfer of albumin across monolayers of cultured 
endothelial cells.
This model as first established by Taylor et a l  has formed the basis of 
many subsequently developed models to assess endothelial barrier function 
in vitro. Such models are all based on the principle of a two-chamber
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system in which monolayers of endothelial cells cultured on polycarbonate 
membranes form the junction between the two chambers. Moreover, they 
have been used extensively to study the effects of various agents on the 
albumin permeability of endothelial monolayers of various tissues including 
porcine pulmonary artery (Shasby et al., 1982; Wilson et al., 1990), human 
umbilical vein (Rotrosen & Gallin, 1986; Casnocha et al., 1989), porcine 
aorta (Gudgeon & Martin, 1989), bovine pulmonary artery (Stelzner et al., 
1989; Phillips et al., 1989; Lum et al., 1989), bovine aorta (Baron et al., 
1989), ovine pulmonary artery (Bechard et al., 1990) and rat coronary 
microvessels (Watanabe et al., 1991). In these studies albumin was either 
radiolabelled, or labelled with a dye such as trypan-blue (Rotrosen & 
Gallin, 1986) which facilitates quantification of albumin transfer by a 
colourometric assay. Alternatively, albumin has been quantified by its 
reaction with bromcresol green to yield a product detectable by measuring 
its absorbance at 630 nm (Shasby et al., 1982).
Albumin is widely used as a marker of endothelial barrier function since 
it is present in the blood and is regarded as a major determinant of 
endothelial hydraulic conductivity (McCandless et al., 1991). Other tracer 
molecules have also been used to determine endothelial barrier function 
in similar two-chamber models including water (Baetschler & Brune, 1983; 
Suttorp et al., 1988; Malik et al., 1989), horseradish peroxidase (Furie et 
al., 1984), low density lipoprotein (Territo et al., 1984; Hennig et al., 
1985), inulin (Brett et al., 1989; Ogawa et al., 1992), sorbitol (Brett et al., 
1989; Ogawa et al., 1992) and culture medium (Schnittler et al., 1990). 
Beynon et al. (1993) demonstrated a model in which the passage of 125i- 
labelled anti-FITC antibody across endothelial monolayers was measured, 
having firstly coated the polycarbonate membranes on which the monolayers 
were grown with FITC-labelled fibronectin.
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In the majority of these studies, macromolecular transfer is measured in 
the absence of a hydrostatic gradient, although some workers have 
conducted experiments under a specifically determined hydrostatic gradient 
(Baetschler & Brune, 1983; Suttorp et al., 1988; Suttorp et al., 1991). 
Suttorp et a l  (1988) showed that maintaining a constant hydrostatic gradient 
across porcine pulmonary artery endothelial monolayers produced a slowly 
developing decrease in the basal permeability of the monolayers to both 
water and albumin which stabilised after a period of approximately 1 5 0  
minutes. They suggested that this represented a “sealing” of the monolayers 
and argued that the use of a hydrostatic gradient represented a more 
physiologically relevant situation since hydrostatic gradients exist in vivo.
Endothelial barrier function has also been studied more simplistically by 
using microscopy to visualise morphological changes and the formation of 
intercellular gaps in endothelial cells monolayers exposed to various agents 
(Antonov et a l, 1986). Additionally, fluorescence microscopy has been 
used to visualise appropriately stained cytoskeletal components of cultured 
endothelial cells and to observe the responses obtained on the organisation 
of these components following the addition of agents which affect 
endothelial barrier function (Morel et a l, 1990; Camussi et a l, 1991).
Another method of assessing barrier properties of cultured endothelial 
monolayers is to measure the electrical resistance across them. Furie et a l  
(1984) demonstrated that after a sufficient growth period, monolayers of 
bovine microvascular endothelial cells generated an electrical resistance 
above basal levels obtained in the absence of cells, and suggested that the 
level of electrical resistance across a monolayer could be taken as an 
indicator of its integrity. Electrical resistance measurements have been 
used to assess the effects of hydrogen peroxide on endothelial barrier 
function (Yamada et a l, 1 9 9 0 b) and to detect shape changes in endothelial
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cells in response to thrombin (Tiruppathi et al., 1992). They have also 
been used to establish monolayer integrity prior to utilising monolayers for 
macromolecular transfer studies (Territo et al., 1984) and have been used 
to correlate with macromolecular transfer studies (Yamada et al., 1990a).
A variant on the two-chamber systems used in macromolecular transport 
studies is the culture of endothelial cells on microcarrier beads. In a model 
described by Boiadjieva et al. (1984), the passage of trypan blue was 
measured across confluent bovine aortic and bovine pulmonary artery 
endothelial cells grown on microcarrier beads. Cells on microcarrier beads 
were suspended in buffer containing trypan blue, agitated and sampled at 
intervals. The extent to which the trypan blue had crossed the endothelial 
cells and entered the underlying microcarrier beads was then determined 
as an indicator of the barrier function of the endothelium. Killackey et al. 
(1986) described a similar system in which Evans blue was used as an 
indicator of the barrier function of human umbilical vein endothelial cells.
Over the past 10-15 years, in vitro models of the endothelial barrier have 
enabled a greater insight to be obtained into the many regulatory 
mechanisms which control the permeability of the endothelium. They are 
therefore valuable tools for investigating the actions of the many and 
various agents which have been observed to affect endothelial barrier 
function.
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C h a p t e r  2
2.1 Reactive oxygen species
Reactive oxygen species play a wide role in the pathogenesis of many clinical conditions, a selection of which is shown in Table 2.1. The 
term “reactive oxygen species” includes “oxygen-derived free radicals”, 
such as superoxide anion and hydroxyl radicals, as well as other related 
species, such as hydrogen peroxide, hypochlorous acid and singlet oxygen, 
which are not in fact radicals but are nonetheless important damaging 
species. (The term “radical” is generally taken to refer to molecules which 
contain a single unpaired electron thus rendering them highly reactive.)
Reactive oxygen species also play an important physiological role. They 
are released, for example, by phagocytic cells (such as macrophages, 
monocytes, neutrophils and eosinophils) as part of the inflammatory 
response to kill invading micro-organisms (Halliwell, 1982; Ahnfelt-Ronne, 
1 9 9 1 ) and also have been implicated in contributing to the ageing process 
(Halliwell & Gutteridge, 1989). Certain cellular enzymes, such as ribo­
nucleotide reductase additionally utilise reactive oxygen species in a catalytic 
role (Reichard & Ehrenberg, 1983).
Under normal conditions, the major source of “accidental” reactive oxygen 
species formation is from electron “leakage” from electron transport chains, 
whilst “leakage” of reactive oxygen species can also occur through the 
actions of phagocytes (see Cheeseman & Slater, 1993 for review). Reactive 
oxygen species can also be produced by the actions of flavin oxidases 
present in peroxisomes and through the autoxidation of various compounds 
including ascorbate, thiols (e.g. glutathione, cysteine, homocysteine),
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Inflammatorv-immune iniurv Red blood cells Gastrointestinal tract
Glomerulonephritis (idiopathic, Phenylhydrazine Endotoxic liver injury
membranous) Primaquine, related drugs Halogenated hydrocarbon liver
Vasculitis (hepatitis B vims, drugs) Lead poisoning injury (e.g. carbon tetrachloride,
Autoimmune diseases Protoporphyrin photoxidation bromobenzene, halothane)
Rheumatoid arthritis Malaria Diabetogenic action of alloxan
Sickle cell anaemia Pancreatitis
Ischaemia-reflow states Favism NSAID-induced gastrointestinal
Stroke/myocardial infarction/ Fanconi’s anaemia tract lesions
arrythmias 
Organ transplantation
Haemolytic anaemia of prematurity Oral iron poisoning
Inflamed rheumatoid joint Lung Brain/nervous svstem /
Frostbite Cigarette smoke effects neuromuscular disorders
Dupuytren’s contracture? Emphysema Hyperbaric oxygn
Hyperoxia Vitamin E deficiency
Drua and toxin-induced reactions Bronchopulmonary dysplasia Neurotoxins
Numerous Oxidant pollutants (ozone, nitric Parkinson’s disease
oxide) Hypertensive cerebrovascular
Iron overload ARDS (some forms) injury
Idiopathic haemochromatosis Mineral dust pneumoconiosis Neuronal ceroid lipofuscinoses
Dietary iron overload (Bantu) Asbestos carcinogenicity Allergic encephalomyelitis and
Thalassaemia and other chronic Bleomycin toxicity other demyelinating diseases
anaemias treated with multiple Sulphur dioxide toxicity Aluminium overload (Alzheimer’s
blood transfusions Paraquat toxicity disease?)
Nutritional deficiencies Potentiation of traumatic injury
(kwashiorkor) Skin Muscular dystrophy
Solar radiation Multiple sclerosis
Alcoholism Thermal injury
including alcohol-induced iron Porphyria Heart and cardiovascular svstem
overload and alcoholic myopathy Hypericin, other photosensitizers Alcohol cardiomyopathy
Contact dermatitis Keshan disease (selenium
Radiation iniurv deficiency)
Nuclear explosions Eve Atherosclerosis
Accidental exposure Cataractogenesis Adriamycin cardiotoxicity
Radiotherapy Ocular haemorrhage
Hypoxic cell sensitizers Degenerative retinal damage Kidnev
Retinopathy of prematurity Autoimmune nephrotic syndromes
Aqeinq (retrolental fibroplasia) Aminoglycoside nephrotoxicity
Disorders of premature ageing Photic retinopathy Heavy metal nephrotoxicity (Pb, 
Cd, Hg)
ARDS—adult respiratory distress syndrome 
NSAID—non-steroidal anti-inflammatory drug
Table 2.1 Clinical conditions in which the involvement of reactive oxygen 
species has been implicated. Reproduced from Halliwell & Gutteridge (1989).
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adrenaline and flavin co-enzymes. Generally, this accidental production of 
reactive oxygen species is kept to a minimum both by the high efficiency 
of enzyme-mediated electron transfer processes and by keeping transition 
metal ions, which may catalyse the production of certain species (see 
below), tightly chelated. Since these precautions are not fully efficient, 
both enzymic and non-enzymic defence mechanisms also exist within cells 
to cope with normal low levels of reactive oxygen species production. 
When this production exceeds normal levels, however, such as in the 
presence of toxic agents or in certain disease conditions, cellular and 
tissue damage may occur.
2.1.1 Superoxide anion
Superoxide anion (-0 2 ')  is produced in many pathological states which cause alterations in metabolic pathways resulting in the incomplete 
reduction of oxygen (McCord, 1987). This reduction involves the transfer 
of a single electron as follows:
O2 + e —^ 0 2
In itself, superoxide anion it is not believed to be widely toxic, but it is 
able both to initiate many radical chain reactions (Link & Riley, 1988) and 
to give rise to the production of other more damaging species such as 
hydrogen peroxide (see below). At low pH it will protonate to form the 
more reactive perhydroxyl radical (-HC^), but at physiological pH less 
than 1% of superoxide anion is found in this form (Cheeseman & Slater, 
1993).
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2 .1.2 Hydrogen peroxide
Chapter 2
Hydrogen peroxide (H2 O2 ) is formed spontaneously from superoxide anion by the dismutation reaction:
'0 2 + 0 2 + 2H+ —> H20 2 + 0 2
This reaction will occur comparatively slowly on its own but in the presence 
of superoxide dismutase, it will occur substantially more quickly, resulting 
in the rapid removal of superoxide anion. Superoxide dismutase is present 
in a large number of cell types and acts as a natural defence against the 
production of superoxide anion.
Hydrogen peroxide is potentially more toxic than superoxide anion since, 
unlike superoxide, it is freely able to diffuse across cell membranes and 
can directly attack certain target components within the cell such as the 
glycolytic enzyme, glyceraldehyde-3-phosphate dehydrogenase (Halliwell 
& Chirico, 1993). Its major significance as a cytotoxic agent is thought to 
lie in its ability to generate hydroxyl radicals in the presence of transition 
metals (see below).
The breakdown of hydrogen peroxide may be catalysed by the enzyme, 
catalase, according to the equation:
2H20 2 catalase > 2H20  + 0 2
Like superoxide dismutase, catalase is also present in many cell types and 
acts as a natural defence against the production of hydrogen peroxide. 
Additionally, many cells possess the enzyme, glutathione peroxidase which 
also protects against hydrogen peroxide by catalysing its reaction with
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reduced glutathione to form glutathione disulphide and water (Smith et a l, 
1989). In the absence of metal catalysts, it is therefore readily removed 
from biological systems, as is superoxide anion, rendering it fairly harmless 
(Cheeseman & Slater, 1993).
2.1.3 Hydroxyl radicals
Hydroxyl radicals (-OH") may be formed in the combined presence of superoxide anion, hydrogen peroxide and trace amounts of ferric 
iron which catalyses its formation by the Fenton reaction, thus:
Fe3+ + 0 2 -> Fe2+ + 0 2
Fe2+ + H20 2 -> Fe3+ + OH + OH'
Ferric iron (Fe3+) is stored within cells as ferritin, a form in which it is 
susceptible to attack from superoxide anion by the above reaction thus 
making it a potential source of available iron. Ferrous iron (Fe2+) is therefore 
formed and, as shown, can react with hydrogen peroxide to generate 
hydroxyl radicals. Additionally, the formation of hydroxyl radical from 
hydrogen peroxide can be catalysed by cuprous copper (Cu+), which may 
similarly be produced by reaction of superoxide anion with stored forms 
of cupric copper (Cu2 +), such as caeruloplasmin which is present in the 
circulation (Cheeseman & Slater, 1993).
Hydroxyl radicals are believed to be substantially more reactive than either 
superoxide anion or hydrogen peroxide and are able to attack biological 
molecules, usually by starting free-radical chain reactions (Halliwell & 
Gutteridge, 1989). In particular, hydroxyl radicals can initiate the process 
of lipid peroxidation (Halliwell & Chirico, 1993), a radical chain reaction
Page 52
M odulation o f  Endothelial Barrier Function Chapter 2
which results in the deterioration of polyunsaturated lipids, thereby impairing 
the integrity and function of cell membranes. Also, by attacking cellular 
DNA, causing both extensive strand breakage and degradation of 
deoxyribose, they may have a carcinogenic action (Halliwell & Gutteridge,
1984).
Being highly reactive, hydroxyl radicals have extremely short half-lives 
and therefore will not diffuse far within a cell from their site of production 
before reacting (Cheeseman & Slater, 1993). As such, they are capable of 
causing highly localised but extensive damage.
2.1.4 Hypochlorous acid
H ypochlorous acid (HOCl) is produced from hydrogen peroxide and chloride ions by the enzyme, myeloperoxidase, which is secreted by 
activated neutrophils (Harrison & Schultz, 1976). This reaction occurs as 
follows:
h 2o 2 + cr myeloperoxidase > HOCl + OH-
HOCl is believed to be the most toxic of the reactive oxygen species 
which neutrophils produce as part of the inflammatory response (Eley 
et a l, 1 9 8 9 ) and has been shown in vitro to be able to kill both bacteria 
and fungi (Halliwell & Gutteridge, 1989). Also, it is able to oxidise many 
biological molecules and, in particular, will attack thiol groups. For instance, 
it has been shown to disrupt contractile function in ventricular myocytes 
by attacking thiol-dependent Ca2+ transport mechanisms (Eley et a l, 1991).
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2.1.5 Peroxynitrite anion
Chapter 2
Peroxynitrite anion (ONOO-) may be formed by interaction of nitric oxide and superoxide anion by the following reaction as was proposed 
by Beckman et al. (1990):
NO + 0 2' -> ONOCT
As well as being a strong oxidant in itself, with a half-life of round a 
second, Beckman et al. also showed that peroxynitrite can act as the 
source of a strong oxidising agent with properties identical to those of the 
hydroxyl radical. They proposed that this may be explained by its ability 
to undergo decomposition to generate hydroxyl radical as follows:
ONOO" + H+ -> ONOOH
ONOOH -> OH + N 0 2
Hence, peroxynitrite may represent another pathway, in addition to the 
Fenton reaction, by which hydroxyl radical may be formed in biological 
systems and by a mechanism that does not require the presence of iron 
to act as a catalyst.
Furthermore, it has been suggested that peroxynitrite can be generated by 
cells such as macrophages, neutrophils, and possibly the vascular 
endothelium, by the simultaneous generation of both superoxide anion 
and nitric oxide (Hogg et al., 1992).
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2.2 Ischaemia-reperfusion injury
Chapter 2
2.2.1 Ischaemia
he deprivation of oxygen i.e. ischaemia from a region of either the
heart or the brain is a major cause of death in current Western society. 
The extent of the damage caused to the affected tissue is dependent on 
both the duration of the ischaemic period and on the extent of the level 
of oxygen deprivation (Braunwald & Kloner, 1986; Simpson & Lucchesi,
1987). If the ischaemic period is short then recovery of the tissue will 
occur, but with longer periods of ischaemia the damage becomes irreversible 
and cell death will result.
Ischaemia results from arterial blockage which prevents the supply to the 
affected area of oxygenated blood. The most common causes of such a 
blockage are that of atherosclerosis (see Section 2.3) and thrombosis.
2.2.2 Reperfusion
R eperfusion of an ischaemic tissue provides both beneficial and deleterious effects. Unless the period of ischaemia has been sufficiently 
long to render cell death in the affected tissue, reperfusion will ultimately 
prevent such cell death and facilitate tissue recovery (Halliwell & Gutteridge, 
1989). Coupled with this restorative effect, however, reperfusion will also 
result in a fresh wave a cell injury including a hastening of the necrosis of 
irreversibly injured cells, cell swelling, an incomplete restoration of blood 
flow (the so-called “no-reflow” phenomenon), haemorrhagic infarction, 
post-ischaemic depression of ventricular function in the heart (myocardial 
“stunning”) and the production of reactive oxygen species (Braunwald &
Kloner, 1986).
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2.2.3 The hypoxanthine-xanthine oxidase free radical generating
he hypoxanthine-xanthine oxidase system has been implicated in
playing a major role in the damage resulting from ischaemia and 
reperfusion. The first evidence for a role of this system in hypoxic injury 
was shown in the late 1960’s. Jones et al. (1968) demonstrated that following 
hypoxia induced by haemorrhage in dogs, there was an accumulation 
within the blood of uric acid, a product of the hypoxanthine-xanthine 
oxidase system. Subsequent work showed that allopurinol, a xanthine 
oxidase inhibitor, exhibited a considerable protective effect on ischaemia- 
induced impairment of myocardial function in the hearts of both dogs and 
sheep (Crowell et a l, 1969; DeWall et a l, 1971). Similarly, allopurinol has 
been shown to inhibit reperfusion-induced injury in the kidney (Hansson 
et a l, 1983) and liver (Adkison et a l, 198 6 ).
During ischaemia, the absence of oxygen forces the purine, adenosine 
triphosphate to follow an anaerobic catabolic pathway leading to an 
accumulation of hypoxanthine within cells (McCord, 1987; Werns & 
Lucchesi, 1990). This pathway is illustrated in Figure 2.1. At the same time, 
xanthine oxidase is formed within cells by conversion from its native state 
of xanthine dehydrogenase. This conversion was first demonstrated by 
Roy & McCord (1983) using segments of rat intestine and is believed to 
occur either by limited proteolysis (Phan et a l, 1989) or by an oxidation 
of essential thiol groups (Halliwell & Gutteridge, 1989).
Unlike xanthine dehydrogenase which uses NAD as an oxidant leading to 
the formation of NADH, xanthine oxidase utilises oxygen, thereby yielding 
superoxide anion on oxidation of either hypoxanthine or xanthine (Engerson 
et al, 1987). Hence, as oxygen once again becomes available on reperfusion,
system
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Figure 2.1 Pathway showing the formation of hypoxanthine under 
ischaemic conditions by the anaeorbic catabolism of adenosine triphosphate. 
ADP—adenosine diphosphate; AMP—adenosine monophophate; ATP— 
adenosine triphosphate.
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xanthine oxidase, as illustrated in Figure 2.2, will convert hypoxanthine to 
xanthine and then to uric acid producing superoxide anion in the process 
of both these reactions. The production of superoxide anion during 
ischaemia-reperfusion injury has been confirmed in many tissues including 
intestine (Granger et al., 1981; Parks et al., 1982), liver (Adkison et al., 
1 9 8 6 ) and skin (Im et al., 1 9 8 5 ) by the ability of superoxide dismutase, 
which rapidly converts superoxide anion to hydrogen peroxide, to inhibit 
the extent of the resultant tissue damage.
2.2.4 Role of neutrophils
Polymorphonuclear leucocytes, specifically neutrophils, have also been implicated in contributing to the injury induced by ischaemia- 
reperfusion (Romson et al., 1983; Grisham et al., 198 6 ). Neutrophils play 
a key role in the development of the inflammatory response (Siflinger- 
Birnboim & Malik, 1993) and have been shown to contribute to endothelial 
injury, increased microvascular endothelial permeability and tissue damage 
at sites of inflammation (Harlan, 1985; Sibille & Reynolds, 1990). In particular, 
neutrophils have been identified as a major mediator of the tissue injury 
associated with inflammatory bowel disease (Grisham et al., 1986).
Neutrophils secrete a wide variety of mediators including prostanoids and 
leukotrienes, as well as various digestive enzymes such as elastase which 
can induce endothelial cell detachment (Harlan et al., 1981). They also 
produce reactive oxygen species, including superoxide anion and hydrogen 
peroxide (Shasby et al., 1983; Siflinger-Bimboim et al., 1992) through the 
activity of a membrane-bound enzyme, NADPH oxidase (Rangan & Bulkley, 
1993). Additionally, neutrophils secrete the enzyme, myeloperoxidase, which 
catalyses the formation of the potent oxidant, hypochlorous acid, from 
hydrogen peroxide and chloride ions (Harrison & Schultz, 1976).
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Figure 2.2 Pathway showing the formation of superoxide anion during 
the xanthine oxidase-catalysed conversions of hypoxathine to xanthine 
and xanthine to uric acid.
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Various findings point to a role for neutrophils in the pathogenesis of 
ischaemia-reperfusion injury. In the heart, neutrophils have been observed 
to begin to infiltrate a site of injury at the onset of ischaemia with their 
numbers progressively increasing as the resultant myocardial infarct develops 
during the following 24 hours (Simpson & Lucchesi, 1987). Similarly, 
neutrophil infiltration has been documented in skeletal muscle following 
experimentally induced ischaemia and reperfusion (Smith et al., 1989). 
Romson et al. (1983) demonstrated that by using neutrophil anti-sera to 
reduce the numbers of circulating neutrophils, myocardial infarcts following 
experimentally induced coronary artery occlusion and reperfusion in dogs 
were reduced by up to 50%. Moreover, neutrophil adhesion to endothelium 
and migration into sub-endothelial tissue has been observed following 
similarly induced coronary artery occlusion and subsequent reperfusion by 
Mullane et al. (1984). They also demonstrated that infarct size could be 
significantly reduced using hydroxyurea, which depletes circulating 
neutrophils, or BW755C, a combined cyclo-oxygenase and lipoxygenase 
inhibitor which inhibits neutrophil infiltration.
A link between neutrophils and the hypoxanthine-xanthine oxidase system 
has been proposed by various workers. Grisham et al. (1986) proposed 
that superoxide anion or other oxidants, produced during ischaemia- 
reperfusion by activation of the hypoxanthine-xanthine oxidase system, 
may act to attract neutrophils to a site of injury. This possibly occurs 
through the formation of some potent chemoattractant formed either by 
activation of the complement system or through reaction with lipoproteins. 
At the same time, certain evidence points to the ability of neutrophils, in 
turn, to activate the hypoxanthine-xanthine oxidase system. Phan et al. 
(1 9 8 9 ) showed, for instance, that addition of neutrophils to cultured rat 
pulmonary artery endothelial cells stimulated the conversion of xanthine 
dehydrogenase to xanthine oxidase. Using an in vitro model of ischaemia-
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reperfusion injury to cultured bovine coronary microvascular endothelial 
cells, Inauen et al. (1988) showed that neither a protective effect on 
endothelial cytotoxicity nor cell detachment was seen on addition of either 
superoxide dismutase or allopurinol unless neutrophils were present. Also, 
they showed that addition of neutrophils enhanced the degree of injury 
that was obtained.
Granger (1988) described an overall scheme for the interactions of ischaemia- 
reperfusion, lipid peroxidation and activation of neutrophils as shown in 
Figure 2.3.
2.3 Atherosclerosis
therosclerosis is the primary cause of heart attacks, stroke and
gangrene, being responsible for about half of all deaths in Western 
civilisation (Ross, 1993). It is a progressive condition which is characterised 
by vascular lesions which are first observable as so-called “fatty streaks”. 
These then develop over a long period of time, by a complex and not 
fully-understood process, to more substantial and potentially-occlusive 
lesions characterised by intimal proliferation of smooth muscle cells and 
the deposition of intracellular and extracellular lipid (Ross & Harker, 1976).
2.3.1 The “response to injury” hypothesis
he “response to injury” hypothesis of the atherogenic process has
been advanced over the past twenty years or so and was recently 
outlined on current understanding by Ross (1993). The trapping of 
lipoproteins at various arterial sites, coupled with the appearance of adhesive 
glycoproteins on the surfaces of endothelial cells, is believed to attract 
both monocytes and T lymphocytes. These migrate across the endothelial
Page 61
M odulation o f  Endothelial Barrier Function Chapter 2
Microvascular injury
Oxidants >  Proteases
CD
ctJ-c:oco
AMP
4
Adenosine
4
Inosine
Xanthine
Dehydrogenase
Hypoxanthine
i
Xanthine
Oxidase
~ r
Polymorphonuclear leukocytes
t
Lipid hydroperoxidest
OHA
Fe3+
/ \
■> Uric a c id +  0 2' +  H20 2
0,
Reperfusion
Figure 2.3 Schematic representation of the development of ischaemia- 
reperfusion-induced microvascular injury as proposed by Granger (1988). 
A suggested link between xanthine oxidase-derived reactive oxygen species, 
lipid peroxidation and activation of polymorphonuclear leukocytes is shown.
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cell layer under the influence of both chemoattractants and growth factors 
which are released from the endothelium, adherent leucocytes and possibly 
underlying smooth muscle cells. The monocytes become macrophages, 
accumulate lipid and then become foam cells which in combination with 
lymphocytes form the basis of the fatty streak. Continued cell infiltration 
and proliferation leads to the development of more advanced lesions, and 
ultimately to the formation of fibrous plaques.
2.3.2 Role of endothelial dysfunction
By facilitating the initial migration across the endothelium of monocytes and lymphocytes, endothelial dysfunction, including barrier dys­
function, is clearly an important early step in the atherogenic process 
(Ross, 1986). It is reasonable therefore to hypothesise that factors which 
are injurious to the endothelium will act as risk factors for the development 
of atherosclerosis. Oxidised low-density lipoprotein, for example, is believed 
to play a significant role in promoting such migration through causing 
direct injury of the endothelium and also through inducing the formation 
of cell-surface adhesion molecules. Also, substances which initiate the 
generation of reactive oxygen species such as homocysteine (see below) 
could act as risk factors for atherosclerosis through causing injury to the 
endothelium.
2.4 Homocystinuria
The condition of homocystinuria is a recognised risk factor for the development of atherosclerosis (Malinow, 1990). It is so named as it 
can be characterised by an elevated level of homocystine secretion in 
urine. Homocystine is the disulphide form of the thiol-containing amino 
acid, homocysteine, an intermediate formed during the metabolism of both
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methionine and cysteine (Refsum & Ueland, 1990). Defects in the 
metabolism of homocysteine, most commonly caused by a deficiency of 
cystathionine (3-synthase (Clarke et al., 1992), lead to an accumulation of 
both homocysteine and homocystine in the circulation, rising from a 
combined level of -10 pM  in normal subjects (Boers et al., 1985) to as 
high as 250 pM  in homozygotic homocystinura sufferers (Perry et a l, 
1967).
Several studies have demonstrated a link between high circulating levels 
of hom ocyst(e)ine (hyperhom ocyst(e)inem ia) and the prem ature 
development of vascular disease including cerebrovascular (Brattstrom et al., 
1984), peripheral vascular (Boers et al., 1985) and coronary vascular disease 
(Kang et al., 1986; Clarke et al., 1992). The mechanisms underlying the 
atherogenic actions of homocysteine are however unclear. Significant platelet 
accumulation has been observed at sites of vascular injury and at occlusive 
thrombi in both human sufferers and experimental models of homocystinuria 
(Harker et al., 1974; Harker et al., 1976 ) whilst, additionally, a direct 
stimulatory action of homocysteine on platelet aggregation has been reported 
(Graeber et al., 1982; McCully & Carvalho, 1987).
In  vitro studies have demonstrated the ability of homocysteine to exert a 
cytotoxic action on cultured endothelium (Wall et al., 1980; Starkebaum & 
Harlan, 1986), confirming in vivo observations of homocysteine-induced 
endothelial injury (Harker et al., 1976; Harker et al., 1983). Starkebaum & 
Harlan (1986) proposed that the injury observed in their study resulted 
from the production of hydrogen peroxide during the copper-catalysed 
oxidation of homocysteine to homocystine (see Figure 2.4). This proposal 
was based on the findings that homocysteine-induced endothelial injury, 
as measured by a 51cr-release assay, was dependent on the presence of 
copper in the form of either copper sulphate or caeruloplasmin, and 
additionally was abolished in the presence of catalase.
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Figure 2.4 Pathway showing the production of reactive oxygen species 
during the copper-catalysed oxidation of homocysteine to its disulphide 
form, homocystine.
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C h a p t e r  3
3.1 Septic Shock
Septic shock, often caused by lipopolysaccharide (LPS) derived from gram-negative bacteria, is a condition which is growing in incidence. 
In the USA, for example, there are around 200,000 cases of septic shock 
currently diagnosed each year with around half of these cases resulting in 
death (Martin & Silverman, 1992). The main characteristics of septic shock 
are profound, persistent hypotension, hyporeactivity to vasoconstrictor 
agents, increased endothelial permeability, inadequate tissue perfusion, 
vascular damage and intravascular coagulation leading, in time, to multiple 
organ failure (Bone, 1991a; Wright et a l 1992).
The majority of deaths from septic shock occur rapidly, within hours to 
days of onset, usually as a direct result of the persistent hypotension. 
About 25% of deaths, however, occur days to weeks after successful 
treatm ent for hypotension and are usually a consequence of the 
development of multiple organ failure (Martin & Silverman, 1992).
Septic shock is a severe shock state which follows on from the development 
firstly of sepsis and then, subsequently, the sepsis syndrome. Bone (1991b) 
attempted to define these different stages in the development of septic 
shock as follows:
Sepsis—clinical evidence of infection plus tachycardia, increased rate 
of respiration and either hyperthermia or hypothermia.
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The sepsis syndrom e—as sepsis plus evidence of altered organ 
perfusion.
Early septic shock—as sepsis syndrome plus hypotension (systolic 
blood pressure below 90 mm Hg or a 40 mm Hg decrease below 
baseline systolic blood pressure) which is responsive to conventional 
therapy within 1 hour of commencement of treatment.
Refractory septic shock—as sepsis syndrome plus hypotension 
(systolic blood pressure below 90 mm Hg or a 40 mm Hg decrease 
below baseline systolic blood pressure) which is not responsive to 
conventional therapy within 1 hour of commencement of treatment.
Septic shock is a serious condition, which develops in about 40% of patients 
with sepsis, and its diagnosis indicates a poor prognosis (Bone, 1991a). 
Different studies, however, have indicated different mortality rates in patients 
who have developed septic shock, ranging from 10% (Cunnion & Parillo,
1989), through 40-50% (The Veterans Administration Systemic Sepsis 
Cooperative Study Group, 1987; Tran et al., 1990) to as high as 90% in one 
study (Parker & Parillo, 1983).
3.1.1 Causes of septic shock
Septic shock, as already stated, is often caused by LPS derived from gram-negative bacteria and is triggered following its release into the 
circulation (Bone, 1991a). LPS from gram-negative bacteria only accounts 
for around 30% of septic shock cases (Bone et al., 1987), however, and 
several other substances have been observed to trigger its onset. These 
include enterotoxin, toxic shock syndrome toxin-1 , cell wall products
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released from both gram-positive bacteria and yeast, and also both viral 
and fungal antigens (Fong et al., 1988; Tracey et al., 1988).
3.1.2 Lipopolysaccharide (LPS)
LPS, which is also known as endotoxin, is a component of bacterial outer cell walls. Its structure varies from species to species but, in 
general, consists of three distinct elements (Westphal et al., 1 9 8 3 ):
R egion I—an O-antigen-specific polysaccharide chain made up of 
repeating oligosaccharide units.
R egion n —an R-antigen-specific core polysaccharide containing both 
an inner and an outer core.
Region HI—a lipid domain, termed Lipid A.
Region I varies quite widely from species to species and carries the primary 
antigenicity of the associated bacterium (Liao & Floren, 1993). In contrast, 
both the core portion of the molecule, Region II, and the Lipid A portion, 
Region III, posses a morphology which is well conserved amongst different 
bacterial species and genera (Priest et al., 1989), with Lipid A having been 
recognised as the region of the molecule which is mainly responsible for 
its ability to activate the host’s immune system (Ltideritz et al., 1973).
3.1.3 The pathogenesis of septic shock
The pathogenesis of septic shock and its preceding conditions is one which is complex and in which many factors are involved. Bone 
(1 9 9 1 a), however, proposed that one key factor is that of endothelial
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dysfunction, in particular barrier dysfunction which results from repetitive, 
focused sites of inflammation thereby leading to a substantial increase in 
capillary permeability and contributing to a deterioration in organ perfusion. 
Such endothelial injury may become widespread and lead to the failure of 
various organs including heart, kidneys, brain, intestine and liver as well 
as leading, in some cases, to the development of the adult respiratory 
distress syndrome as a result of lung failure (Martin & Silverman, 1992).
On its release into the circulation, LPS is known to trigger a cascade of 
events leading to an increase in the circulation of many different mediators, 
all of which may contribute to the eventual development of sepsis and 
septic shock (shown schematically in Figure 3.1). LPS, for example, is 
believed to directly stimulate the release of tumour necrosis factor-a (TNF-a), 
interleukin-1, interleukin-6 , interleukin-8  and platelet activating factor (PAF) 
from a variety of cells including both macrophages and endothelial cells 
themselves (Wolff, 1973; Michalek et al., 1980; Johnston, Jr, 1988; Tracey 
et al., 1989). The precise role played by each of these mediators is not 
clear, but many play a role in triggering the release of further mediators to 
generate the “sepsis cascade”. For instance, both the complement system 
and the coagulation cascade are subsequently activated although it is not 
in fact known whether this is caused by LPS directly, or through LPS- 
stimulated release of TNF-a or some other mediator (Bone, 1991a). Following 
the release of TNF-a, interleukin-1 and PAF, the formation of arachidonic 
acid metabolites is stimulated. These include leukotrienes, thromboxane A2 , 
and prostaglandins (particularly prostaglandin E2  and prostacyclin) (Petrak 
et al., 1989). At the same time, interleukin-1 and interleukin- 6  will activate 
T cells leading to the production on interferon-y (IFN-y), interleukin-2, 
interleukin-4 and granulocyte-monocyte colony-stimulating factor (Dinarello 
& Mier, 1987; Jacobs & Tabor, 1989; Kuhweide et al., 1990; Thornhill et al.,
1990).
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Figure 3.1 Schematic representation of the pathogenesis of septic shock. 
Modified from Bone (1991b). IFN-y—interferon-y; IL-1—interleukin-1; 
IL-2—interleukin-2; IL-6—interleukin-6; PAF—platelet activating factor; 
TNF-a—tumour necrosis factor-a.
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Virtually all of these agents can exert a direct action on the vascular 
endothelium and many have been shown to have the ability to induce 
endothelial barrier dysfunction. For instance, in vivo, LPS has been observed 
to induce plasma leakage, shown by the leakage of Evan’s Blue dye, in rat 
duodenum, stomach and lung (Ibbotson & Wallace, 1989), as well as to 
increase the permeability of the endothelium of rat aortas, shown by an 
increase in the accumulation in the intima and media of intravenously 
administered horseradish peroxidase (Penn & Chisolm, 1991). In vitro, LPS 
has been observed to induce an increase in the albumin permeability of 
bovine pulmonary artery endothelial cell monolayers (Meyrick et al., 1986), 
whilst TNF-a has been shown to induce an increase in the albumin, inulin, 
sorbitol, cytochrome C and co-vitamin B1 2  permeability of monolayers of 
BAEC (Brett et al., 1989; Royall et al., 1989), as well as the albumin 
permeability of monolayers of human umbilical vein endothelial cells (Burke- 
Gaffney & Keenan, 1993a). Interleukin-1 has been shown to induce an 
increase in the albumin, cytochrome C and co-vitamin B12  permeability of 
bovine aortic endothelial cell monolayers (Royall et al., 1989), whilst, 
additionally, both IFN-y and interleukin-1 were found to induce an increase 
in the albumin permeability of human umbilical vein endothelial cell 
monolayers (Burke-Gaffney & Keenan, 1993b).
Activation of the complement cascade can also lead to vascular dysfunction 
(Lundberg et al., 1987) and to neutrophil activation (Frank, 1987). 
Neutrophils may also be activated by many of the other already-mentioned 
mediators and can also, in themselves, bring about endothelial dysfunction 
through release of reactive oxygen species and lysosomal enzymes, through 
aggregation and through adherence to the endothelium causing vaso­
dilatation (Bone, 1991a). Various studies have demonstrated the ability of 
neutrophils to induce endothelial barrier dysfunction. For instance, 
neutrophils have been observed, in vitro, to induce an increase in the
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albumin permeability of bovine pulmonary microvessel endothelial cells 
(Siflinger-Bimboim et al., 1993) which may result as a consequence of the 
generation of hydrogen peroxide (Siflinger-Bimboim & Malik, 1993).
Other mediators which have been implicated as being involved in the 
sepsis cascade include platelets (Heffner et a l, 1987), transforming growth 
factor (3i (Wahl et al., 1987), adhesion molecules (Cotran & Pober, 1990), 
kinins (Katori et al., 1989), thrombin (Esmon, 1987), myocardial depressant 
substance (Reilly et al., 1989), beta-endorphin (Hughes, Jr., 1985) and heat 
shock protein (Rinaldo et a l, 1990). The relative role that each of these 
mediators plays, however, has yet to be determined.
3.1.4 Role of TNF-a
O f all the mediators so far mentioned, TNF-a is believed to be the most important (Bone, 1991a) and, indeed, until a few years ago 
was regarded as the prime mediator of sepsis and septic shock (Tracey 
et a l, 1988). It was noted, for instance, that intravenous administration of 
TNF-a in animal models generated very similar cardiovascular, haemato- 
logical and inflammatory effects to those observed in septic shock (Tracey 
et al., 1986) and that circulating levels of TNF-a are often elevated in a 
number of septic states (Bone, 1991a). Furthermore, it has been observed 
that LPS can promote macrophage production of TNF-a (Tracey et al.,
1988) and, when injected, cause a substantial elevation of TNF-a levels in 
animals (Hesse et al., 1988). Finally, administration of anti-TNF-a antibodies 
has been shown to prevent the induction of septic shock following 
subsequent challenge with LPS (Tracey et a l, 1987).
TNF-a levels, however, are also observed to rise in a variety of other 
conditions including cancer (Aderka et a l, 1985), the acquired immuno­
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deficiency syndrome (AIDS) (Lahdevrita et al., 1988), congestive heart 
failure (Levine et al., 1990), leprosy and leishmaniasis (Pisa et al., 1990). 
Also, TNF-a levels in septic shock patients are not always found to be 
raised (Debets et al., 1989) and can often be found to be high in healthy 
individuals (Damas et al., 1989). Furthermore, administration of other 
mediators, such as interleukin-1 and PAF, has also been shown to generate 
septic shock-like symptoms (Lefer et al., 1984; Kurt-Jones et al., 1987).
3.1.5 Circulatory failure in septic shock
s previously indicated, one of the primary features of septic shock is
that of profound hypotension. Total blood flow may in fact be normal, 
however, but flow to metabolically active tissues is inadequate and this 
reduced level of perfusion can, in time, lead to organ failure (Dal Nogare,
1991). The hypotension observed in septic shock results from vasodilatation 
leading to a substantial decrease in peripheral vascular resistance (Brady & 
Poole-Wilson, 1993) and this is often accompanied, at least in the early 
stages of shock, by tachycardia (Dal Nogare, 1991). In early septic shock 
both stroke volume and cardiac output are generally maintained but as the 
condition develops further, left ventricular dilatation is observed leading to 
a decrease in ejection volume and, therefore, a fall in cardiac output 
(MacLean et al., 1967; Ellrodt et al., 1985). Additionally, a global deterioration 
in the contractility of cardiac myocytes has been observed (Brady & Poole- 
Wilson, 1993).
3.1.6 Role of the L-arginine nitric oxide system
R ecently, much attention in elucidating the mechanisms by which septic shock is mediated has fallen on the L-arginine nitric oxide system. 
Nitric oxide (or a nitric oxide-like substance), synthesised in the vascular
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endothelium from L-arginine by a constitutive nitric oxide synthase, plays 
a key physiological role in the regulation of both blood flow and blood 
pressure (see Chapter 1). This isoform of nitric oxide synthase is Ca2+/  
calmodulin-dependent and generates nitric oxide in small (picomolar) 
quantities (Moncada, 1992). In contrast, many cell types can produce 
nanom olar amounts of nitric oxide w hen challenged with certain 
immunological stimuli, such as LPS and cytokines, through the induction of 
a Ca2+-independent inducible form of nitric oxide synthase (Wright et al., 
1992; Moncada, 1992; Brady & Poole-Wilson, 1993). Cells types in which 
inducible nitric oxide synthases have been identified include macrophages 
(Marietta et al., 1988), vascular smooth muscle cells (Rees et al., 1990), 
hepatocytes (Curran et al., 1989) and Kupffer cells (Billiar et al., 1989). 
Endothelial cells themselves have also been shown to express this inducible 
isoform of nitric oxide synthase in response to appropriate stimulation 
such as with LPS and IFN-y (Radomski et al., 1990). In the case of 
macrophages, production of nitric oxide is believed to account for much 
of their cytotoxic activity against both tumour cells and invading micro­
organisms (Pellat et al., 1990; Nathan, 1992).
In contrast to the constitutive from of nitric oxide synthase, the inducible 
form has been shown not to require Ca^+ for its activity, although it does 
require calmodulin, which it binds with high affinity (Xie et al., 1992), as 
well as NADPH, tetrahydrobiopterin, FAD and FMN (Marietta et al., 1988; 
Tayeh & Marietta, 1989; Marietta, 1993). Also, it is only observed to be 
present in cells following appropriate stimulation which causes its induction, 
whereas in the cells in which the constitutive form is known to be found, 
it is present all the time (Moncada, 1992). The activity of the inducible form 
of nitric oxide synthase has been shown to be inhibited by l-NMMA, l-NAME, 
N®-iminoethyl-L-omithine (l-NIO) and, unlike the constitutive form, by 
L-canavanine (Iyengar et al., 1987; McCall et al., 1991). Another important
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way in which the inducible form of nitric oxide synthase differs from its 
constitutive counterpart is the fact that its induction (but not its activity) 
may be inhibited by glucocorticoids, including dexamethasone, hydro­
cortisone and cortisol (Moncada, 1992).
Over the last three years, growing evidence has been put forward suggesting 
the involvement of nitric oxide production septic shock. It has been shown, 
for example, that endothelium-denuded rings incubated in vitro with LPS 
(Fleming et a l, 1990), or obtained from rats that had been treated with LPS 
(Knowles et al., 1990), exhibited production of nitric oxide by the vascular 
smooth muscle that was Ca2+-independent. Rees et al. (1990) demonstrated 
using rat aortic rings with or without endothelium, and which were 
contracted with phenylephrine, that treatment with LPS resulted in a 
progressive loss of tone after a lag of 2 hours. This was accompanied by 
an increase in cyclic GMP levels, a decreased response to phenylephrine 
and an ability to relax in response to L-arginine. All these effects were 
prevented by treatment with inhibitors of nitric oxide synthase and were 
associated with production in the tissue of a Ca2+-independent nitric oxide 
synthase.
Various studies have also demonstrated the induction by cytokines of nitric 
oxide synthase in cultured vascular smooth muscle cells. For instance, 
Busse & Miilsch (1990b) showed that TNF-a and interleukin-1 both induced 
a Ca2 +/calmodulin-independent increase in guanylate cyclase activity in 
rabbit aortic smooth muscle cells which was blocked in the presence of 
either l-NMMA or the protein synthesis inhibitor, cycloheximide. They also 
showed that the increase in guanylate cyclase activity induced by TNF-a 
was time-dependent and was enhanced in the presence of IFN-y. Using rat 
aortic smooth muscle cells, Beasley et al. (1991) similarly showed that 
interleukin- 1 induced an increase in guanylate cylcase activity and further
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showed that this was dependent on the availability of L-arginine and was 
accompanied by the formation of nitrite, a breakdown product of nitric 
oxide. Also using rat aortic smooth muscle cells, Kilbourn et a l  (1992) 
showed that incubation with interleukin- 1 caused a time- and concentration- 
dependent increase in nitrite formation which was inhibited by L-NMMA. 
A Fe2+-myoglobin assay confirmed that the nitrite was indeed being formed 
as a consequence of nitric oxide production.
The induction of nitric oxide synthase by cytokines in various cell types 
has been shown to be inhibited by transforming growth factor-(3 and by 
platelet-derived growth factors. For instance, Ding et a l  (1990) showed 
that transforming growth factors-(31 , -(32  and P3  inhibited nitric oxide 
synthase induction in macrophages by IFN-y, whilst Pfeilschifter & Vosbeck 
( 1 9 9 1 ) showed that transforming growth f a c to r^  inhibited nitric oxide 
synthase induction by interleukin-1 and TNF-a in rat mesangial cells. In rat 
aortic smooth muscle cells, transforming growth factor-pi, platelet-derived 
growth factor-AB and platelet-derived growth factor-BB were all found to 
inhibit the induction of nitric oxide synthase by interleukin-1 (Schini et a l,
1992). Additionally, thrombin has also been shown to inhibit the induction 
of nitric oxide synthase by interleukin- 1 in rat aortic smooth muscle cells 
(Schini et a l, 1993).
Using in vivo models of septic shock, inhibition of nitric oxide synthesis 
has been shown to reduce the hypotension induced by treatment with LPS 
in rat (Thiemermann & Vane, 1990) or rabbit (Wright et a l, 1992) or by 
treatment with either LPS or TNF-a in dog (Kilbourn et a l, 1990a; Kilbourn 
et a l, 1990b). In addition, the induction of nitric oxide synthase has been 
shown to be responsible for the hyporesponsiveness to vasoconstrictors 
induced by LPS in isolated rabbit hearts (Smith et a l, 1991). Further evidence 
supporting a role for nitric oxide are the findings that nitric oxide levels,
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measured as nitrite and nitrate in plasma, are elevated in septic shock in 
both animals (Westenberger et al., 1990) and humans (Ochoa et al., 1991).
Time-course studies of the development of the hypotension, following 
administration of LPS, in in vivo animal models of septic shock, have 
revealed a biphasic time-course (Wright et al., 1992). In addition to the 
sustained fall in blood pressure which develops after several hours of LPS 
challenge, and which is now attributed to induction of an inducible nitric 
oxide synthase, there has also been observed an immediate, transient fall 
in blood pressure which occurs within 1-5 minutes (Fleming et al., 1992). 
Moreover, Salvemini et al. (1990) demonstrated the ability of LPS to cause 
the immediate release of a nitric oxide-like factor from bovine aortic 
endothelial cells in vitro. Using both human umbilical vein and porcine 
aortic endothelial cells, Fleming et al. (1992) showed that this immediate 
release of nitric oxide, following challenge with LPS, was prevented by a 
bradykinin B2 receptor antagonist. This suggests that it may mediated by 
LPS-induced release of kinins which can activate the constitutive isoform 
of nitric oxide synthase within the endothelium.
Szabo et al. (1993) have also demonstrated that hyporeactivity to the 
vasoconstrictor effects of noradrenaline in anaesthetised rats, induced 
following intravenous injection with LPS, exhibits a biphasic development 
which parallels the time-course of the development of the hypotension. 
The immediate hyporeactivity to noradrenaline, preceded the induction of 
a Ca2+-independent nitric oxide synthase but was reversed by the nitric 
oxide synthase inhibitor, l-NAME. From these findings, it was postulated 
that the early phase of the LPS response, in terms of the effects on both 
hyporeactivity to noradrenaline and on blood pressure, is mediated by 
nitric oxide production via a constitutive nitric oxide synthase. This is in
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contrast to the later, sustained phase of the response which is mediated by 
nitric oxide production via an inducible nitric oxide synthase.
Thus, it is clear that production of nitric oxide, by activation of both 
constitutive and inducible nitric oxide synthases, is required for both the 
hypotension and the hyporeactivity to vasoconstrictors associated with septic 
shock. In contrast, little is known at present of the mechanism by which 
LPS induces endothelial barrier dysfunction.
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C h a p t e r  4
4.1 Cytochrome C assay for the production of 
reactive oxygen species
Before assessing the effects of the hypoxanthine-xanthine oxidase free radical generating system on endothelial barrier function, it was 
necessary to validate the ability of the system to generate oxygen-derived 
free radicals. Therefore, the cytochrome C assay, a well-established assay 
for the production of superoxide anion (Fridovich, 1970), was employed.
4.1.1 Basis of the cytochrome C assay
As supplied commercially, cytochrome C exists predominantly in its oxidised form, ferricytochrome C. Superoxide anion has been 
demonstrated to cause the reduction of cytochrome C to its reduced form, 
known as ferrocytochrome C according to the equation:
cytochrome C+++ + 0 2~ —> cytochrome C++ + 0 2
In this form, cytochrome C has an absorbance peak at 550 nm (Figure 4.1) 
and a linear relationship therefore exists between the absorbance of 
cytochrome C at this wavelength and the proportion of the sample which 
is in its reduced form. As such, by following the absorbance of a sample 
of cytochrome C at 550 nm with time, its oxidation state can also be 
followed. Since superoxide anion causes the reduction of cytochrome C, 
an increase in the absorbance at 550 nm can therefore be taken as an 
indicator of the production of the anion.
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Figure 4.1 Absorption spectra (450-650 nm) generated from a 10 g iM  
sample of cytochrome C both in its commercially supplied oxidised state 
and in its reduced state, induced by addition of the reducing agent, sodium 
dithionite (300 /iM). The absorbance peak at 550 nm, by which the oxidation 
state of the sample can be determined, is clearly visible in the spectrum 
of the sample when in the reduced state.
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Hydrogen peroxide may be formed by spontaneous dismutation of 
superoxide anion:
2 0 2 + 2 H+ —> 0 2 + H20 2
In contrast to superoxide anion, hydrogen peroxide will oxidise cytochrome 
C, restoring it from its reduced form, ferrocytochrome C, to its oxidised 
form, ferricytochrome C:
cytochrome C++ + H20 2 —» cytochrome C+++ + OH- + OH
Therefore, as hydrogen peroxide is produced, the absorbance of the 
cytochrome C sample at 550 nm will decrease as it re-oxidises.
4.1.2 Measurement of superoxide anion and hydrogen peroxide 
production by the hypoxanthine-xanthine oxidase system
In order to measure the production of superoxide anion and hydrogen peroxide by the hypoxanthine-xanthine oxidase free radical generating 
system, a 1 ml sample of 10 /iM cytochrome C was placed in a glass 
cuvette. A reference blank sample was also prepared using 1 ml of distilled 
water. Using a Shimadzu dual-beam spectrophotometer (Model No. UV-240), 
the absorbance of the cytochrome C at 550 nm was then recorded for the 
duration of the experiment. Where appropriate according to the protocol 
being followed, superoxide dismutase (6000 U ml‘1) and/or catalase 
(100 U ml~l) was first added to the cytochrome C sample, following which 
both hypoxanthine (0.2 mM) and then xanthine oxidase (20 mU m l'l) 
were added. All drugs were added in volumes of 20 /il.
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4.2 Isolation of bovine aortic endothelial cells (BAEC)
Bovine thoracic aortae were obtained from a local abattoir shortly after death and were initially flushed with sterile saline supplemented with 
200 U m l'l benzyl penicillin and 200 fig m l'l streptomycin. The end of 
each aorta which had been proximal to the heart was then ligated with 
strong string whilst the distal end was canulated with an adapter and a 
60 ml syringe which also contained this supplemented sterile saline. The 
saline was infused into each aorta to keep it moist during transportation 
to the laboratory where the remainder of the isolation procedure was 
conducted.
At the laboratory, all subsequent work was carried out under aseptic 
conditions in a laminar flow cabinet (Flow Laboratories—Model No. Gelaire 
TC48). Using fresh, sterile saline, the aorta was again flushed through to 
remove any remaining blood and other debris. The aortic intercostal arteries 
were cleared of adhering fat to allow ligation with surgical thread, thus 
sealing off the aorta. Using a syringe, the aorta was drained of saline which 
was then replaced with 10 ml of sterile collagenase solution (Type II, 
Sigma; 0.1% in Dulbecco’s modification of Eagle’s medium (DMEM) ). The 
aorta was incubated at 37°C for 20 minutes after which it was gently 
massaged and the resulting cell suspension harvested using a syringe. 
2 0  ml of sterile saline was then infused into the vessel lumen to remove 
any remaining cells. The collected cell suspensions were then centrifuged 
(200g; 4 minutes; 10°C) and the supernatants discarded. The resulting cell 
pellets were resuspended in 10 ml of growth medium (DMEM supplemented 
with 10% foetal calf serum, 10% newborn calf serum, 4 mM glutamine, 
200 U ml"l penicillin and 200 jjg  ml"* streptomycin) and centrifuged again 
(200g; 4 minutes, 10°C). After again discarding the supernatants, the pellets 
from each aorta were resuspended in 2 0  ml of growth medium and seeded
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a)
b)
Figure 4.2 Differential interference contrast micrographs of primary 
cultures of bovine aortic endothelial cells are shown a) 1 day and b )3  
days after isolation by collagenase treatment. The cells, which were grown 
on glass coverslips to facilitate micrographic visualisation, are initially isolated 
as clumps which adhere to the underlying surface within 24 hours. After 
subsequent division, the cells multiply to form a confluent monolayer 
which exhibits the characteristic “cobblestone” appearance of the vascular 
endothelium.
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into 80 cm^ culture flasks (Nunc). The flasks were placed in an incubator 
(Flow Laboratories—Model No. 220) at 37°C in an atmosphere of 5% CO2  
and 95% air and grown until confluent (3-7 days). During this period the 
growth medium in each flask was renewed, initially one day following the 
isolation and, subsequently, every 2 -3  days.
The cells were validated as endothelial cells by the fact that they formed 
a single layer with a characteristic “cobblestone” morphology. Previous 
work in this laboratory has further confirmed the identification of pig 
aortic endothelial cells, which had been isolated in a similar manner, by 
their ability to produce both prostacyclin (Martin et al., 1989) and EDRF 
(Martin et al., 1988), and by using a fluorescent LDL assay, the cell 
population has been shown to have >98% purity (Martin et al., 1988).
4.3 Assessment of endothelial barrier function
4.3.1 In vitro model of the vascular endothelial barrier
Endothelial barrier function was investigated in this study using an in vitro model of the arterial endothelial barrier (Gudgeon & Martin, 
1989). Such a model is a useful tool since, unlike in vivo models, it 
facilitates the elimination of both the indirect influences on permeability of 
other physiological actions of the agents being studied, and any interactions 
which occur with other cell types (see Chapter 1). Therefore, it enables the 
direct actions of agents solely on endothelial barrier function to be observed.
The model used in this study consisted of a two-chamber system in which 
monolayers of BAEC were grown on Costar Transwell membranes (Figure 
4.3). Albumin was chosen as a marker of endothelial barrier function since 
it is an endogenous substance and, being a major component of blood, is
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Figure 4.3 a) Photographic and b ) diagrammatic representation of 
Transwell membrane filter units. First passage BAEC’s were cultured on 
polycarbonate membranes for 3-4 days after which, where appropriate, 
drugs were added to both upper and lower chambers as timed pre­
treatments. The membranes were then transferred to wells, the lower 
chamber of which was filled with HEPES-buffered Krebs, whilst trypan 
blue-labelled albumin (4% in HEPES-buffered Krebs) was placed in the 
upper chamber. Again, where appropriate, drugs were added to both 
chambers and the wells placed on an orbital shaker for 90 minutes. After 
this time, samples were taken from each lower chamber and the transfer 
of trypan blue-labelled albumin assessed by colourometric assay.
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believed to be an important determinant of the hydraulic conductivity of 
the endothelium in vivo (McCandless et al., 1991). Endothelial cell 
monolayers were grown on polycarbonate membranes (diameter 6 .5  mm; 
pore size 3  /ini) and the passage of trypan blue-labelled albumin across 
these monolayers was measured by a spectrophotometric assay.
4.3.2 Preparation of endothelial monolayers
pon reaching confluence, an 80 cm^ flask of BAEC was taken, the
growth medium removed and the cells washed twice using 2 0  ml of 
sterile saline. 10 ml of a solution of trypsin (0.05%) and EDTA (0.02%) was 
then added, and the flask was incubated at 37°C for approximately 2-4 
minutes to facilitate cell detachment. The resultant cell suspension was 
added to 2  ml of newborn calf serum, which acted to inhibit the trypsin, 
and then twice centrifuged (200g; 4 minutes; 10°C) followed by resuspension 
in 5 ml of growth medium. Transwell membranes were prepared by adding 
1 ml of growth medium to the lower chamber of each of 48 wells, with 
a polycarbonate filter being placed on top. 100 /il of the BAEC suspension 
was then added to the upper chamber of each well on top of the 
polycarbonate filter. The cells were incubated again at 37#C in an atmosphere 
of 95% air/5% CO2  for 3-4 days to allow these secondary cultures to attain 
confluence after which drug treatments and albumin transfer studies were 
carried out to assess endothelial barrier function.
4.3.3 Preparation of trypan blue-labelled albumin
Bovine serum albumin (Fraction V; 4g) was dissolved in 100 ml of Krebs containing (mM): NaCl 118, KCl 4.8, MgSC>4 1, KH2 PO4  1.2, 
NaHCC>3 2.4, glucose 11 and HEPES (N-2-hydroxyethylpiperazine-N'-2- 
ethanesuplhonic acid) 5. Trypan blue (180 mg) was then added to form
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a stable complex with an absorption peak at 590 nm. Precipitation with 6 % 
trichloroacetic acid showed that the trypan blue was >9 9 .8 % bound to 
albumin. The stable trypan blue-labelled albumin complex appeared 
therefore to constitute a suitable high molecular weight marker for use in 
assessing the barrier function of endothelial monolayers.
4.3.4 Addition of drugs as pretreatments
In all experiments in which drug pretreatments were performed, the drugs were initially added to confluent monolayers in culture at 
appropriate time intervals prior to the assessment of barrier function. These 
drugs, which included deferoxamine w hen added as an overnight 
pretreatment, lipopolysaccharide (LPS) and all drugs added concomitantly 
with LPS, were added to both upper and lower chambers of each Transwell 
in volumes of 11 jA. The monolayers were then returned to the incubator 
at 37°C in 5% CC>2 / 9 5 % air for the duration of the pretreatments. Full 
details of timings and concentrations used are listed in the appropriate 
sections in the Results.
4.3.5 M easurement of albumin transfer across endothelial 
monolayers
ranswell membranes with BAEC monolayers attached were initially
washed twice by gentle immersion in HEPES-buffered Krebs (as 
described in section 4.3.3) at 37°C and pH 7.4. The membranes were 
transferred to a 24-well cluster plate with 600 /il of HEPES-buffered Krebs 
being placed in the lower chamber and 1 0 0  lA of trypan blue-labelled 
albumin (4%) being placed in the upper chamber of each well above the 
endothelial monolayer. The volumes were chosen so as to avoid generating 
a hydrostatic gradient across the monolayer. With the exception of LPS and
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dexamethasone, which were added as pretreatments, drugs were then 
added in volumes of 7 /il to both upper and lower chambers and the 
plates were transferred to an orbital shaker (Luckham) which ensured 
gentle, continuous agitation, and placed in air in an incubator (ICN Flow— 
Model No. 160) at 37°C for 90 minutes. At the end of this period, 100 /il 
samples were removed from the lower chamber of each well and transferred 
to plastic cuvettes for quantification of albumin transfer.
In some experiments involving LPS pretreatments, a shorter incubation 
time than 90 minutes with trypan-blue labelled albumin was employed. 
This was because the monolayers in these cases were found to be more 
permeable than normal. Thus, the albumin transfer rate was found to be 
high enough to have enabled sufficient albumin transfer to have occurred 
by either 30 or 60 minutes to facilitate quantification of transfer. Such 
modifications of the procedure could only be performed in experiments, 
such as those with LPS, in which the drugs were added as pretreatments 
and whose action was therefore not dependent on the time period of this 
incubation. Since each experiment was performed with its own internal 
controls, valid qualitative analysis could still be performed.
4.3.6 Quantification of albumin transfer
The 1 0 0  /il samples collected from the lower chamber of each well were diluted 1 in 10 by addition of 900 /il HEPES-buffered Krebs to 
each cuvette. The content of trypan blue-labelled albumin in each sample 
was subsequently determined using a dual-beam spectrophotometer 
(Shimadzu) to measure the absorbance of each at 590 nm. These results 
were then expressed as a percentage of that which would have been 
obtained had full equilibrium occurred. 1 ml of HEPES-buffered Krebs was 
used as the 0 % reference sample whilst the 1 0 0 % reference sample was
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prepared by adding 14.3 /il of trypan blue-labelled albumin to 985.7 /il of 
HEPES-buffered Krebs.
4.4 Materials
4.4.1 Tissue culture reagents and materials
DMEM, foetal calf serum, newborn calf serum, glutamine and penicillin/ streptomycin were all obtained from Gibco, Paisley, UK. Trypsin/ 
EDTA was obtained from Flow Laboratories, Irvine, UK whilst bovine 
serum albumin and collagenase (Type II) were obtained from Sigma, Poole, 
UK. Collagenase was dissolved in DMEM to yield a 0.1% solution which 
was then sterilised by filtration through a millipore filter (0.22 /im; Flow 
Laboratories).
Tissue culture flasks (80 cm^) were obtained from Life Technologies, 
Uxbridge, UK. Transwell membranes (6.5 mm diameter; 3 /iM pore size) 
were obtained from Costar (UK) Ltd., High Wycombe, UK. Sterile centrifuge 
tubes (15 ml and 50 ml; Falcon) were obtained from R.& J. Wood, Paisley, 
UK. Sterile saline (0.9% w/v) was obtained from Baxter Health Care, 
Thetford, UK. Cylinders of CO2  were obtained from B.O.C., Ltd., UK.
4.4.2 Drugs
llopurinol, catalase (bovine liver), cytochrome C (horse heart),
deferoxamine mesylate, dexamethasone, DL-dithiothreitol, DL- 
homocysteine, hydrogen peroxide (3 0 %), hypoxanthine, lipopolysaccharide 
from Salmonella typhosa (prepared by phenol extraction), D-mannitol, 
N-(2-mercaptopropionyl)-glycine, N^-nitro L-arginine, N®-nitro-L-arginine 
methyl ester, superoxide dismutase (bovine erythrocyte), polymixin B
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sulphate, xanthine and xanthine oxidase (buttermilk) were obtained from 
Sigma, Poole, UK. 1,3-dimethy 1-2-thiourea was obtained from Aldrich, 
Gillingham, UK. Human recombinant interferon-y was obtained from the 
National Institute for Biological Standards and Control, Potters Barr, 
Hertfordshire. Sodium flurbiprofen dihydrate was a generous gift from Dr. 
R.V. Holland, Boots Pure Drug Co., UK, whilst N03-monomethy 1-L-arginine 
acetate was a generous gift from Dr. D.D. Rees, Wellcome Laboratories, 
Beckenham, Kent, UK. All drugs were dissolved in distilled water except 
for hypoxanthine and xanthine, which were dissolved in sodium hydroxide 
(10 mM), and dexamethasone which was dissolved in absolute ethanol. 
The final concentration of sodium hydroxide in experiments did not exceed 
0.2 mM whilst that of ethanol did not exceed 0.2%. These concentrations 
did not, in themselves, affect albumin transfer across monolayers of BAEC. 
None of the drugs used displaced trypan blue from the trypan blue-labelled 
albumin complex.
4.5 Statistical analysis of results
Results are expressed as means±s.e. mean and were compared by one-way analysis of variance to determine if any significant differences 
existed between treatment groups. This was followed by Fisher’s test to 
determine where differences lay. Analysis was conducted using Minitab 
Release 8 , (Minitab Inc., State College, USA). Due to the variability 
encountered in resting transfer of albumin amongst different batches of 
cells, each experiment was performed with its own internal controls. A 
probability of 0.05 or less was taken to be significant.
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C h a p t e r  5
5.1 Production of reactive oxygen species by the 
hypoxanthine-xanthine oxidase system
he cytochrome C assay enables the time-course of the production of
free radical species by the hypoxanthine-xanthine oxidase system to 
be observed (Fridovich, 1970). As purchased, cytochrome C is found 
predominantly in its oxidised form. At 550 nm, the absorbance of a sample 
of cytochrome C increases as it becomes reduced, but in the absence of 
any added agents it will remain at a stable level.
Addition of either hypoxanthine or xanthine oxidase alone to oxidised 
cytochrome C has no effect on its oxidation state and hence does not alter 
its absorbance at 550 nm. However, as shown in Figure 5.1a, when the 
combination of 0.2 mM hypoxanthine and 20 mU ml“l  xanthine oxidase 
was added to a 10 ptM sample of oxidised cytochrome C, a rapid increase 
in its absorbance at 550 nm occurred, indicating that the sample was being 
rapidly reduced. The absorbance reached a maximum within a time period 
of 1 - 2  minutes, levelled off and then, after around 1 5  minutes, began to 
slowly decrease as the cytochrome C sample became re-oxidised.
When the experiment was repeated in the presence of 6000 U m l'l 
superoxide dismutase which rapidly converts superoxide anion to hydrogen 
peroxide, the initial rapid increase in absorbance at 550 nm was significantly 
inhibited (Figure 5.1b). This would indicate that the initial rapid reduction 
of cytochrome C induced by addition of the hypoxanthine-xanthine oxidase 
system, results from the production of superoxide anion.
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Figure 5.1 Traces showing absorption changes at 550 nm with time of 
10 /iM samples of cytochrome C on addition of 0.2 mM hypoxanthine (HX) 
followed by 20 mU m l'1 xanthine oxidase (XO). a) shows the control 
response. b )  shows the response obtained in the presence of 6000 U ml"1 
superoxide dismuase (SOD), c) shows the response obtained in the presence 
of 100 U m l'1 catalase (CAT), d) shows the response obtained in the 
combined presence of 6000 U ml"1 superoxide dismuase and 100 U ml"1 
catalase.
Page 94
M odulation o f  Endothelial Barrier Function Chapter 5
In contrast, in the presence of 100 U ml-1  catalase which catalyses the 
breakdown of hydrogen peroxide to both water and oxygen, the initial 
rise in absorption at 550 nm induced by hypoxanthine (0.2 mM) and 
xanthine oxidase (2 0  mU ml-1) was unaffected, but the subsequent decrease 
in absorption was completely blocked (Figure 5.1c). This would indicate 
that the re-oxidation phase of the response is induced by the formation of 
hydrogen peroxide which can be formed through spontaneous dismutation 
of superoxide anion.
As would be expected, in the presence of a combination of both superoxide 
dismutase and catalase (Figure 5.Id), both the initial rapid reduction and 
the subsequent slower re-oxidation of the cytochrome C sample were 
inhibited since the actions of both superoxide anion and hydrogen peroxide 
are being blocked.
These results confirm the ability of the hypoxanthine-xanthine oxidase 
system to produce both superoxide anion and, subsequently, hydrogen 
peroxide, thereby validating its use as a free radical generating system for 
use in studying the effects of free radicals on endothelial barrier function. 
Additionally, since the system produces both superoxide anion and 
hydrogen peroxide, it is also possible that further reactive oxygen species 
may be generated such as hydroxyl radical, which given a source of iron, 
can be formed in the presence of both these species by the Fenton reaction 
(Repine et al., 1981), and also hypochlorous acid which may be produced 
by an interaction between hydrogen peroxide and chloride ions in the 
presence of the enzyme, myeoloperoxidase (Halliwell & Gutteridge, 1989)— 
see Introduction.
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5.2 Validation of the i n  v i t r o  model of endothelial 
permeability
Endothelial cells grown on membranes have been shown to maintain a profile of barrier function similar to that obtained in vivo (Del- 
Vecchio et al., 1987). The validity of the in vitro model employed in this 
study to assess endothelial permeability has been demonstrated by previous 
work in the same laboratory. A time-course study was undertaken to 
determine the passage of trypan blue-labelled albumin (4%) across Transwell 
membranes both alone and with monolayers of first passage pig aortic 
endothelial cells attached (Figure 5.2). In the absence of cells, equilibration 
of albumin across the membranes was rapid reaching maximum (1 0 0 % 
equilibration) within 20-40 minutes. In the presence of endothelial cells, 
however, albumin transfer was substantially restricted, thereby demonstrating 
the ability of the model to recreate in intro the barrier properties of the 
vascular endothelium.
Similarly, in this study, monolayers of BAEC were found to be able to 
restrict the passage of albumin across Transwell membranes. Typically, 
after a 9 0  minutes incubation period, control levels of albumin transfer 
ranged from 2-25% (Figures 5.3-5.7).
5.3 Study of the effects of the hypoxanthine-xanthine 
oxidase system on barrier function
5.3.1 Effects of hypoxanthine and xanthine oxidase on albumin 
transfer
Using the in vitro model of bovine aortic endothelial permeability employed in this study, the effects of the hypoxanthine-xanthine
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Figure 5.2 Time-course showing the passage of trypan blue-labelled 
albumin across Transwell membranes in the presence (+EC) and absence 
(-EC) of pig aortic endothelial cells. HEPES-buffererd Krebs containing 4% 
trypan blue-labelled albumin was placed in the upper chamber and its 
passage into the lower chamber, containing HEPES-buffered Krebs only, 
was measured at various time points. Each point is the mean of 2 
observations with full equilibration between both chambers being 100%. 
Modified from Gudgeon and Martin (1989).
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oxidase free radical generating system were investigated. When either 
hypoxanthine (0.2 mM) or xanthine oxidase (20 mU m H ) was added 
alone to monolayers of BAEC during a 90 minute incubation, there was no 
significant alteration in the equilibration of albumin across the monolayers 
relative to the control level (4.6±0.9%) in the absence of any added drug 
(Figure 5.3). However when hypoxanthine and xanthine oxidase were 
added in combination, a significant increase in albumin transfer (18.2±1.8%) 
was observed demonstrating the ability of the hypoxanthine-xanthine 
oxidase system to induce an increase in endothelial permeability.
In the presence of a fixed concentration of hypoxanthine (0.2 mM), xanthine 
oxidase (3-300 U m H ) was shown to induce a concentration-dependent 
increase in albumin transfer across monolayers of BAEC (Figure 5.4). The 
maximum increase obtained was 47.6±1.3% at a xanthine oxidase 
concentration of 300 U ml-1. Thus, the xanthine oxidase concentration of 
20 U ml"l was not a maximal concentration in terms of its effects on 
endothelial permeability. This concentration of xanthine oxidase, together 
with a fixed hypoxanthine concentration of 0.2 mM, was chosen as a 
standard concentration in all subsequent experiments involving the 
hypoxanthine-xanthine oxidase system.
The effects of concomitant addition of the xanthine oxidase inhibitor, 
allopurinol (4 mM) on the increase in albumin transfer across monolayers 
of BAEC induced by hypoxanthine and xanthine oxidase (added at the 
chosen standard concentrations of 0.2 mM and 20 U ml~l, respectively) are 
shown in Figure 5.5. As would be expected, allopurinol significantly reduced 
the increase in albumin transfer induced by the hypoxanthine-xanthine 
oxidase system, confirming the need for the complete enzyme-substrate 
system to induce endothelial barrier dysfunction.
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Figure 5.3 Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
hypoxanthine (HX) and 20 mU ml“l xanthine oxidase (XO), added alone 
and in combination, on albumin transfer across monolayers of bovine 
aortic endothelial cells. Each column is the mean of 6 observations with 
vertical bars representing s.e. mean. ***p<0.001, indicates a significant 
difference from Control.
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Figure 5.4 Graph showing the effects of 90 m inutes’ exposure to 
0-300 mM xanthine oxidase (XO) on albumin transfer across monolayers 
of bovine aortic endothelial cells in presence of 0.2 mM hypoxanthine (Y 77X ). 
Control responses in the absence of both xanthine oxidase and 
hypoxanthine are also shown (□□). Each column is the mean of 6 
observations with vertical bars representing s.e. mean. ***p<0.001, indicates 
a significant difference from Control.
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Figure 5.5 Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
hypoxanthine (HX) and 20 mU ml-* xanthine oxidase (XO) on albumin 
transfer across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 4 mM allopurinol (ALLO) are also shown. Each 
column is the mean of 12 observations with vertical bars representing s.e. 
mean. *p<0.05; ***p<0.001, indicates a significant difference from Control, 
whilst ffipcO.OOl, indicates a significant difference between groups joined 
by a bracket.
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The inhibition obtained on addition of allopurinol was incomplete, only 
producing approximately a 51% reduction of the hypoxanthine-xanthine 
oxidase-induced permeability increase. Higher concentrations of allopurinol, 
however, were not tested due to its relative insolubility in aqueous solutions.
In order to investigate any involvement of superoxide anion in mediating 
the permeability increase induced by the hypoxanthine-xanthine oxidase 
system, the effects of superoxide dismutase (30 U m l'l)  were investigated 
(Figure 5.6). When added alone, superoxide dismutase had no effect on 
the level of albumin transfer compared to control and when it was added 
in combination with hypoxanthine (0.2 mM) and xanthine oxidase 
(20 mU m l'l), it showed no inhibitory effect. This result would indicate 
that superoxide anion does not mediate the permeability increase.
Since it is possible that the reason for its failure to show an inhibitory 
effect was because the superoxide dismutase was not added at a sufficiently 
high concentration, this experiment was repeated at a much increased 
superoxide dismutase concentration of 6000 U m l'l to ensure maximum 
effectiveness of the drug. However, w hen 6000 U m l'l superoxide 
dismutase, which itself had no effect of albumin transfer across monolayers 
of BAEC (Figure 5.7), was added in combination with hypoxanthine 
(0.2 mM) and xanthine oxidase (20 mU ml”1), it was also found to have no 
inhibitory effect on the increase in albumin transfer stimulated by the free 
radical generating system. This would therefore confirm the observation 
that superoxide anion is not involved in mediating the hypoxanthine- 
xanthine oxidase-induced increase in endothelial permeability.
To investigate any involvement of hydrogen peroxide in the increase in 
albumin transfer across monolayers of BAEC, catalase (0.3-30 U m l'l) was 
co-incubated with hypoxanthine (0.2 mM) and xanthine oxidase
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Figure 5 .6  Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
hypoxanthine (HX) and 20 mU ml“l xanthine oxidase (XO) on albumin 
transfer across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 30 U m H  superoxide dismutase (SOD) are also 
shown. Each column is the mean of 6 observations with vertical bars 
representing s.e. mean. **p<0.01, indicates a significant difference from 
control.
Page 103
Modulation o f  Endothelial Barrier Function Chapter 5
50-1
40-
&
1 30-
Z3£2
CO
o
czo
2  20-  
-O
'3
O '
LU
10 -
Control HX SOD HX
XO XO
SOD
Figure 5.7 Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
hypoxanthine (HX) and 20 mU m l'l xanthine oxidase (XO) on albumin 
transfer across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 6000 U m l'l superoxide dismutase (SOD) are also 
shown. Each column is the mean of 6 observations with vertical bars 
representing s.e. mean. **p<0.01, indicates a significant difference from 
control.
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(20 mU m l'l)  (Figure 5.8). At concentrations of 0.3-1 U m l'l, catalase had 
no effect but at 3 U m l'l and above, it was found to abolish the increase 
in albumin transfer stimulated by the hypoxanthine-xanthine oxidase system. 
This therefore indicates that hydrogen peroxide must play a key role in 
mediating the barrier dysfunction induced by the hypoxanthine-xanthine 
oxidase system.
5.3.2 Effects of xanthine and xanthine oxidase on albumin transfer
In order to establish if xanthine can equally well be used as a substrate for xanthine oxidase in terms of its effects on barrier function, certain 
experiments were repeated substituting xanthine in place of hypoxanthine 
at the same concentration.
Figure 5.9 shows that like hypoxanthine, xanthine (0.2 mM) had no effect 
on albumin transfer across monolayers of BAEC compared to control levels 
(6.4±.05%) when added alone. However, when xanthine was added in 
combination with xanthine oxidase ( 2 0  mU m l'l), which again was shown 
to have no significant effect by itself, a significant increase in albumin 
transfer was observed (3 0 .8 ±1 .6 %).
When catalase (0.3-30 U m l'l) was added concomitantly with xanthine 
(0.2 mM) and xanthine oxidase (20 mU m l'l), ft was observed to be 
without effect at concentrations of 0.3-1 U m l'l, but at concentrations of 
3 U m l'l and greater, it was found to abolish the induced increase in 
albumin transfer (Figure 5.10).
These two experiments revealed that there was little difference observed 
in this system in either the increase in albumin transfer obtained, or the 
susceptibility of this increase to be inhibited by catalase, when xanthine
Page 105
M odulation o f  Endothelial Barrier Function Chapter 5
60 -i
* * *
50- * * *
_ Q
CO
•s 30-
o
03i_
- Q
1 0 -
Control 0.3
[CAT] U m M
Figure 5.8 Graph showing albumin transfer across monolayers of bovine 
aortic endothelial cells after 90 m inutes’ incubation both in the 
presence (£23) and absence (fZd) of 0.2 mM hypoxanthine and 20 mU ml"l 
xanthine oxidase. The effects of concomitant addition of 0.3-30 U ml~l 
catalase (CAT) are also shown. Each column is the mean of 6-9 observations 
with vertical bars representing s.e. mean. ***p<0.001, indicates a significant 
difference from Control.
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Figure 5.9 Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
xanthine (X) and 20 mU m l'l xanthine oxidase (XO), added alone and in 
combination, on albumin transfer across monolayers of bovine aortic 
endothelial cells. Each column is the mean of 6 observations with vertical 
bars representing s.e. mean. ***p<0.001, indicates a significant difference 
from Control.
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Figure 5.10 Graph showing albumin transfer across monolayers of bovine 
aortic endothelial cells after 90 m inutes’ incubation both in the 
presence (fZ Z ff) and absence (CU D  of 0.2 mM xanthine and 20 mU ml-1 
xanthine oxidase. The effects of concomitant addition of 0.3-30 U ml-1 
catalase (CAT) are also shown. Each column is the mean of 6-9 observations 
with vertical bars representing s.e. mean. ***p<0.001; **p<0.01, indicates a 
significant difference from Control.
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(0.2 mM) was substituted in place of hypoxanthine and used in combination 
with xanthine oxidase at the chosen standard concentration of 2 0  mU m l'l.
5.3.3 Effects of hydrogen peroxide on albumin transfer
H aving shown through the effectiveness of catalase that hydrogen peroxide is implicated in mediating the increase in albumin transfer 
produced by the hypoxanthine-xanthine oxidase system, the effects of 
addition to monolayers of BAEC of native hydrogen peroxide itself were 
then examined (Figure 5.11). Hydrogen peroxide was found to induce a 
biphasic concentration-response curve in terms of its effects on albumin 
transfer across monolayers of BAEC. A lower peak was observed at 0.1- 
0.3 mM (with a maximum of 12.2±1.0% at 0.1 mM) which then declined 
towards basal levels as the concentration was increased, whilst a higher 
peak was observed at around 10-30 mM (with a maximum of 25.6±1.8% 
at 10 mM). This therefore clearly shows that hydrogen peroxide can itself 
induce endothelial barrier dysfunction.
Figure 5.12 shows the effects of catalase (0.3 and 1 U m l'l)  on the increase 
in albumin transfer across BAEC induced by 0.1 mM hydrogen peroxide. 
As expected, at both concentrations tested, catalase was found to abolish 
the increase stimulated by hydrogen peroxide.
Similarly in Figure 5.13, the effects of catalase (30-3000 U m l'l) Qn the 
increase in albumin transfer induced by 10 mM hydrogen peroxide are 
shown. Catalase show ed no inhibitory effect at concentrations of 
30-300 U m l'l, but at concentrations of 1000 U m l'l and above, it was 
observed to abolish the hydrogen peroxide-induced permeability increase.
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Figure 5.11 Graph showing the effects of 90 minutes’ exposure to 
0-30 mM hydrogen peroxide [H2 O2 ] on albumin transfer across monolayers 
of bovine aortic endothelial cells. Each column is the mean of 6 observations 
with vertical bars representing s.e. mean. *p<0.05; ***p<0.001, indicates a 
significant difference from control (no H2 O2 ).
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Figure 5.12 Graph showing albumin transfer across monolayers of bovine 
aortic endothelial cells after 9 0  m inutes’ incubation both in the 
presence QZ23) and absence ( □ )  of 0.1 mM hydrogen peroxide. The effects 
of concomitant addition of 0.3 and 1 U m H  catalase (CAT) are also shown. 
Each column is the mean of 6  observations with vertical bars representing 
s.e. mean. ***p<0.001, indicates a significant difference from Control.
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Figure 5.13 Graph showing albumin transfer across monolayers of bovine 
aortic endothelial cells after 9 0  m inutes’ incubation both in the 
presence QZE2) and absence (Em) of 10 mM hydrogen peroxide. The effects 
of concomitant addition of 30-3000 U ml-1  catalase (CAT) are also shown. 
Each column is the mean of 6-9 observations with vertical bars representing 
s.e. mean. ***p<0.001, indicates a significant difference from Control.
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5.3.4 Involvement of the hydroxyl radical in the hypoxanthine- 
xanthine oxidase-induced increase in albumin transfer
Since it is possible that hydrogen peroxide may not be the sole mediator of the permeability increase induced by the hypoxanthine-xanthine 
oxidase system, investigation of the involvement of other reactive oxygen 
species was undertaken. Hydroxyl radical may be formed in the combined 
presence of superoxide anion, hydrogen peroxide and iron (Repine et a l, 
1981; Starke & Farber, 1985). Both hydrogen peroxide and superoxide 
anion have been shown to be formed by the hypoxanthine-xanthine oxidase 
system, whilst iron is present within endothelial cells in the form of ferritin 
(Dognin & Crichton, 1975). Thus, the effects of hydroxyl radical scavengers 
were studied on the increase in albumin transfer across BAEC induced by 
hypoxanthine and xanthine oxidase.
Figure 5.14 shows the effects of mannitol, a membrane-impermeant hydroxyl 
radical scavenger, on the actions of the hypoxanthine-xanthine oxidase 
system. Mannitol itself (15 mM) did not affect the level of albumin transfer 
across monolayers of BAEC relative to the control value and, additionally, 
when it was co-incubated with hypoxanthine (0.2 mM) and xanthine oxidase 
(20 mU m l'l)  it failed to show any inhibitory effect on the increase in 
albumin transfer observed. This result would indicate that there is no 
involvement of hydroxyl radical in mediating the barrier dysfunction induced 
by hypoxanthine and xanthine oxidase.
However, being a membrane-impermeant scavenger, mannitol can only 
scavenge extracellularly produced hydroxyl radical and so, in order to 
investigate any involvement of intracellularly produced hydroxyl radical, 
two membrane-permeant hydroxyl radical scavengers, dimethylthiourea 
and N-(2-mercaptopropionyl) glycine, were employed.
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Figure 5.14 Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
hypoxanthine (HX) and 20 mU m l'l xanthine oxidase (XO) on albumin 
transfer across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 15 mM mannitol (MAN) are also shown. Each 
column is the mean of 6  observations with vertical bars representing s.e. 
mean. ***p<0.001, indicates a significant difference from Control.
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The effects of dimethylthiourea (10 mM) are shown in Figure 5.15. When 
added alone, dimethylthiourea had no effect on albumin transfer across 
monolayers of BAEC and when it was co-incubated with hypoxanthine 
(0.2 mM) and xanthine oxidase (20 mU m l'l), ft showed no inhibitory 
effect on the increase in albumin transfer observed.
Further investigation employing higher concentrations of dimethylthiourea, 
in order to show that the reason for its failure to cause an inhibition was 
not merely because it was not added at a high enough concentration, was 
not possible. This was because at higher concentrations than 10 mM, 
dimethylthiourea itself stimulated an increase in albumin transfer across 
monolayers of BAEC.
As shown in Figure 5.16, N-(2-mercaptopropionyl)-glycine (1 mM) similarly 
had neither an effect by itself on albumin transfer across monolayers of 
BAEC relative to control levels, nor did it inhibit the increase in albumin 
transfer induced when it was added in combination with hypoxanthine 
(0.2 mM) and xanthine oxidase (20 mU m l'l).
As with dimethylthiourea, the use of higher concentrations of N-(2- 
mercaptopropionyD-glycine was not possible since above 1 mM, it was 
found itself to induce an irreversible block in albumin transfer across 
endothelial cell monolayers. This may have been due to some interaction 
occurring between N-(2-mercaptopropionyl)-glycine and the endothelial 
cells themselves, the polycarbonate membranes on which they were grown, 
or some component of the trypan blue-labelled albumin complex.
These results (Figures 5.14-5.16) therefore indicate that it is unlikely that 
hydroxyl radical plays a role in mediating the endothelial barrier dysfunction
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Figure 5.15 Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
hypoxanthine (HX) and 20 mU m l'l xanthine oxidase (XO) on albumin 
transfer across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 10 mM dimethylthiourea (DMTU) are also shown. 
Each column is the mean of 6  observations with vertical bars representing 
s.e. mean. **p<0 .0 1 ; ***p<0 .0 0 1 , indicates a significant difference from 
Control.
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Figure 5.16 Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
hypoxanthine (HX) and 20 mU ml~l xanthine oxidase (XO) on albumin 
transfer across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 1 mM N-(2-mercaptopropionyl)-glycine (MPG) are 
also shown. Each column is the mean of 6  observations with vertical bars 
representing s.e. mean. ***p<0 .0 0 1 , indicates a significant difference from 
Control.
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induced by the hypoxanthine-xanthine oxidase free radical generating 
system.
If hydroxyl radical is being produced by the hypoxanthine-xanthine oxidase 
system, however, it is most probably being formed through the Fenton 
reaction which relies on a source of intracellular iron. Hence, in order to 
independently assess if production of hydroxyl radical via the Fenton 
reaction is involved in mediating the hypoxanthine-xanthine oxidase- 
induced permeability increase, the effects of both removing and augmenting 
available iron were then investigated.
The effects of deferoxamine, an iron chelator (Starke & Farber, 1985), on 
the permeability increase induced by the hypoxanthine-xanthine oxidase 
system are shown in Figure 5.17. Deferoxamine (500 /iM) was found to 
have no effect compared to control levels when added alone to monolayers 
of BAEC and was observed to have no inhibitory effect on the increase in 
albumin transfer obtained when added concomitantly with hypoxanthine 
(0.2 mM) and xanthine oxidase (20 mU ml~l).
Since, when added concomitantly in this way, deferoxamine is unable to 
enter the endothelial cells, it would therefore only be able to chelate 
extracellular iron. Thus, as shown in Figure 5.18, the experiment was 
repeated with deferoxamine (500 /iM) being added to monolayers of BAEC 
as an overnight pretreatment prior to the addition of hypoxanthine (0.2 mM) 
and xanthine oxidase (20 mU ml~l). This enabled the drug sufficient time 
to enter the endothelial cells and so chelate both intracellular and 
extracellular iron (Starke & Farber, 1985). Following this pretreatment, for 
the purposes of measuring albumin transfer, deferoxamine was re-added 
to both chambers in each monolayer preparation to ensure maximum 
effectiveness. The overnight deferoxamine pretreatment itself was found to
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Figure 5.17 Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
hypoxanthine (HX) and 20 mU m l'l xanthine oxidase (XO) on albumin 
transfer across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 500 /iM deferoxamine (DEF) are also shown. Each 
column is the mean of 6  observations with vertical bars representing s.e. 
mean. ***p<0.001, indicates a significant difference from Control.
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Figure 5.18 Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
hypoxanthine (HX) and 20 mU ml"l xanthine oxidase (XO) on albumin 
transfer across monolayers of bovine aortic endothelial cells. The effects of 
overnight pretreatment with 500 /iM deferoxamine (DEF) are also shown. 
Each column is the mean of 6  observations with vertical bars representing 
s.e. mean. ***p<0.001, indicates a significant difference from Control.
Page 120
Modulation o f  Endothelial Barrier Function Chapter 5
have no effect on albumin transfer relative to control levels. Similarly, the 
pretreatment was found to have no effect on the increase in albumin 
transfer across monolayers of BAEC resulting from subsequent addition of 
hypoxanthine (0.2 mM) and xanthine oxidase (20 mU ml"1).
The effects of augmenting available iron were investigated through addition 
of ferric chloride in combination with hypoxanthine and xanthine oxidase 
(Figure 5.19). Ferric chloride (50 /iM) itself had no effect on albumin 
transfer across monolayers of BAEC relative to control levels after a 90 
minute incubation. Also, when ferric chloride was added in combination 
with hypoxanthine (0.2 mM) and xanthine oxidase (20 mU m l'l), ^  failed 
to enhance the observed increase in albumin transfer.
Taken together, the results of this series of experiments (Figures 5.14- 
5.19) would indicate that hydroxyl radical plays no role in mediating the 
endothelial barrier dysfunction induced by the hypoxanthine-xanthine 
oxidase free radical generating system.
5.3.5 Involvement of nitric oxide and peroxynitrite anion in the 
hypoxanthine-xanthine oxidase-induced increase in albumin 
transfer
Beckman et al. (1990) proposed that an interaction can take place between superoxide anion produced by the hypoxanthine-xanthine 
oxidase system and nitric oxide released from endothelial cells, leading to 
the formation of the peroxynitrite anion. This anion is itself a powerful 
oxidant and, additionally, undergoes decomposition leading to the formation 
of nitrogen dioxide radical and hydroxyl radical, by a mechanism which 
does not involve iron catalysation. The inability of superoxide dismutase 
(30 and 6000 U m l'1) to inhibit the permeability increase induced by the
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Figure 5.19 Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
hypoxanthine (HX) and 20 mU ml-1  xanthine oxidase (XO) on albumin 
transfer across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 50 /iM ferric chloride (FeC^) are also shown. 
Each column is the mean of 6  observations with vertical bars representing 
s.e. mean. **p<0 .0 1 ; ***p<0 .0 0 1 , indicates a significant difference from 
Control.
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hypoxanthine-xanthine oxidase system has already been demonstrated 
(Figures 5.6-5.7). However, in order to independently investigate the 
involvement of nitric oxide and/or peroxynitrite anion in mediating this 
permeability increase, the effects of the nitric oxide synthase inhibitor, 
l-NOARG were studied.
Figure 5.20 shows that l-NOARG (30 /iM) itself had no effect on albumin 
transfer across monolayers of BAEC relative to control levels during a 90 
minute incubation. Additionally, w hen added in combination with 
hypoxanthine (0.2 mM) and xanthine oxidase (20 mU ml-*), it exhibited 
no inhibitory effect on the resultant increase in albumin transfer indicating 
that nitric oxide does not play a role in mediating this increase. This would 
suggest that it is unlikely that peroxynitrite, formed through the interaction 
of superoxide anion and nitric oxide, contributes to the endothelial barrier 
dysfunction induced by the hypoxanthine-xanthine oxidase system.
5.3.6 Involvement of hypochlorous acid in the hypoxanthine- 
xanthine oxidase-induced increase in albumin transfer
Hypochlorous acid is a known product of the activated neutrophil (Lewis & Granger, 1986) which may be formed by the enzyme 
myeloperoxidase in the presence of both hydrogen peroxide and chloride 
ions (Halliwell & Gutteridge, 1989). Dithiothreitol has been shown to reverse 
the damaging effects of hypochlorous acid on both calcium homeostasis 
in rabbit isolated ventricular myocytes (Eley et al., 1991) and cardiac 
muscle contractile function during ischaemia-reperfusion injury (Eley et al., 
1989). Thus, in order to determine if hypochlorous acid also plays a role 
in the permeability increase induced by the hypoxanthine-xanthine oxidase 
free radical generating system, the effects of dithiothreitol were studied.
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Figure 5.20 Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
hypoxanthine (HX) and 20 mU ml“l xanthine oxidase (XO) on albumin 
transfer across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 30 jjM N^-nitro-L-arginine (l-NOARG) are also 
shown. Each column is the mean of 6  observations with vertical bars 
representing s.e. mean. ***p<0 .0 0 1 , indicates a significant difference from 
Control.
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When added alone, dithiothreitol (3 mM) had no effect on albumin transfer 
across BAEC relative to the control value during a 90 minute incubation, 
and when it was added concomitantly with hypoxanthine (0.2 mM) and 
xanthine oxidase (20 mU ml“l), it failed to show any inhibitory effect on 
the observed increase in albumin transfer (Figure 5.21). This would indicate 
that hypochlorous acid plays no role in mediating the permeability increase 
induced by hypoxanthine and xanthine oxidase.
5.4 Study of the effects of homocysteine on barrier 
function
5.4.1 Effects of homocysteine and copper sulphate on albumin 
transfer
Homocysteine is a recognised risk factor for atherosclerosis, a condition in which a key role of its development is played by dysfunction of 
the endothelial barrier. Therefore, having established more about the way 
in which the hypoxanthine-xanthine free radical generating oxidase system 
modulates barrier function, the ability of homocysteine to affect endothelial 
monolayer permeability was then investigated.
When added alone to monolayers of BAEC at either 0.5 mM or 1.5 mM, 
homocysteine was found to exhibit no significant alteration in albumin 
transfer relative to control levels during a 90 minute incubation (Figure 
5.22). Starkebaum & Harlan (1986) demonstrated, however, that homo­
cysteine can undergo copper-catalysed oxidation. This process may occur 
in vivo through the actions of copper present as circulating caeruloplasmin 
but may be simulated in vitro using copper in the form of copper sulphate 
for sake of both convenience and economy. Thus, the effects of addition 
to endothelial monolayers of homocysteine in the presence of copper
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Figure 5.21 Graph showing the effects of 90 minutes’ exposure to 0.2 mM 
hypoxanthine (HX) and 20 mU ml" 1 xanthine oxidase (XO) on albumin 
transfer across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 3 mM dithiothreitol (DTT) are also shown. Each 
column is the mean of 6  observations with vertical bars representing s.e. 
mean. ***p<0.001, indicates a significant difference from Control.
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Figure 5.22 Graph showing the effects of 90 minutes’ exposure to 0, 0.5 
and 1.5 mM homocysteine (HC) on albumin transfer across monolayers of 
bovine aortic endothelial cells (CHI). The effects of concomitant addition 
of copper sulphate at 5 /iM (&S3) and 50 ju M  (fZ Z f) are also shown. Each 
column is the mean of 6  observations with vertical bars representing s.e. 
mean. ***p<0.001, indicates a significant difference from control (no HC, 
no copper sulphate).
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sulphate were studied. When homocysteine at either 0.5 mM or 1.5 mM 
was added in combination with copper sulphate at a concentration of 
50 /iM, significant increases in albumin transfer were observed. Within the 
limited concentration range tested, this increase would appear to be 
concentration-dependent on the concentration of homocysteine, giving an 
increase in albumin equilibration from the control level of 6.9±1.0 to 
14.8±0.6% at 0.5 mM homocysteine and 20.8±2.0% at 1.5 mM homocysteine. 
Similarly, the increase was found to be concentration-dependent on the 
copper sulphate concentration. When 1.5 mM homocysteine was added in 
combination with copper sulphate at 5 /iM, it produced a significant increase 
in monolayer permeability reaching 13.9±1.4% (compared to 20.8±2.0% 
for the combination of 1.5 mM homocysteine and 50 /iM copper sulphate). 
It can be clearly seen, therefore, that copper-catalysed oxidation of 
homocysteine, rather than addition of homocysteine itself, can cause an 
increase in endothelial permeability.
In all further experiments involving homocysteine and copper sulphate, 
standard concentrations of 1.5 mM homocysteine and 50 /iM copper 
sulphate were chosen to induce an increase in albumin transfer across 
endothelial monolayers. These concentrations gave a sufficient stimulation 
of albumin transfer against which the effects of potential inhibitors could 
be guaged.
To establish whether superoxide anion plays a contributory role in mediating 
the endothelial barrier dysfunction induced by the copper-catalysed 
oxidation of homocysteine, superoxide dismutase (6000 U ml"l) was co­
incubated with homocysteine and copper sulphate (added to endothelial 
monolayers at the chosen standard concentrations of 1.5 mM and 50 /iM, 
respectively) (Figure 5.23). Superoxide dismutase itself had no effect on 
albumin transfer across monolayers of BAEC and was also found to be
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Figure 5.23 Graph showing the effects of 90 minutes’ exposure to 1.5 mM 
homocysteine (HC) and 50 /iM copper sulphate (CUSO4 ) on albumin transfer 
across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 6000 U m \~^  superoxide dismutase (SOD) are also 
shown. Each column is the mean of 6  observations with vertical bars 
representing s.e. mean. ***p<0 .0 0 1 , indicates a significant difference from 
Control.
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without effect when added in combination with homocysteine and copper 
sulphate. This would indicate that superoxide anion is not involved in 
mediating the endothelial barrier dysfunction induced by homocysteine 
and copper sulphate.
To investigate any involvement of hydrogen peroxide in the homocysteine- 
copper sulphate-induced permeability increase, the effects of catalase 
(1-100 U ml-1) were studied (Figure 5.24). At all the concentrations of 
catalase investigated, it was found to abolish the increase in albumin transfer 
across monolayers of BAEC stimulated by homocysteine (1.5 mM) and 
copper sulphate (50 /iM). Thus, as was the case with the hypoxanthine- 
xanthine oxidase system, hydrogen peroxide appears to play a key role in 
mediating the endothelial barrier dysfunction.
5.4.2 Involvement of hydroxyl radical in the homocysteine-copper 
sulphate-induced increase in albumin transfer
As was considered with the hypoxanthine-xanthine oxidase system, hydrogen peroxide may not be the sole mediator of the homocysteine- 
copper sulphate-induced increase in endothelial monolayer permeability 
and may instead, for example, be a necessary precursor for some other 
damaging species. Therefore, the involvement of hydroxyl radical was 
investigated.
Figure 5.25 shows the effects of the membrane-impermeant hydroxyl radical 
scavenger, mannitol (15 mM), on the increase in albumin transfer across 
monolayers of BAEC induced by homocysteine (1.5 mM) and copper 
sulphate (50 /iM) during a 90 minute incubation. Addition of mannitol 
itself did not effect the level of albumin transfer relative to the control 
level. Similarly, when it was co-incubated with homocysteine and copper
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Figure 5.24 Graph showing albumin transfer across monolayers of bovine 
aortic endothelial cells after 9 0  m inutes’ incubation both in the 
presence (EZ23) and absence (□□) of 1.5 mM homocysteine and 50 p tM  
copper sulphate. The effects of concomitant addition of 1-100 U ml" 1 
catalase (CAT) are also shown. Each column is the mean of 6-9 observations 
with vertical bars representing s.e. mean. ***p<0 .0 0 1 , indicates a significant 
difference from Control.
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Figure 5.25 Graph showing the effects of 90 minutes’ exposure to 1.5 mM 
homocysteine (HC) and 50 /iM copper sulphate (CUSO4 ) on albumin transfer 
across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 15 mM mannitol (MAN) are also shown. Each 
column is the mean of 6  observations with vertical bars representing s.e. 
mean. ***p<0.001, indicates a significant difference from Control.
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sulphate, mannitol had no effect on the observed increase in albumin 
transfer.
The effects of the membrane-permeant hydroxyl radical scavenger, 
dimethylthiourea (1 mM), are shown in Figure 5.26. When added alone to 
monolayers of BAEC, dimethylthiourea was found to have no effect on 
albumin transfer. Furthermore, when it was co-incubated with homocysteine 
(1.5 mM) and copper sulphate (50 /iM), it was found to have no inhibitory 
effect on the increase in albumin transfer observed.
In order to investigate any involvement of the Fenton reaction which could 
lead to the generation of hydroxyl radical (Repine et al., 1981), the effects 
of the iron chelator, deferoxamine (500 /iM), were then investigated (Figure 
5.27). As before, deferoxamine was added to monolayers of BAEC as an 
overnight pretreatment prior to the addition of homocysteine (1.5 mM) and 
copper sulphate (50 /iM). For the purposes of measuring albumin transfer, 
deferoxamine was re-added on commencing the experiment. The overnight 
pretreatment itself was found to have no effect on albumin transfer relative 
to control levels during a 90 minute incubation and also was without effect 
on the increase in albumin transfer stimulated by the subsequent addition 
of homocysteine and copper sulphate.
Taking these results together (Figures 5.25-5.27), it would therefore seem 
unlikely that the generation of hydroxyl radical plays a role in mediating 
the barrier dysfunction induced by the homocysteine-copper sulphate 
system.
Page 133
M odulation o f  Endothelial Barrier Function Chapter 5
30 -i
- Qca
o
"ca
-Q
2 5 -
2 0 -
1 5 -
.B- 10-
5 -
Control HC
C11SO4
DMTU HC 
C11SO4 
DMTU
Figure 5.26 Graph showing the effects of 90 minutes’ exposure to 1.5 mM 
homocysteine (HC) and 50 /iM copper sulphate (CUSO4 ) on albumin transfer 
across monolayers of bovine aortic endothelial cells. The effects of 
concomitant addition of 1 mM dimethylthiourea (DMTU) are also shown. 
Each column is the mean of 6  observations with vertical bars representing 
s.e. mean. ***p<0.001, indicates a significant difference from Control.
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Figure 5.27 Graph showing the effects of 90 minutes’ exposure to 1.5 mM 
homocysteine (HC) and 50 p iM  copper sulphate (CUSO4 ) on albumin transfer 
across monolayers of bovine aortic endothelial cells. The effects of overnight 
pretreatment with 500 b M  deferoxamine (DEF) are also shown. Each column 
is the mean of 6  observations with vertical bars representing s.e. mean. 
*p<0.05; **p<0.01, indicates a significant difference from Control.
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C hapter 6
6.1 Study of the effects of bacterial endotoxin on 
barrier function
6.1. 1 Effects of lipopolysaccharide (LPS) on albumin transfer
Endotoxin, also known as lipopolysaccharide (LPS), derived from gram- negative bacteria is a common cause of septic shock, a condition 
characterised by severe hypotension, hyporeactivity to vasoconstrictors and 
profound vascular leakage leading to multiple organ failure and ultimately 
death (Pinsky et al., 1993). Whilst it is now accepted that the severe 
hypotension of septic shock results from the production of nitric oxide 
(Parker & Adams, 1993), little is known of the m ediators) responsible for 
the associated vascular leakage. Hence, by using the in vitro model of 
endothelial permeability employed in this study, the ability of LPS to induce 
barrier dysfunction was investigated.
Figure 6.1 shows the effects of LPS (0-1000 ng m l'l)  from Salmonella 
typhosa on albumin transfer, measured during a 90 minute incubation 
period, following the exposure of BAEC monolayers in culture to LPS for 
24 hours. LPS was found to exhibit a concentration-dependent increase in 
albumin transfer, demonstrating statistically significant increases at 
concentrations of 3 ng m l'l and greater. The maximum level of albumin 
transfer achieved was 39.9*2.6% at a concentration of 1000 ng m l'l of LPS. 
This therefore demonstrates the ability of LPS to induce endothelial barrier 
dysfunction through a direct action on the endothelium.
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Figure 6.1 Graph showing the effects of 24 hours’ prior exposure to 
0-1000 ng ml~l lipopolysaccharide (LPS) on albumin transfer across 
monolayers of bovine aortic endothelial cells during a 9 0  minute incubation 
period. Each column is the mean of 6-23 observations with vertical bars 
representing s.e. mean. **p<0 .0 1 ; ***p<0 .0 0 1 , indicates a significant difference 
from control (0 ng ml-* LPS).
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From the concentration-response curve, a standard LPS concentration of 
30 ng m l'l was chosen for use in all subsequent experiments. This 
concentration was sufficiently high to yield a consistently reproducible 
response in terms of its effects on albumin transfer whilst yet being 
sufficiently sub-maximal to enable the effects of possible inhibitors of its 
action to be investigated.
The time-course of the development of the increase in albumin transfer 
induced by 30 ng m l'l pps was examined as shown in Figure 6.2. This 
time-course was found to be biphasic in nature with two distinct peaks. 
An early, transient peak (45.6±3.7%) was observed after around 2 hours’ 
exposure to LPS which was followed by a decline in the level of albumin 
transfer to near basal levels. The level of transfer was then observed to rise 
once again, approaching a maximum (44.4±4.7%) by 24 hours. In order to 
ensure that this biphasic time-course was not merely the result of 
experimental error, this experiment was repeated on three separate 
occasions with three different batches of cells (data not shown). A similar 
biphasic profile was, however, observed on these occasions demonstrating 
that the original observation was clearly not just one aberrant finding.
The increases in albumin transfer stimulated following both 2 hours’ and 
24 hours’ exposure to LPS are conceivably m ediated by different 
mechanisms. Thus, in subsequent experiments in which the mechanisms 
of action of LPS were investigated, these were in the main conducted on 
both 2 hours’ and 24 hours’ exposures to LPS.
Polymixin B is an inhibitor of the actions of LPS which acts by binding the 
LPS molecule with high affinity (Lasfargues et al., 1989). Figure 6.3 shows 
the effects of concomitant addition of Polymixin B (10 pg  m l'l) Qn a 
2 hour exposure to LPS (added at the chosen standard concentration of
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Figure 6.2 Graph showing the time-course of the development of the 
increase in albumin transfer across monolayers of bovine aortic endothelial 
cells induced by 30 ng ml"l lipopolysaccharide. The time points indicate 
the duration of prior exposure to LPS but in each case albumin transfer 
was measured over a subsequent 90 minute period. Each point is the 
mean of 12-24 observations with vertical bars representing s.e. mean. 
**p<0 .0 1 ; ***p<0 .0 0 1 , indicates a significant difference from control ( 0  hours).
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Figure 6.3 Graph showing the effects of 2 hours’ exposure to 30 ng ml-1  
lipopolysaccharide (LPS) on albumin transfer across monolayers of bovine 
aortic endothelial cells during a 90 minute incubation period. The effects 
of concomitant addition of 10 u g  ml"* polymixin B (PMB) are also shown. 
Each column is the mean of 6  observations with vertical bars representing 
s.e. mean. **p<0.01, indicates a significant difference from Control. MpcO.Ol, 
indicates a significant difference between groups joined by a bracket.
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30 ng m l'l). Polymixin B itself did not affect the level of albumin transfer, 
measured during a 90 minute incubation period, relative to the control 
value. However, when it was added in combination with LPS, it was found 
to abolish the resultant increase.
Similarly, in Figure 6.4 the effects of polymixin B (10 /ig m l'l)  on a 2 4  
hour exposure to LPS (30 ng m l'l) are shown. Again, by itself, polymixin 
B had no effect compared to control and, again, when it was added in 
combination with LPS, it abolished the induced increase in albumin transfer 
observed during a 90 minute incubation period.
These results (Figures 6.3-6.4) show that is possible, using this in vitro 
model of the endothelial barrier, to effectively demonstrate an inhibition 
of the increases in albumin transfer induced by LPS.
6.1.2 Involvement of the L-arginine-nitric oxide system in the LPS- 
induced increase in albumin transfer
In order to establish if the L-arginine-nitric oxide system plays a role in mediating the endothelial barrier dysfunction induced by incubation 
with LPS, various experiments were subsequently conducted. The first set 
of these experiments involved looking at the effects of various nitric oxide 
synthase inhibitors on the increases in albumin transfer across BAEC induced 
by LPS.
Figure 6.5 shows the effects of 100 /iM N® -nitro-L-arginine (l-NOARG) on 
the increase in albumin transfer stimulated by 24 hours’ exposure to LPS 
(30 ng m l'l)  and measured during a subsequent 60 minute incubation 
period. When added alone to BAEC monolayers, l-NOARG did not itself 
significantly affect the level of albumin transfer compared to control levels
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Figure 6.4 Graph showing the effects of 24 hours’ exposure to 30 ng m l'l 
lipopolysaccharide (LPS) on albumin transfer across monolayers of bovine 
aortic endothelial cells during a 90 minute incubation period. The effects 
of concomitant addition of 10 /ig ml" 1 polymixin B (PMB) are also shown. 
Each column is the mean of 6  observations with vertical bars representing 
s.e. mean. ***p<0.001, indicates a significant difference from Control. 
MtpO.OOl, indicates a significant difference between groups joined by a 
bracket.
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Figure 6.5 Graph showing the effects of 24 hours’ exposure to 30 ng ml-1  
lipopolysaccharide (LPS) on albumin transfer across monolayers of bovine 
aortic endothelial cells during a 60 minute incubation period. The effects 
of concomitant addition of 100 /iM N^-nitro-L-arginine (l-NOARG) are 
also shown. Each column is the mean of 6  observations with vertical bars 
representing s.e. mean. ***p<0 .0 0 1 , indicates a significant difference from 
Control.
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and when it was added in combination with LPS, it showed no inhibitory 
effect on the stimulated increase in albumin transfer.
Since l-NOARG is a relatively insoluble substance in aqueous solutions, 
and since it is possible that the reason for its failure to show an inhibition 
was because it was not added at a sufficiently high concentration, subsequent 
experiments were carried out using its more soluble methyl ester form, 
N®-nitro-L-arginine methyl ester (l-NAME). This therefore allowed higher 
concentrations of the drug to be studied. Thus, the effects of L-NAME 
(500 /iM) on a 2 hour incubation with LPS (30 ng ml"l) were investigated 
(Figure 6 .6 ). l-NAME itself did not affect the level of albumin transfer, 
measured during a 90 minute incubation period, compared to control 
levels. Also, when it was added concomitantly with LPS, it failed to show 
any inhibition of the induced increase in albumin transfer.
Similarly, the effects of L-NAME (500 /iM) on a 24 hour incubation with LPS 
(30 ng ml-l)  are shown in Figure 6.7. l-NAME itself had no significant 
effect on albumin transfer across BAEC monolayers, measured during a 
90 minute incubation period, relative to control levels. Furthermore, when 
it was added in combination with LPS, it again failed to show any inhibitory 
effect on the resultant increase in albumin transfer.
Figure 6 .8  shows the effects of another nitric oxide synthase inhibitor, 
N^-m onom ethyl-L-arginine (l-NMMA), added at an even higher 
concentration of 2 mM, on the increase in albumin transfer across BAEC 
monolayers stimulated by 2 hours’ exposure to LPS (30 ng ml~l). Again, 
addition of the inhibitor itself did not significantly alter the level of albumin 
transfer, measured during a 90 minute incubation period, compared to 
control levels. Also, when it was added in combination with LPS, rather 
than inhibiting the induced increase in albumin transfer, it was observed
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Figure 6.6 Graph showing the effects of 2 hours’ exposure to 30 ng ml"l 
lipopolysaccharide (LPS) on albumin transfer across monolayers of bovine 
aortic endothelial cells during a 90 minute incubation period. The effects 
of concomitant addition of 500 /iM N^-nitro-L-arginine methyl ester 
(l-NAME) are also shown. Each column is the mean of 6  observations with 
vertical bars representing s.e. mean. ***p<0 .0 0 1 , indicates a significant 
difference from Control.
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Figure 6.7 Graph showing the effects of 24 hours’ exposure to 30 ng ml-1  
lipopolysaccharide (LPS) on albumin transfer across monolayers of bovine 
aortic endothelial cells during a 90 minute incubation period. The effects 
of concomitant addition of 500 /iM N^-nitro-L-arginine methyl ester 
(l-NAME) are also shown. Each column is the mean of 6  observations with 
vertical bars representing s.e. mean. ***p<0 .0 0 1 , indicates a significant 
difference from Control.
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Figure 6.8 Graph showing the effects of 2 hours’ exposure to 30 ng ml-1  
lipopolysaccharide (LPS) on albumin transfer across monolayers of bovine 
aortic endothelial cells during a 90 minute incubation period. The effects 
of concomitant addition of 2 mM N^-monomethyl-L-arginine (l-NMMA) 
are also shown. Each column is the mean of 6  observations with vertical 
bars representing s.e. mean. ***p<0 .0 0 1 , indicates a significant difference 
from Control. WtpcO.OOl, indicates a significant difference between groups 
joined by a bracket.
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to enhance it. Though this enhancement was small in magnitude, it was 
found to be statistically significant.
The effects of l-NMMA (2 mM) on the increase in albumin transfer induced 
by a 24 hour incubation with LPS (30 ng m l'l) were also investigated 
(Figure 6.9). Again, l-NMMA itself was observed to exhibit no significant 
effect on the level of albumin transfer across monolayers of BAEC, measured 
during a 90 minute incubation period, compared to control levels. When 
l-NMMA was added concomitantly with LPS, it was again found to cause 
a small, but significant enhancement in the induced level of albumin transfer 
rather than causing an inhibition.
These results (Figures 6 .5-6.9) therefore show that blocking the synthesis 
of nitric oxide, using inhibitors of nitric oxide synthase, does not appear 
to prevent induction of the increase in albumin transfer across monolayers 
of BAEC induced by both 2 hours’ and 24 hours’ exposure to LPS.
To assess independently if the L-arginine-nitric oxide system is involved in 
mediating the LPS-induced increase in albumin transfer, the effects of 
dexamethasone, a glucocorticoid which inhibits the induction of the Ca^+- 
independent, inducible form of nitric oxide synthase (Moncada, 1992), 
were investigated.
In initial experiments with dexamethasone (1 /iM), the drug was added as 
a pretreatment 30 minutes prior to the addition of LPS. The effects of this 
30 minute pretreatment on a 24 hour exposure to LPS (30 ng ml"1) are 
shown in Figure 6.10. Dexamethasone itself had no significant effect on 
albumin transfer across BAEC monolayers measured during a subsequent 
30 minute incubation period. When dexamethasone was added as a
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Figure 6.9 Graph showing the effects of 24 hours’ exposure to 30 ng ml" 1 
lipopolysaccharide (LPS) on albumin transfer across monolayers of bovine 
aortic endothelial cells during a 90 minute incubation period. The effects 
of concomitant addition of 2 mM N^-monomethyl-L-arginine (l-NMMA) 
are also shown. Each column is the mean of 6  observations with vertical 
bars representing s.e. mean. ***p<0 .0 0 1 , indicates a significant difference 
from Control. ^<0.05, indicates a significant difference between groups 
joined by a bracket.
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Figure 6.10 Graph showing the effects of 24 hours’ exposure to 
30 ng ml"! lipopolysaccharide (LPS) on albumin transfer across monolayers 
of bovine aortic endothelial cells during a 3 0  minute incubation period. 
The effects of 30 minutes’ pretreatment with 1 / j M  dexamethasone (DEX) 
are also shown. Each column is the mean of 6  observations with vertical 
bars representing s.e. mean. ***p<0 .0 0 1 , indicates a significant difference 
from Control.
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pretreatment to LPS, it was found to be without any inhibitory effect on the 
stimulated increase.
Since it is possible that a 30 minute pretreatment may not be sufficiently 
long to enable dexamethasone to be fully effective, the duration of the 
pretreatment was subsequently extended to 20 hours. Figure 6.11 shows 
the effects of a 20 hour pretreatment with dexamethasone (1 /iM) on a 
subsequent 2 hour incubation with LPS (30 ng m l'l). The dexamethasone 
pretreatment did not, in itself, affect albumin transfer, measured during a 
90 minute incubation period, compared to control levels. Also, when it 
was added as a pretreatment to LPS, it was found to be without any 
significant effect on the LPS-induced increase in albumin transfer.
Figure 6.12 shows the effects of a 20 hour pretreatment with dexamethasone 
(1 /iM) on the increase in albumin transfer induced by 24 hours’ exposure 
to LPS (30 ng ml"l) measured during a 90 minute incubation period. Again, 
the dexamethasone pretreatment itself had no effect, and again when it 
was added as a pretreatment to the addition of LPS, it showed no inhibitory 
effect.
These results (Figures 6.10-6.12) show that preventing the induction of 
nitric oxide synthase does not inhibit the increases in albumin transfer 
across BAEC monolayers induced by exposure to LPS for either 2 hours or 
24 hours. Taking these results together with the results shown in Figures 
6 .5 - 6 .9 , it would appear therefore that nitric oxide does not play a role in 
mediating the endothelial barrier dysfunction observed on exposure of 
BAEC to LPS.
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Figure 6.11 Graph showing the effects of 2 hours’ exposure to 30 ng ml" 1 
lipopolysaccharide (LPS) on albumin transfer across monolayers of bovine 
aortic endothelial cells. The effects of 20 hours’ pretreatment with 1 /iM 
dexamethasone (DEX) are also shown. Each column is the mean of 6  
observations with vertical bars representing s.e. mean. **p<0 .0 1 ; ***p<0 .0 0 1 , 
indicates a significant difference from Control.
Page 152
M odulation o f  Endothelial Barrier Function Chapter 6
35
c
EZJ
co
30-
25-
2 0 -
o
"co
- Q
"E5CT
8  15-
CO
1 0 -
5-
Control LPS DEX LPS
DEX
Figure 6.12 Graph showing the effects of 24 hours’ exposure to 
30 ng ml'* lipopolysaccharide (LPS) on albumin transfer across monolayers 
of bovine aortic endothelial cells during a 9 0  minute incubation period. 
The effects of 20 hours’ pretreatment with 1 /iM dexamethasone (DEX) are 
also shown. Each column is the mean of 6  observations with vertical bars 
representing s.e. mean. ***p<0 .0 0 1 , indicates a significant difference from 
Control.
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6 .1.3 Involvement of prostaglandins in the LPS-induced increase in 
albumin transfer
Prostaglandins have been implicated in the development of septic shock (Parratt & Sturgess, 1975). Hence, in order to investigate if prostaglandin 
production plays a role in LPS-induced endothelial barrier dysfunction, the 
effects of the flurbiprofen, a cyclo-oxygenase inhibitor, were studied.
Flurbiprofen (30 )L/M) did not itself effect albumin transfer across BAEC, 
measured during a 6 0  minute incubation period, compared to control 
levels when added alone (Figure 6.13). Also, when flurbiprofen was added 
concomitantly with a 24 hour exposure to LPS, it was found to be ineffective 
in inhibiting the induced increase in albumin transfer.
This result would indicate that the production of prostaglandins plays no 
role in the mediating the endothelial barrier dysfunction induced by a 24 
hour incubation with LPS.
6 .1.4 Involvement of hydrogen peroxide in the LPS-induced increase 
in albumin transfer
> was shown in the previous chapter, hydrogen peroxide plays a key
ole in mediating the endothelial barrier dysfunction induced by 
both the hypoxanthine-xanthine oxidase and homocysteine-copper free 
radical generating systems. Thus, in order to determine if hydrogen peroxide 
is also involved in mediating the barrier dysfunction induced by LPS, the 
effects of catalase were investigated. The catalase concentration studied 
was 1000 U ml"l. This concentration was chosen as it is a substantially 
high concentration which is many-fold in excess of that which was found 
to be effective in abolishing the endothelial barrier dysfunction induced by
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Figure 6.13 Graph showing the effects of 24 hours’ exposure to 
30 ng ml"* lipopolysaccharide (LPS) on albumin transfer across monolayers 
of bovine aortic endothelial cells during a 6 0  minute incubation period. 
The effects of concomitant addition of 30 /iM flurbiprofen (FPB) are also 
shown. Each column is the mean of 6  observations with vertical bars 
representing s.e. mean. **p<0 .0 1 , indicates a significant difference from 
Control.
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either the hypoxanthine-xanthine oxidase system or the homocysteine- 
copper system.
Catalase (1000 U ml~l) itself was found to have no effect when compared 
to the control level of albumin transfer across BAEC monolayers measured 
during a 30 minute incubation period (Figure 6.14). When catalase was 
added in combination with a 24 hour incubation with LPS (30 ng ml~l), it 
was found to exhibit no inhibitory action on the resultant increase in 
albumin transfer.
This result therefore indicates that hydrogen peroxide is not involved in 
mediating the increase in albumin transfer induced by a 24 hour exposure 
to LPS.
6.2 Effects of interferon-y (IFN-y) on barrier function
Stolpen e t  a l .  (1986) demonstrated the ability of IFN-y to alter cell shape and morphology using monolayers of human umbilical vein 
endothelium. Additionally, IFN-y expression i n  v i v o  has been shown in 
mice to be up-regulated following stimulation with LPS (Cockfield e t  a l . ,  
1993) and thus IFN-y could conceivably be a mediator of LPS-induced 
endothelial barrier dysfunction. Consequently, the ability of IFN-y to induce 
an increase in albumin transfer was investigated.
The effects of 24 hours’ exposure of BAEC monolayers to IFN-y (0.75-75 
U ml"l) are shown in Figure 6.15. At all the concentrations tested, IFN-y 
was found to be without effect on the level of albumin transfer, measured 
during a 90 minute incubation period, compared to basal levels. Thus it 
would appear that IFN-y does not directly affect endothelial barrier function 
over a 24 hour time period within the concentration range tested.
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Figure 6.14 Graph showing the effects of 24 hours’ exposure to 
30 ng ml-1  lipopolysaccharide (LPS) on albumin transfer across monolayers 
of bovine aortic endothelial cells during a 30 minute incubation period. 
The effects of concomitant addition of 1000 U ml-1 catalase (CAT) are also 
shown. Each column is the mean of 6  observations with vertical bars 
representing s.e. mean. ***p<0 .0 0 1 , indicates a significant difference from 
Control.
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Figure 6.15 Graph showing the effects of 24 hours’ exposure to 
0-75 U m l'l interferon-y (IFN-y) on albumin transfer across monolayers of 
bovine aortic endothelial cells during a 90 minute incubation period. Each 
column is the mean of 6 observations with vertical bars representing s.e. 
mean.
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C h a p t e r  7
7.1 Effects of the hypoxanthine-xanthine oxidase 
system
7.1.1 Production of reactive oxygen species
he hypoxanthine-xanthine oxidase free radical generating system has
been widely implicated as a major cause of the damage which results 
from ischaemia-reperfusion injury (Jones et al., 1968; Crowell et al., 1969; 
DeWall et al., 1971; Hansson et al., 1983; Adkison et al., 1986), including 
damage specifically to the vascular endothelium (Braunwald & Kloner, 
1986). However, before investigating the actions of the hypoxanthine- 
xanthine system on endothelial barrier function in this study, it was necessary 
to validate the ability of the system to generate reactive oxygen species. 
This therefore enabled the establishment of suitable reagent concentrations, 
reaction conditions and an appropriate time-course for the production of 
reactive oxygen species.
The cytochrome C assay is an established assay which has been used to 
demonstrate the production of superoxide anion (Fridovich, 1970). In this 
study, neither hypoxanthine nor xanthine alone were found to have any 
effect on the oxidation state of an oxidised sample of cytochrome C, but 
when both were present in combination, an initial rapid reduction of the 
sample was observed indicating that formation of a reducing species was 
occurring. Only when both hypoxanthine and xanthine oxidase were present 
in combination was this reducing species produced, indicating that the 
complete enzyme-substrate system is needed for this to occur.
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In the presence of superoxide dismutase, which rapidly converts superoxide 
anion to hydrogen peroxide, the initial rapid reduction of cytochrome C 
was inhibited. This finding therefore confirmed that the reducing species 
formed by the reaction between hypoxanthine and xanthine oxidase was 
superoxide anion.
The initial rapid reduction of cytochrome C in the control response to 
hypoxanthine and xanthine oxidase was found to give way after around 
15 minutes to a more slowly developing reoxidation. This reoxidation 
could be blocked in the presence of catalase, which breaks down hydrogen 
peroxide to water and oxygen, therefore indicating that it is caused by the 
production of hydrogen peroxide which can be produced spontaneously 
from superoxide anion or through the actions of superoxide dismutase.
These results confirm the ability of the hypoxanthine-xanthine oxidase 
system to generate both superoxide anion and hydrogen peroxide. This 
finding therefore concurs with previous reports describing the generation 
of these species by hypoxanthine and xanthine oxidase (McCord & 
Fridovich, 1968; Fridovich, 1970).
Although it was not shown using this assay, it is possible that other reactive 
oxygen species may also be produced by the hypoxanthine xanthine oxidase 
system. Since both superoxide anion and hydrogen peroxide are produced, 
and provided there is a sufficient source of ferric iron, it is possible that 
hydroxyl radicals could be formed by the Fenton reaction (Beauchamp & 
Fridovich, 1970; Repine et a l, 1981; Starke & Farber, 1985) as follows:
Fe3+ + 0 2‘ ->■ Fe2+ + 0 2 
Fe2+ + H20 2 -»  Fe3+ + OH + OH'
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Also, since endothelial cells are known to release nitric oxide, it is feasible 
that nitric oxide could react with superoxide anion to generate peroxynitrite 
anion which itself is a powerful oxidant and which can also give rise to 
hydroxyl radical independently of a source of iron (Beckman et al., 1990):
he use of a two-chamber model to measure albumin transfer across
endothelial monolayers as an indicator of endothelial barrier function 
is well established (Taylor et al., 1981; Shasby et al., 1982; Rotrosen & 
Gallin, 1986). Using the particular model employed in this study which 
was originally developed by Gudgeon & Martin (1989), the effects of the 
hypoxanthine-xanthine oxidase system on arterial endothelial barrier 
function of bovine aortic endothelial cell monolayers were studied.
Typically, the basal level of albumin transfer obtained using this system 
during a 90 minute incubation period following addition of trypan blue- 
labelled albumin to the upper chamber of each well was between 2 and 
25%. Previous experiments in this laboratory had shown that the presence 
of endothelial monolayers, substantially retarded albumin transfer compared 
to that obtained across polycarbonate m em branes alone, thereby 
demonstrating the ability of this system to recreate the endothelial barrier 
in vitro. However, since the basal level of albumin transfer varied from 
one batch of cells to another, it was necessary to perform each experiment
NO + 0 2" -»  ONOO'
ONOO" + H+ ONOOH
ONOOH OH + N 0 2
7.1.2 Effects on albumin transfer
Page 162
M odulation o f  Endothelial Barrier Function Chapter 7
with its own internal controls to enable fair comparison of the effects of 
agents being tested against basal levels. Thus, in the main, each individual 
experiment had to be performed using only one batch of cells. Only if 
basal levels were not statistically different between different cell batches 
could the results from these different batches be collated.
Addition of either hypoxanthine or xanthine oxidase alone was found to 
be without effect on the level of albumin transfer obtained compared to 
control levels, but when both were added in combination a significant 
increase resulted. As was found to be the case when using the cytochrome 
C assay to observe the formation of superoxide anion and hydrogen 
peroxide, this would suggest that the full free radical generating system of 
both hypoxanthine and xanthine oxidase together was required in order 
to induce endothelial barrier dysfunction. It would appear, therefore, that 
this barrier dysfunction is likely to be occurring as a result of the reaction 
taking place between hypoxanthine and xanthine oxidase. This observation 
is backed up by the fact that the hypoxanthine-xanthine oxidase-induced 
increase in albumin transfer across endothelial monolayers was inhibited 
by concomitant addition of allopurinol (4 mM), a xanthine oxidase inhibitor 
(Crowell et al., 1969) which inhibits its reaction with hypoxanthine.
The increase above control levels of albumin transfer obtained on addition 
of the standard concentrations chosen for use in this study, i.e. 0.2 mM 
hypoxanthine and 20 mU ml-1 xanthine oxidase, was not maximal. The 
concentration-response curved performed in the presence of a hypoxanthine 
concentration fixed at 0.2 mM showed that greater levels of albumin transfer 
could be obtained by increasing the concentration of xanthine oxidase (up 
to 300 mU ml“l). The standard concentrations were, however, sufficient to 
give a reproducible, sub-maximal increase in albumin transfer against which 
the effects of potential inhibitors could be gauged.
Page 163
M odulation o f  Endothelial Barrier Function Chapter 7
In vivo studies have demonstrated an impairment of endothelial barrier 
function caused by experimentally-induced ischaemia and reperfusion. For 
instance, Svendsen et al. (1991) showed that after 20 minutes occlusion of 
the left anterior descending coronary artery followed by 1 hour of 
reperfusion in dog hearts, an increased capillary perm eability to 
diethylenetriaminepentaacetic acid was observed. The extent to which 
activation of the hypoxanthine-xanthine oxidase system contributes to the 
injury produced on ischaemia followed by reperfusion, including impairment 
of barrier function, remains, however, to be determined. Other factors, 
such as neutrophil activation for instance, may play a more important role 
and, indeed, activated neutrophils have been shown to increase albumin 
transfer across monolayers of bovine pulmonary artery microvessel 
endothelial cells (Siflinger-Bimboim & Malik, 1993; Siflinger-Bimboim et al., 
1993). The mediator of this neutrophil-induced endothelial barrier 
dysfunction has, however, not yet been identified. Neutrophils produce 
many substances including superoxide anion, hypochlorous acid, 
prostanoids and digestive enzymes, all of which are potentially injurious 
to the endothelium, and all of which could therefore be responsible for 
inducing barrier dysfunction. Hydrogen peroxide derived from neutrophil 
release of superoxide anion, has however, been shown to be a major 
mediator of neutrophil-induced killing of endothelial cells (Weiss et al., 
1981), with hydroxyl radical possibly mediating this action (Varani et al., 
1985).
In vitro, the hypoxanthine-xanthine oxidase system has been shown to 
exert a toxic action on cultured calf pulmonary artery cells measured as 
51cr-release (Kvietys et a l, 1989) whilst, in vivo, evidence has shown that 
the hypoxanthine-xanthine oxidase system certainly contributes to injury 
in ischaemia-reperfusion since allopurinol has been found to inhibit the 
injury induced by ischaemia-reperfusion. For instance, allopurinol was found
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to inhibit the deleterious effects on myocardial function measured by various 
indices following occlusion of the left anterior descending coronary artery 
in both dog and sheep (DeWall et al., 1971). Additionally, in rat livers, 
allopurinol inhibited the increases in enzyme activities and oxygen 
consumption which were induced by 2 hours of global ischaemia followed 
by 1 hour of reperfusion (Adkison et al., 1986). Accumulation of hypo­
xanthine accompanied by an increase in xanthine oxidase activity has also 
been observed in many tissues during ischaemia (Granger, 1988). This 
increase in xanthine oxidase activity appears to vary from species to species 
with activity in humans being considerably less than in other species such 
as dog and rat (Southard et al., 1987). Evidence has now also shown that 
both superoxide anion release and an increase in albumin transfer could 
be induced in intro using monolayers of bovine pulmonary microvessel 
endothelial cells placed in hypoxic conditions (0.1% O2 ) for between 2 
and 24 hours, followed by reoxygenation in room air for a period between 
16 seconds and 2 hours (Lum et al., 1992). This indicates that impairment 
of endothelial barrier function can be achieved in the absence of other 
cells, including neutrophils, and can therefore be mediated by the 
endothelial cells themselves.
Using xanthine in combination with xanthine oxidase, Shasby et al. (1985) 
demonstrated an increase in albumin transfer across monolayers of porcine 
pulmonary artery endothelial cells on addition of these agents. This concurs 
with findings in this study in which it was found that substituting xanthine 
for hypoxanthine at the same concentration elicited a similar increase in 
albumin transfer above basal when added in combination with xanthine 
oxidase. Since superoxide anion is produced on both the conversions of 
hypoxanthine to xanthine and xanthine to uric acid, it is conceivable to 
suppose that when using xanthine, it is possible to generate only half the 
amount of superoxide anion compared to that which can be produced
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using hypoxanthine. However, as the concentration response-curve to 
xanthine oxidase performed in this study showed, at the concentration 
used, there is an excess of hypoxanthine present and the rate of reaction 
is limited only by the amount of xanthine oxidase present. Since a similar 
m agnitude of response was obtained using xanthine in place of 
hypoxanthine, it would appear that at the concentrations used there is still 
an excess of substrate and so no difference is seen. It would appear, 
therefore, that xanthine and hypoxanthine can equally well be used as 
substrates for xanthine oxidase, when added at these concentrations, in 
terms of their ability to induce superoxide anion production and endothelial 
barrier dysfunction.
7.1.3 Role of superoxide anion
In order to attempt in this study to establish the nature of the species produced by the hypoxanthine-xanthine oxidase system responsible for 
mediating its effects on barrier function, various potential inhibitors were 
co-incubated with hypoxanthine and xanthine oxidase. The first of these, 
superoxide dismutase, was however found to be ineffective in inhibiting 
the hypoxanthine-xanthine oxidase-induced increase in albumin transfer 
either when added at an initial concentration of 30 U ml-1, or when added 
at a substantially higher concentration of 6000 U ml-*. This latter 
concentration, in particular, should have been more than sufficient to abolish 
any effects produced directly by superoxide anion production and indeed 
using the cytochrome C assay it had been found to almost completely 
abolish the reduction of cytochrome C by hypoxanthine and xanthine 
oxidase. From these findings, it can clearly be concluded that superoxide 
anion is not the damaging species produced by the hypoxanthine-xanthine 
oxidase system responsible for mediating the system’s effects on endothelial 
barrier function.
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These findings, however, would appear to conflict with in vivo reports of 
the actions of superoxide dismutase during ischaemia-reperfusion-induced 
increased capillary permeability in both feline intestine (Granger et al., 
1981; Granger, 1988) and canine coronary vasculature (Dauber, et al., 
1991; Svendsen et al., 1991). In each of these studies, superoxide dismutase 
was found to cause a reduction in the extent of the increase in capillary 
permeability observed. Moreover, superoxide dismutase was found to inhibit 
the increase in capillary permeability seen in vivo in feline intestine following 
intra-arterial infusion of hypoxanthine and xanthine oxidase (Granger, 1988). 
Superoxide dismutase has also been found to be effective in vivo in 
inhibiting ischaemia-reperfusion-induced cell necrosis in feline intestine 
(Parks et al., 1982) and, in vitro, in inhibiting both the cytotoxic effects of 
ischaemia-reperfusion on bovine coronary microvascular endothelial cells, 
determined by 51cr release (Inaunen et al., 1988), and the increase in 
albumin transfer across monolayers of bovine pulmonary microvessel 
endothelial cells induced by hypoxia followed by reoxygenation (Lum 
et al., 1992).
In contrast, Ager & Gordon (1984) found that superoxide dismutase did 
not inhibit the injurious effects of xanthine and xanthine oxidase on cell 
function of porcine aortic endothelial cells measured by K+ efflux, 
prostaglandin production and the release of cytoplasmic purines. 
Additionally, Link & Riley (1988) found that superoxide dismutase had no 
effect on xanthine-xanthine oxidase-induced cell death in a mammalian 
epithelial cell line, GPK. Furthermore, Kvietys et al. (1989) found that 
superoxide dism utase was ineffective in inhibiting the actions of 
hypoxanthine and xanthine oxidase as determined by the induction of 
51cr release from calf pulmonary artery endothelial cells.
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7 .1.4 Role of hydrogen peroxide
Chapter 7
In contrast to the effects of superoxide dismutase, catalase was found in this study to abolish the increase in albumin transfer induced by 
hypoxanthine and xanthine oxidase, thereby strongly implicating hydrogen 
peroxide in mediating the actions of this system on endothelial barrier 
function. This inhibitory effect of catalase appeared to be an all-or-nothing 
response as indicated by the catalase concentration-response curve which 
demonstrated a switch from no inhibitory effect to total abolition of the 
hypoxanthine-xanthine oxidase-induced response on increasing the catalase 
concentration tested from 1 U ml“l  to 3 U m H .
This observed inhibitory effect of catalase would appear to be in agreement 
with reports from other workers. It has been shown, for instance, that 
catalase inhibited xanthine-xanthine oxidase-induced 51cr release from 
bovine pulmonary artery endothelial cells (Martin, 1984), inhibited 
hypoxanthine-xanthine oxidase-induced 51cr release from calf pulmonary 
artery endothelial cells (Kvietys et al., 1989) and prevented cell death 
induced by xanthine and xanthine oxidase in the GPK epithelial cell line 
(Link & Riley, 1988). Catalase was also found to inhibit the increase in 
capillary permeability in dog skeletal muscle induced by ischaemia- 
reperfusion (Korthuis et a l, 1985) as well as the increase in albumin 
transfer across monolayers of bovine pulmonary microvessel endothelium 
induced by hypoxia and reoxygenation (Lum et a l, 1992). Also, when 
added in combination with superoxide dismutase, catalase was found to 
reduce ischaemia-reperfusion-induced infarct size in both canine heart (Jolly 
et al., 1984) and rat brain (Liu et al., 1989). Since in both these studies, 
neither catalase nor superoxide dismutase were tested on their own, it is 
impossible to say, however, whether both were in fact required to reduce 
infarct size or whether either would have been effective on its own.
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The effects of catalase on the increase in albumin transfer induced by 
xanthine and xanthine oxidase were also investigated in this study. Catalase 
was found to exhibit a very similar profile of response when inhibiting this 
increase in albumin transfer compared to that obtained when using 
hypoxanthine as a substrate for xanthine oxidase, and was found to be 
active over precisely the same concentration-range (1-3 U ml"l). This 
therefore confirms the earlier conclusion that xanthine and hypoxanthine 
are both equally valid substrates for use with xanthine oxidase when 
investigating its effects on endothelial barrier function.
Several studies have demonstrated cytotoxic actions of hydrogen peroxide 
on endothelial cells. For instance, Ager & Gordon (1984) showed that 
hydrogen peroxide stimulated 51cr release, adenine uptake, K+ efflux, 
prostaglandin production and the release of cytoplasmic purines in porcine 
aortic endothelial cells. Additionally, hydrogen peroxide has been shown 
to induce cells death in cultured mammalian epithelial cells (Link & Riley,
1988), 51cr release from rat pulmonary artery endothelial cells (Varani 
et al., 1990), and both lactate dehydrogenase release and 5-HT uptake in 
porcine pulmonary artery endothelial cells (Block, 1991). Moreover, 
hydrogen peroxide was found to increase macromolecular transfer across 
monolayers of canine kidney epithelial cells (Welsh et al., 1985), as well 
as porcine pulmonary artery (Wilson et al., 1990), human umbilical vein 
(Yamada et al., 1990b) and bovine pulmonary microvessel (Siflinger- 
Bimboim et al., 1992) endothelial cells. Having then established in this 
study, through the effectiveness of catalase, that hydrogen peroxide is 
implicated in mediating the effects of the hypoxanthine-xanthine oxidase 
system on endothelial barrier function, the effect of adding exogenous 
hydrogen peroxide was investigated to confirm its ability to increase albumin 
transfer in this system. This was indeed found to be the case, with hydrogen
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peroxide eliciting a biphasic concentration response curve, showing a 
lower peak at around 0.1-0.3 mM and a higher peak at around 10-30 mM.
The lower peak of this curve correlates with the theoretical maximum 
concentration of hydrogen peroxide, i.e. 0.2 mM, which could be formed 
from the chosen standard concentrations of hypoxanthine and xanthine 
oxidase employed in this study. (This is based on the fact that complete 
conversion of hypoxanthine to xanthine and then to uric acid will produce 
two molecules of superoxide anion which gives rise to one molecule of 
hydrogen peroxide for every one molecule of hypoxanthine initially 
present—see Introduction.) It is therefore quite conceivable that the 
hypoxanthine-xanthine oxidase-induced increase in albumin transfer across 
monolayers of BAEC is, in fact, mediated by hydrogen peroxide.
The precise reason for the biphasic-nature of the hydrogen peroxide 
concentration-response curve which was obtained is unclear. One possible 
explanation is that at low concentrations (corresponding to the lower peak 
at 0.1-0.3 mM), sufficient hydrogen peroxide is present to cause impairment 
of the barrier function of the endothelial monolayer, but when this 
concentration is increased, some form of protective mechanism (e.g. release 
of intracellular catalase) is triggered within the cells and this is able to 
counter the effects of hydrogen peroxide on barrier function. As the 
concentration of hydrogen peroxide is further increased (corresponding to 
the higher peak at 10-30 mM), then enough hydrogen peroxide becomes 
available to overcome this protective effect and so a second wave of 
endothelial barrier dysfunction is observed. An alternative explanation is 
that hydrogen peroxide may be causing its effects on barrier function at 
two distinct target sites in the endothelial cell thereby acting by two distinct 
mechanisms, one of which has a low sensitivity to hydrogen peroxide and
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one of which has a higher sensitivity, with each of these corresponding to 
a  peak in the concentration-response curve.
The findings of Siflinger-Birnboim et al. (1992) perhaps back up the latter 
of these two hypotheses. They showed that protein kinase C was involved 
in mediating the hydrogen peroxide-induced increase in albumin transfer 
across monolayers of bovine pulmonary microvessel endothelial cells as 
shown by a partial inhibition of the actions of hydrogen peroxide using 
two protein kinase C inhibitors, H7 and calphotsin C. This inhibition, 
however, was at its highest against a hydrogen peroxide concentration of 
0.1 mM and was found to diminish as the hydrogen peroxide concentration 
was increased. From this they concluded that at low concentrations (around
0.1 mM) the effects of hydrogen peroxide on endothelial barrier function 
w ere mediated, at least in part, by protein kinase C but at higher 
concentrations some other mechanism might be involved such as release 
of prostanoids or PAF.
As would be expected, catalase was found in this study to abolish the 
increase in albumin transfer induced across monolayers of BAEC by 
hydrogen peroxide. This inhibitory action of catalase was tested against 
hydrogen peroxide concentrations of both 0.1 and 10 mM, each of these 
concentrations representing a peak in the hydrogen peroxide concentration- 
response curve, respectively. To abolish the increase in albumin transfer 
induced by 10 mM hydrogen peroxide, a correspondingly high concentration 
of catalase was required, namely around 3000 U ml"*. In contrast, the 
increase in albumin transfer induced by 0.1 mM hydrogen peroxide was 
found to be abolished using only 0.3 U ml"* catalase which is nearer in 
magnitude to the catalase concentration (3 U m H ) found in this study to 
be required to abolish the increase induced by the hypoxanthine-xanthine 
oxidase system. However, lower concentrations of catalase were not tested
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against the effects of 0.1 mM hydrogen peroxide, so it is conceivable that 
even lower concentrations of catalase would also have been effective.
Since hydrogen peroxide production is clearly required for the endothelial 
barrier dysfunction induced by the hypoxanthine-xanthine oxidase system, 
it would perhaps have been expected that addition of superoxide dismutase 
would have enhanced the level of albumin transfer obtained. However, as 
has already been described, this was not in fact the case with superoxide 
dismutase being found to have no effect on the actions of the hypoxanthine- 
xanthine oxidase system. The likeliest explanation for this observation is 
that conversion of superoxide anion to hydrogen peroxide is already 
occurring sufficiently rapidly in the absence of exogenously added 
superoxide dismutase to yield an increase in albumin transfer which is 
maximal for the concentrations of hypoxanthine and xanthine oxidase 
used. This conversion of superoxide anion to hydrogen peroxide may 
either be occurring spontaneously or may be being catalysed by endogenous 
superoxide dismutase present in the endothelial cells.
7.1.5 Role of hydroxyl radicals
Whilst the results so far discussed would indicate that hydrogen peroxide is clearly an important mediator of the hypoxanthine- 
xanthine oxidase-induced increase in albumin transfer, it may, however, 
not be the sole damaging species produced which is responsible for this 
increase. It is quite possible, for example, that hydrogen peroxide is merely 
acting as a precursor for the formation of some other mediator of endothelial 
barrier dysfunction. One such possible mediator is the hydroxyl radical 
(Beauchamp & Fridovich, 1970) and in a number of studies, hydroxyl 
radicals have been implicated in causing damage to both endothelium and 
other tissues. For instance, hydroxyl radical scavengers have been shown
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to inhibit neutrophil-induced killing of bovine pulmonary artery endothelial 
cells (Varani et al., 1985), and to inhibit both ischaemia-reperfusion-induced 
contractile dysfunction (Bolli et al., 1989) and ischaemia-reperfusion-induced 
increased coronary microvascular permeability (Dauber, et al., 1991) in 
dog hearts. Hydroxyl radical scavengers have also proved effective in 
inhibiting ischaemia-reperfusion-induced lactate dehydrogenase release and 
haemodynamic dysfunction in isolated perfused rat hearts (Karwatowska- 
Prokopczuk & Beresewicz, 1992) and, additionally, have been shown to 
inhibit hypoxanthine-xanthine oxidase-induced 51cr release from calf 
pulmonary artery endothelial cells (Kvietys et al., 1989). Moreover, 
intracellular formation of hydroxyl radicals following exposure of porcine 
pulmonary artery endothelial cells to hydrogen peroxide has been 
demonstrated using spin trapping techniques (Britigan et al., 1992).
In order, therefore, to investigate if hydroxyl radicals are involved in 
mediating the endothelial barrier dysfunction induced in this study by the 
hypoxanthine-xanthine oxidase system, the effects of co-incubating various 
hydroxyl radical scavengers with hypoxanthine and xanthine oxidase were 
studied. The first hydroxyl radical scavenger to be studied was mannitol 
which is a membrane-impermeant scavenger (Kvietys et al., 1989). Mannitol 
which did no affect albumin transfer in itself was, however, found to be 
totally ineffective in abolishing the increase in albumin transfer across 
monolayers of BAEC which was induced by incubation w ith the 
hypoxanthine-xanthine oxidase system. However, since mannitol is unable 
to cross the endothelial cell membrane, it is only able to scavenge, and 
therefore inhibit the effects of, any hydroxyl radicals which are produced 
extracellularly. So whilst it would seem likely from this result that 
extracellular generation of hydroxyl radicals is not involved in mediating 
the effects of the hypoxanthine-xanthine oxidase system on endothelial
Page 173
M odulation o f  Endothelial Barrier Function Chapter 7
barrier function, the possibility still exists that intracellular generation of 
hydroxyl radicals is involved.
To investigate any involvement of intracellular hydroxyl radical generation 
in mediating the increase in albumin transfer induced by hypoxanthine 
and xanthine oxidase, the effects of comcomitant addition of two membrane- 
permeant hydroxyl radical scavengers, namely dimethylthiourea (Kvietys 
et al., 1989) and N-(2-mercaptopropionyl)-glycine (MPG) (Bolli et a l,
1989), were therefore studied. Neither dimethylthiourea (10 mM), nor MPG 
(1 mM) had any effect on the basal level of albumin transfer and, 
additionally, neither agent was found to affect the increase in albumin 
transfer induced by the hypoxanthine-xanthine oxidase system. This 
therefore indicates that hydroxyl radicals, whether generated extracellularly 
or intracellularly, do not appear to be responsible for mediating the effects 
of the hypoxanthine-xanthine oxidase system on endothelial barrier function.
The use of higher concentrations of both dimethylthiourea and MPG than 
those tested in this study, in order to ensure that the ineffectiveness of 
each was not merely due to the agents being added at an insufficiently 
high concentration, was not possible. W hen the concentration of 
dimethylthiourea was increased above 10 mM, it was found by itself to 
induce an increase in albumin transfer. This was presumably due to a 
cytotoxic action of the agent on the endothelial cell monolayers. In the 
case of MPG, any concentration tested above 1 mM was found to induce 
some form of irreversible block on the transfer of albumin. The cause of 
this effect was unclear but it may have resulted from an interaction taking 
place between MPG and some component of the endothelial cell mono­
layers. Alternatively, it could have been due to an interaction occurring 
between MPG and either the polycarbonate filters on which the cell
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monolayers were grown or a component of the trypan-blue labelled albumin 
complex which was used as a marker of endothelial barrier function.
Since hydroxyl radicals have been shown to be produced from superoxide 
anion and hydrogen peroxide, in the presence of a source of ferric iron 
through the Fenton reaction (Beauchamp & Fridovich, 1970), the effects of 
both removing and augmenting available ferric iron were investigated in 
this study. This allowed an independent assessment to be made of the 
involvement of hydroxyl radical production in mediating the increase in 
albumin transfer across monolayers of BAEC stimulated by the hypo­
xanthine-xanthine oxidase system.
Removal of ferric iron was achieved by using the iron chelator, 
deferoxamine. Initial experiments in which deferoxamine (500 pM) was 
added concomitantly with hypoxanthine and xanthine oxidase showed no 
effect of the iron chelator. Starke & Farber (1985) suggested, however, that 
cells must be pretreated with deferoxamine for several hours in order for 
it to be able to enter the cells and chelate intracellular iron, including iron 
stored as ferritin, in addition to merely chelating any iron present in the 
surrounding medium. Thus, in order to ensure chelation of both intracellular 
and extracellular iron was occurring in this study, the effects of pretreating 
endothelial cell monolayers overnight with deferoxamine (500 pM), prior 
to the addition of hypoxanthine and xanthine oxidase, was subsequently 
investigated. However, even when added as an overnight pretreatment, 
deferoxamine was found to have no inhibitory effect on the increase in 
albumin transfer induced by the hypoxanthine-xanthine oxidase system.
Additionally, augmenting available ferric iron, by concomitant addition of 
ferric chloride (50 pM) with hypoxanthine and xanthine oxidase, failed to 
generate an enhancement of the resultant increase in albumin transfer.
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Taking this finding together with those obtained in this study for 
deferoxamine, it would clearly appear that the endothelial barrier dys­
function induced by the hypoxanthine-xanthine oxidase system is not 
dependent on the availability of ferric iron and therefore the Fenton reaction 
would appear not to be involved. Moreover, when the results for mannitol, 
dimethylthiourea and MPG are also taken into account, it seems clear that 
production of hydroxyl radicals is not necessary to obtain an increase in 
albumin transfer in response to addition of the hypoxanthine-xanthine 
oxidase system. It can be concluded, therefore, that the effects of this 
system on endothelial barrier function are not mediated by hydroxyl radicals.
These findings for the effects of hypoxanthine and xanthine oxidase on 
albumin transfer would appear to conflict with previous reports on the 
cytotoxic actions of both the hypoxanthine-xanthine oxidase system and 
hydrogen peroxide in which hydroxyl radicals have been implicated as the 
mediating the effects of these agents. For instance, Starke & Farber (1985) 
demonstrated that hydrogen peroxide-induced killing of hepatocytes 
required the presence of both superoxide anion and ferric iron suggesting 
that these effects of hydrogen peroxide were mediated by production of 
hydroxyl radicals by way of the Fenton reaction. Additionally, when 
measuring 51cr release from bovine pulmonary artery cells as an indicator 
of cytotoxicity induced by neutrophils, which also generate superoxide 
anion and hydrogen peroxide, these effects were found to be inhibited by 
the hydroxyl radical scavengers, dimethylthiourea and mannitol, as well as 
by deferoxamine (Varani et al., 1985). Moreover, Kvietys et al. (1989) 
showed that 51cr release induced by the hypoxanthine-xanthine oxidase 
system from calf pulmonary artery endothelial cells was inhibited by the 
membrane-permeant hydroxyl radical scavengers, dimethylthiourea and 
dimethyl sulphoxide, as well as by a 5 hour pretreatment with deferoxamine.
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In all these studies, however, cell death or 51cr release was taken as an 
indicator of the effects of the agents being tested whereas in this study 
endothelial barrier function, a physiological function, was measured. 
Furthermore, cell death was measured after a 24 hour period, whilst 51 Cr 
release was only detectable at significant levels after around at least 4 hours. 
In contrast, an increase in albumin transfer, measured in this study as an 
indicator of endothelial barrier function, was observable following a standard 
90 minute incubation period, and indeed could be seen after around only 
30 minutes. Hence, it would seem that whilst hydroxyl radical production 
might be necessary to cause cytotoxicity/cell death in endothelial and 
other cells, it is not necessary to cause endothelial barrier dysfunction in 
BAEC which develops over a much shorter period of time. Ager & Gordon 
(1984) demonstrated that 51cr release is a substantially less sensitive index 
of the actions of the xanthine-xanthine oxidase system on vascular 
endothelial cells than other indices such as prostaglandin production, purine 
release and, in particular, K+ efflux. Endothelial barrier function, as measured 
in this study, would appear also to be a much more sensitive indicator of 
the effects of the hypoxanthine-xanthine oxidase free radical generating 
system than 51cr release, and, additionally, is perhaps more physiologically 
relevant.
7.1.6 Role of peroxynitrite anion
It has been recognised for some years that both EDRF (which may be nitric oxide or a related substance) and authentic nitric oxide can be 
inactivated by superoxide anion (Gryglewski et al., 1986; Rubanyi & 
Vanhoutte, 1986). In 1990, Beckman et al. speculated that the reaction 
which takes place between nitric oxide and superoxide anion gives rise to 
the production of peroxynitrite anion (ONOO"), a powerful oxidant in 
itself which additionally gives rise to the formation of hydroxyl radicals in
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an iron-independent manner. Since endothelial cells are known to release 
nitric oxide (or a related substance which gives rise to nitric oxide), it is 
conceivable that this nitric oxide could react with superoxide anion, 
generated on addition of the hypoxanthine-xanthine oxidase system, to 
yield peroxynitrite anion. Additionally, endothelial cells have been shown 
to release superoxide anion (Matsubara & Ziff, 1986) which could react 
with nitric oxide. Thus, it is possible that peroxynitrite anion can contribute 
to the actions of the hypoxanthine-xanthine oxidase system on endothelial 
barrier function, either in itself or through peroxynitrite anion-derived 
formation of hydroxyl radicals.
In order to test this hypothesis, the nitric oxide synthase inhibitor, N^-nitro- 
L-arginine (l-NOARG) was co-incubated with hypoxanthine and xanthine 
oxidase in order to block any production of nitric oxide by the endothelial 
cells and therefore prevent any possible formation of peroxynitrite anion. 
The concentration of L-NOARG used was 30 jjM which is sufficient, for 
instance, to block nitric oxide production in the endothelium of both 
rabbit aortic rings and rat perfused mesentery (Moore et al., 1990). l-NOARG 
was found, however, to have no effect on the resultant increase in albumin 
transfer across BAEC monolayers, indicating that formation of nitric oxide, 
and therefore by implication formation of peroxynitrite anion through an 
interaction of nitric oxide with superoxide anion, does not contribute to 
the endothelial barrier dysfunction induced by the hypoxanthine-xanthine 
oxidase system. Additionally, l-NOARG was found to have no effect in 
itself on the basal level of albumin transfer, thereby indicating that nitric 
oxide plays no role in the regulation of endothelial barrier function.
This conclusion is backed up by the fact that removing the source of 
available superoxide anion using superoxide dismutase did not inhibit the 
increase in albumin transfer induced by the hypoxanthine-xanthine oxidase
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system, and also by the fact that catalase did inhibit this increase since if 
peroxynitrite anion were the damaging species produced responsible for 
the system’s effects on endothelial barrier function, then formation of 
hydrogen peroxide would not be necessary. Also, if peroxynitrite anion- 
derived formation of hydroxyl radical was responsible for inducing the 
endothelial barrier dysfunction, then hydroxyl radical scavengers would 
have been effective and, as has already been described, they were not.
The inability of l-NOARG to inhibit the increase in albumin transfer induced 
by the hypoxanthine-xanthine oxidase system is therefore internally 
consistent with previous results in this study. Overall, it can been clearly 
seen that peroxynitrite, formed through an interaction between endothelium- 
derived nitric oxide and superoxide anion, does not play a role in mediating 
the effects of the hypoxanthine-xanthine oxidase system on the endothelial 
barrier function of BAEC.
7.1.7 Role of hypochlorous acid
ypochlorous acid is a reactive oxygen species which is a powerful
oxidant and which is known to be produced during ischaemia- 
reperfusion injury by activated neutrophils (Harrison & Schultz, 1976). 
Neutrophils contain the enzyme myeloperoxidase which catalyses the 
formation of hypochlorous acid from hydrogen peroxide and chloride 
ions. It has been shown, additionally, that dithiothreitol can reverse the 
damaging effects of hypochlorous acid on contractile function of rat cardiac 
muscle (Eley et al., 1989) and on calcium homeostasis in rabbit ventricular 
myocytes (Eley et al., 1991).
Since hypochlorous acid represents another mediator which hydrogen 
peroxide could potentially give rise to, dithiothreitol (3 mM) was co­
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incubated with hypoxanthine and xanthine oxidase in order to assess if 
hypochlorous acid is in any way involved in mediating the actions of the 
hypoxanthine-xanthine oxidase system on the endothelial barrier function 
of BAEC. Dithiothreitol, which had no effect on basal levels, was similarly 
found to have no effect on the level of albumin transfer obtained on 
addition of hypoxanthine and xanthine oxidase to BAEC monolayers. 
Therefore, it can be concluded that hypochlorous acid plays no role in 
mediating the effects of the hypoxanthine-xanthine oxidase system on 
endothelial barrier function.
7.2 Effects of homocysteine
high circulating level of homocysteine, as seen in sufferers of
homocystinuria, is a recognised risk factor for the development of 
atherosclerosis (Malinow, 1990). Moreover, various studies have revealed 
that homocysteine can induce endothelial injury. For instance, visible patches 
of destruction of aortic endothelium accompanied by the formation of
continuous infusion of homocysteine in baboons (Harker et al., 1976; 
Harker et al., 1983). The development of endothelial barrier dysfunction 
has been suggested to be a key step in the development of atherosclerosis 
(Ross, 1986). However, it has not been established whether the ability of 
homocysteine to cause an increase in the incidence of atherosclerosis in 
sufferers of homocystinuria is linked to an ability to induce endothelial 
barrier dysfunction.
7.2.1 Effects on albumin transfer
When added alone to monolayers of BAEC, homocysteine was found to have no effect on the level of albumin transfer obtained. Thus,
atherosclerotic lesions could be observed following three months of
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homocysteine, itself, would appear not to directly induce endothelial barrier 
dysfunction.
Starkebaum & Harlan (1986) demonstrated, however, that homocysteine- 
induced cytotoxicity, determined by 51q- release from both human umbilical 
vein and bovine aortic endothelial cells, was dependent on the presence 
of copper to catalyse the oxidation of homocysteine to its dimeric form, 
homocystine. They also showed that this oxidation could be catalysed 
using caeruloplasmin, the form in which copper is predominately found in 
the circulation, as well as by normal human serum which contains 
caeruloplasmin. These results indicate, therefore, that it is perfectly 
conceivable that this oxidation of homocysteine can occur readily in the 
circulation in vivo.
Thus, the effects of homocysteine, in the presence of copper added 
conveniently in the form of copper sulphate, were subsequently investigated 
in this study. When copper sulphate (5 and 50 /iM), which itself did not 
affect albumin transfer, was co-incubated with homocysteine (0.5 and
1.5 mM), a significant increase in albumin transfer across monolayers of 
BAEC was indeed observed to result. Thus, it would appear that endothelial 
barrier dysfunction is induced by the copper-catalysed oxidation of 
homocysteine, as opposed to occurring through a direct action of 
homocysteine itself.
Within the limited concentration ranges tested in this study, the induction 
of endothelial barrier dysfunction by the copper-catalysed oxidation of 
homocysteine was found to be dependent on the concentrations of both 
homocysteine and copper sulphate used. Standard concentrations of 1.5 mM 
homocysteine and 50 jjM copper sulphate were chosen for subsequent 
experiments against which the effects of various potential inhibitors were
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assessed. In conjunction with the chosen standard concentration of copper 
sulphate, this concentration of homocysteine afforded a reasonable 
compromise in that it was sufficient to yield a reproducible response, in 
terms of its ability to induce an increase in albumin transfer, and yet was 
not too far removed from the concentration of homocysteine which has 
been observed in the circulation of homozygotic homocystinuria sufferers,
i.e. up to 250 /iM (Perry et al., 1967). Whilst this concentration is a around 
six times less than that used as a standard in this study, an increase in 
albumin transfer was also observed using a homocysteine concentration as 
low as 500 /iM, only around twice that which has been observed clinically. 
Also, in this study, the effects of homocysteine on endothelial barrier 
function w ere assessed using only a 90 m inute incubation w ith 
homocysteine. In the in vivo situation where homocysteine is continually 
present within the circulation, it is quite conceivable that a lower 
concentration, such as that in fact observed of 250 /iM or less, would be 
sufficient over a longer time period to induce a similar effect on endothelial 
barrier function to that observed in this study in vitro.
7.2.2 Role of superoxide anion
aving established that, in the presence of copper sulphate,
homocysteine can induce endothelial barrier dysfunction, an 
investigation was then conducted in an attempt to establish the nature of 
the damaging species produced on the oxidation of homocysteine to 
homocystine. The first possible species to be investigated was superoxide 
anion since it is conceivable that this anion is produced during the oxidation 
of homocysteine in a similar fashion to its production by the hypoxanthine- 
xanthine oxidase free radical generating system. Hence, superoxide 
dismutase was co-incubated with homocysteine and copper sulphate to 
establish any inhibitory actions it might have. However, when superoxide
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dismutase was added, initially at a concentration of 3 U m l'l and
anion production were eliminated, no inhibition of the homocysteine- 
copper sulphate-induced increase in albumin transfer was observed.
This would indicate, therefore, that superoxide anion production does not 
mediate the endothelial barrier dysfunction which is induced on addition 
of homocysteine and copper sulphate to BAEC monolayers. Starkebaum & 
Harlan (1986) found that superoxide dismutase was similarly ineffective in 
inhibiting 51q - release from BAEC monolayers induced by homocysteine 
and copper sulphate, thereby agreeing with the conclusion from this study 
that superoxide anion does not mediate the effects of oxidation of 
homocysteine.
7.2.3 Role of hydrogen peroxide
sing a previously described assay for the production of hydrogen
peroxide assessed by its ability to stimulate the horseradish 
peroxidase-mediated oxidation of fluorescent scopoletin (Root et al., 1975), 
Starkebaum & Harlan (1986) demonstrated the production of hydrogen 
peroxide from homocysteine and copper sulphate. Additionally, it has 
already been established in this study and in others (Wilson et al., 1990; 
Yamada et al., 1990b; Siflinger-Birnboim et al., 1992) that hydrogen peroxide 
can induce an increase in macromolecular transfer across endothelial cell 
monolayers. In order, therefore, to investigate in this study if the endothelial 
barrier dysfunction induced by homocysteine and copper sulphate occurs 
as a consequence of the production of hydrogen peroxide, catalase was 
co-incubated with homocysteine and copper sulphate to investigate its 
effects on the increase in albumin transfer across BAEC monolayers.
subsequently at 6000 U ml~l to fully ensure that any effects of superoxide
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Catalase (1-100 U m H ) was found to abolish the increase in albumin 
transfer induced by homocysteine and copper sulphate thereby suggesting, 
as with the hypoxanthine-xanthine oxidase system, that hydrogen peroxide 
plays a key role in mediating the system’s effects on endothelial barrier 
function. This finding is in agreement with the observations of Starkebaum 
& Harlan (1986) who found that catalase inhibited the 51cr release which 
was induced by homocysteine and copper sulphate from monolayers of 
BAEC.
7.2.4 Role of hydroxyl radicals
s with the hypoxanthine-xanthine oxidase system, the possibility
existed that hydrogen peroxide was not the sole damaging species 
produced which mediated the actions of the copper-catalysed oxidation of 
homocysteine on endothelial barrier function. Hydroxyl radicals which 
have been implicated in previous studies as mediators of the injurious 
actions of hydrogen peroxide (Starke & Farber, 1985; Britigan et al., 1992), 
in the presence of a source of both superoxide anion and ferric iron 
(Beauchamp & Fridovich, 1970), may again be the damaging species 
responsible for inducing endothelial barrier dysfunction. Their involvement 
in the actions of the copper-catalysed oxidation of homocysteine had, 
however, not been previously investigated. In order, therefore, to investigate 
an involvement of hydroxyl radicals in this study, the effects of co-incubating 
homocysteine and copper sulphate with both hydroxyl radical scavengers 
and with the iron-chelator, deferoxamine, were studied.
The first hydroxyl radical scavenger to be investigated, mannitol (15 mM), 
was found to be without effect on the increase in albumin transfer across 
monolayers of BAEC induced by incubation with homocysteine and copper 
sulphate. Since mannitol is a membrane-impermeant scavenger, this would
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therefore indicate that extracellularly produced hydroxyl radicals do not 
contribute to the development of the endothelial barrier dysfunction induced 
by homocysteine and copper sulphate.
When the membrane-permeant hydroxyl radical scavenger, dimethylthiourea 
(1 mM), was similarly co-incubated with homocysteine and copper sulphate, 
it too was found to have no effect on the resultant increase in albumin 
transfer. This would therefore confirm the result obtained for mannitol, 
and would further suggest that, in addition to there being no role played 
by extracellular generation of hydroxyl radicals, there is also no role played 
by intracellular generation of these radicals in mediating the endothelial 
barrier dysfunction induced by the actions of homocysteine and copper 
sulphate.
When independently assessing a role played by hydroxyl radicals, by 
employing an overnight pretreatment with the iron chelator, deferoxamine 
(500 /iM), to inhibit any production of hydroxyl radicals occurring through 
the ferric-iron catalysed Fenton reaction, there was again found to be no 
resultant inhibition of the increase in albumin transfer induced by the 
copper-catalysed oxidation of homocysteine. This therefore backs up the 
two previous findings for mannitol and dimethylthiourea in indicating that 
there would appear to be no involvement of hydroxyl radical production 
in the generation of the effects of homocysteine and copper sulphate on 
endothelial barrier function.
7.3 Conclusions
In conclusion, the ability of the hypoxanthine-xanthine oxidase system to generate endothelial barrier dysfunction has been confirmed in this 
study using an in vitro model of the endothelial barrier in which albumin
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transfer across monolayers of BAEC was measured. Since both activation 
of the hypoxanthine-xanthine oxidase system and the induction of 
endothelial barrier dysfunction has been observed in vivo following 
ischaemia and reperfusion, it is therefore conceivable that the system is a 
major cause of endothelial barrier dysfunction following ischaemia- 
reperfusion injury.
When certain experiments were repeated using xanthine in place of 
hypoxanthine when added in combination with xanthine oxidase, similar 
profiles of response were obtained. Although using xanthine potentially 
only offers half the opportunity for superoxide anion and hydrogen peroxide 
production as that afforded by hypoxanthine, no difference was in fact 
observed since at the concentrations used both xanthine and hypoxanthine 
were present in excess. Therefore, it would seem that at the concentrations 
employed, both xanthine and hypoxanthine may equally well be used as 
substrates for xanthine oxidase when assessing the effects of the system on 
endothelial barrier function in vitro.
It has been shown, in this study, that the endothelial barrier dysfunction 
induced by the hypoxanthine-xanthine oxidase system does not arise as a 
consequence of the production of superoxide anion, hydroxyl radical, 
peroxynitrite anion or hypochlorous acid, but that there is a clear 
requirement for the generation of hydrogen peroxide. This requirement 
was revealed by the ability of catalase to inhibit the endothelial barrier 
dysfunction induced by hypoxanthine and xanthine oxidase. It is likely, 
therefore, that hydrogen peroxide is the sole mediator of this endothelial 
barrier dysfunction.
In confirmation of this conclusion, exogenously added hydrogen peroxide 
was also found to be able to induce endothelial barrier dysfunction as
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shown by an increase in albumin transfer across monolayers of BAEC. In 
particular, a concentration of hydrogen peroxide equivalent to that which 
could theoretically be generated by hypoxanthine and xanthine oxidase, 
when added at the concentrations used in this study, was found to induce 
an increase in albumin transfer which could similarly be inhibited by 
catalase.
Whilst the injurious effects on endothelial cells of copper-catalysed oxidation 
of homocysteine have been previously demonstrated (Starkebaum & Harlan, 
1986), the effects of this oxidation on endothelial barrier function have not. 
In this study, however, it has been shown that the copper-catalysed 
oxidation of homocysteine, rather than a direct action of homocysteine 
itself, can indeed lead to the induction of endothelial barrier dysfunction 
as shown by an increase in albumin transfer across monolayers of BAEC. 
It is possible that dysfunction also occurs in  vivo in sufferers of 
homocystinuria and therefore contributes to the increased incidence of 
atherosclerosis which is observed.
The endothelial barrier dysfunction induced by the copper-catalysed 
oxidation of homocysteine was observed not to arise as a consequence of 
the production of superoxide anion or hydroxyl radical, but the production 
of hydrogen peroxide was clearly required. As with the hypoxanthine- 
xanthine oxidase system, it is likely that hydrogen peroxide is the sole 
damaging species produced on the oxidation of homocysteine and is 
therefore the sole mediator of the endothelial barrier dysfunction which is 
observed to result.
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C hapter 8
8 .1 Effects of lipopolysaccharide (LPS)
ipopolysaccharide (LPS), also known as endotoxin, derived from gram-
negative bacteria is a common cause of septic shock. Amongst other 
symptoms, such as most notably profound hypotension and hyporeactivity 
to vasoconstrictors, septic shock is characterised by profound vascular 
leakage resulting from the development of endothelial barrier dysfunction. 
Whilst increasing evidence has indicated that both the hypotension (Rees 
et al., 1990; Thiemermann & Vane, 1990; Kilboum et al., 1990b; Nava et 
al., 1991; Wright et al., 1992) and hyporeactivity to vasoconstrictors (Fleming 
et al., 1991; Gray et al., 1991; Vallance et al., 1992; Szabo et a l, 1993) 
result from the generation of nitric oxide, the mediator of the endothelial 
barrier dysfunction of septic shock has not as yet been identified. The 
possibility, however, that this mediator might also be nitric oxide has not, 
so far, been investigated.
8.1.1 Effects on albumin transfer
ollowing a 24 hour incubation period, after which the transfer of
albumin across monolayers of BAEC was measured during 90 minutes, 
LPS (0.1-1000 ng m l'l) was found to stimulate an increase in albumin 
transfer in a concentration-dependent manner. This would indicate that the 
ability of LPS to induce endothelial barrier dysfunction can be demonstrated 
in vitro using the model of the endothelial barrier which was employed 
in this study. Additionally, this finding demonstrates that LPS can cause 
endothelial barrier dysfunction through a direct action on the endothelial 
cells themselves. The presence of other cell types is therefore not necessary
Page 188
M odulation o f  Endothelial Barrier Function Chapter 8
to facilitate the mediation of the effects of LPS on endothelial barrier 
function, however, in vivo, other cell types may play a contributory role.
This ability of LPS to induce endothelial barrier dysfunction is in accord 
with previous findings of other workers. Meyrick et al. (1986) showed, for 
instance, that following 24 hours’ exposure, LPS similarly caused a 
concentration-dependent increase in both the w ater and albumin 
permeability of cultured monolayers of bovine pulmonary artery endothelial 
cells. Induction of endothelial barrier dysfunction by LPS has also been 
observed in vivo. Using intravenously administered horseradish peroxidase 
as an indicator of endothelial barrier function of rats which had previously 
been injected with LPS for a specific time period, Penn & Chisolm (1991) 
demonstrated that LPS induced a significant increase in the accumulation 
of horseradish peroxidase within the intima and media of the aorta. This 
implied that LPS had induced dysfunction of the endothelial barrier which 
had therefore enabled the horseradish peroxidase to cross the endothelial 
layer and accumulate within the underlying intima and media. Kang & 
Williams (1991) similarly demonstrated the ability of LPS to increase 
endothelial permeability in rat aortas in  vivo using the horseradish 
peroxidase assay.
In order to determine the time-course of the development of the increase 
in albumin transfer observed in this study in response to incubation with 
LPS, a standard concentration of 30 ng m H  was chosen for subsequent 
investigation. This concentration of LPS was found to generate a reproducible 
increase in albumin transfer and was also sufficiently sub-maximal so as to 
allow the effects of various potential inhibitors of its action to be observed 
in subsequent experiments.
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W hen albumin transfer across monolayers of BAEC was measured following 
incubation with this chosen standard concentration of LPS for various time 
intervals, a biphasic time-course was revealed with an early, transient peak 
being observed that was maximal around after 2 hours’ exposure to LPS. 
A later, sustained peak was also observed and this appeared to near a 
maximum by 24 hours. Incubation periods longer than 24 hours were not, 
however, investigated in order to in fact confirm this.
Co-incubation with polymixin B, which inhibits the actions of LPS by 
binding the Lipid A portion of the LPS molecule with high affinity (Morrison 
& Jacobs, 1976), was found, as would be expected, to abolish the increases 
in albumin transfer which were induced by LPS following both 2 hours’ 
and 24 hours’ incubation. Previous investigations have revealed that the 
immunological activity of LPS is mediated by the Lipid A portion of the 
molecule (Liideritz et al., 1973). The findings in this study for the actions 
of polymixin B would therefore suggest that the Lipid A portion of the LPS 
molecule is also responsible for mediating its effects on endothelial barrier 
function.
Interestingly, the biphasic nature of the time-course of the development of 
endothelial barrier dysfunction induced by LPS, in many ways parallels the 
time-course which has been observed in vivo for the development of the 
hypotension also induced by LPS. Wright et al. (1992) showed, for instance, 
that administration of LPS to the anaesthetised rabbit produced a biphasic 
fall in both mean arterial pressure and regional blood flow. The initial, 
transient phase of the response was observed to occur immediately following 
injection of LPS and recovery was achieved within a 10 minute period. The 
second phase of the response began to develop approximately 30 minutes 
following injection and consisted of a slow progressive fall in mean arterial 
pressure which was sustained throughout the duration of the experiment.
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Additionally, Szabo et a l  (1993) demonstrated, that whilst the hyporeactivity 
to the vasoconstrictor actions of noradrenaline in LPS treated rats was 
evident within 1 hour of LPS administration, the regulation of this 
hyporeactivity at 1 hour differed from the regulation of the hyporeactivity 
which was observed after 3 hours. Although both components were found 
to be dependent on the generation of nitric oxide, results showed that at 
1 hour this was due to stimulation of a constitutive isoform of nitric oxide 
synthase whilst at 3 hours, nitric oxide production occurred as a result of 
the induction of an inducible isoform. This was indicated by the ability of 
dexamethasone to abolish the hyporeactivity observed at 3 hours but not 
that observed at 1 hour.
8.1.2 Role of the L-arginine-nitric oxide system
Since activation of the L-arginine-nitric oxide system has been shown to be responsib le  for m ediating both  the hypo tension  and the 
hyporeactivity to vasoconstrictors which is induced by LPS in animal models 
of septic shock, the possibility that activation of the L-arginine-nitric oxide 
system is also responsible for the endothelial barrier dysfunction induced 
by LPS was therefore investigated in this study. Initial investigation involved 
co-incubation of LPS with 3 different inhibitors of nitric oxide synthase to 
establish their ability to inhibit the effects of LPS on albumin transfer across 
monolayers of BAEC.
The first of these nitric oxide synthase inhibitors, N03-nitro-L-arginine 
(l-NOARG), was assessed for its ability to inhibit the increase in albumin 
transfer which was stimulated by 24 hours’ incubation with LPS. The 
concentration of l-NOARG used was 100 j j M  which is sufficient, for instance, 
to bbck nitric oxide production in the endothelium of both rabbit aortic 
rings and rat perfused mesentery (Moore et al.} 1990). This concentration
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of l-NOARG was, however, found to have no effect on the increase in 
albumin transfer which was induced by LPS in this study.
Since l-NOARG is relatively insoluble in aqueous solution, it could only be 
tested at a maximum concentration of 100 /iM. In order, therefore, to 
assess the effects of higher concentrations so as to rule out the possibility 
that its ineffectiveness was due to the fact that it had not been added at 
a sufficiently high concentration, further experiments were conducted using 
its more soluble methyl ester form, N^-nitro-L-arginine methyl ester 
(l-NAME). This enabled the concentration tested to be increased to 500 /iM. 
Additionally, the effects of L-NAME were assessed against the increase in 
albumin transfer induced by 2 hours’ exposure to LPS as well as that 
induced by 24 hours’ exposure. l-NAME was, however, found to be similarly 
ineffective to l-NOARG in terms of its ability to inhibit the increase in 
albumin transfer induced by LPS at both these time-points.
The third nitric oxide synthase inhibitor studied, N® -monomethy 1-L-arginine 
(l-NMMA), was added at an even higher concentration of 2 mM. It also did 
not inhibit the increases in albumin transfer induced by incubation with 
LPS for either 2 hours or 24 hours and, indeed, it was found to induce a 
statistically significant enhancement of the level of albumin transfer obtained 
at both time-points.
Taking the results for all three nitric oxide synthase inhibitors together, it 
would quite clearly appear that generation of nitric oxide is not responsible 
for mediating the effects of LPS on endothelial barrier function at either of 
the two time-points investigated, i.e. 2 hours and 24 hours. Indeed, when 
taking into account the results obtained for l-NMMA, it is possible that 
basal nitric oxide production might play a role in inhibiting the LPS-induced 
endothelial barrier dysfunction. However, the fact that this enhancement
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was only observed using l-NMMA, and not when using l-NOARG or 
L-NAME, might suggest that it occurs through some action other than 
inhibition of nitric oxide synthase which is specific to l-NMMA. Another 
possible explanation for the differential effects of l-NMMA compared to 
the effects of both l-NOARG and l-NAME is that the enhancement is 
concentration-dependent with the concentrations of l-NOARG and l-NAME, 
which were considerably less than that employed for L-NMMA, being 
insufficient for this effect to be observed.
These results clearly conflict with the observed effects of the actions of 
nitric oxide synthase inhibitors on the hypotension induced by LPS both 
in vivo and in vitro. l-NMMA has been shown, for instance, to reduce the 
hypotension induced by LPS in both rat (Thiemermann & Vane, 1990; 
Nava et al., 1991; Nava et al., 1992) and dog (Kilboum et al., 1990b). 
Additionally, both L-NMMA and l-NAME were observed to increase blood 
pressure in human sufferers of septic shock after conventional therapy for 
hypotension had failed (Petros et al., 1991).
Nitric oxide synthase inhibitors have also been found to be effective in 
inhibiting LPS-induced hyporeactivity to vasoconstrictors. l-NAME was 
observed to inhibit the hyporeactivity to noradrenaline which was observed 
in vitro in aortic rings obtained from LPS-treated rats (Fleming et al., 1991) 
and in vivo in anaesthetised LPS-treated rats (Gray et al., 1991; Szabo 
et al., 1993). Also, l-NMMA was found to inhibit the hyporeactivity to the 
thromboxane-mimetic, U-46619, which was induced in vitro in rings of 
jugular veins obtained from LPS-treated rabbits (Vallance et al., 1992) as 
well as the hyporeactivity to noradrenaline which was observed in vivo in 
anaesthetised rats (Gray et al., 1991).
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Also, in contrast to the results observed in this study, Palmer et a l  (1992) 
found that LPS-induced cell death of porcine aortic endothelial cells was 
inhibited by incubation with L-NMMA. This would suggest that LPS-induced 
cytotoxicity of endothelial cells, measured as cell death, is mediated by 
nitric oxide. However, this cytotoxic response was only evident using a 
standard stimulus of 10 /ig ml~l LPS which was more than 300 times 
greater than the standard concentration of LPS, i.e. 30 ng ml-1, used in this 
study to induced endothelial barrier dysfunction. Cytotoxicity is perhaps a 
less physiologically relevant means by which to assess the effects of LPS 
on the vascular endothelium.
In order to independently investigate the involvement of nitric oxide 
production through stimulation of an inducible isoform of nitric oxide 
synthase in the actions of LPS on endothelial barrier function, the effects 
of the glucocorticoid, dexam ethasone w ere subsequently studied. 
Dexamethasone has been shown to prevent the induction of Ca2+- 
independent inducible isoforms of nitric oxide synthase (Knowles et a l, 
1990; Rees et a l, 1990), but has no effect on the activity of either constitutive 
or inducible isoforms (Moncada, 1992).
In initial experiments, dexamethasone (1 /iM) was added as a 30 minute 
pretreatment prior to addition of LPS and was found to have no effect on 
the increase in albumin transfer across monolayers of BAEC stimulated by 
24 hours’ incubation with LPS. Since it was possible, however, that a 
longer pretreatment was necessary in order for dexamethasone to establish 
its effects, further experiments were conducted using a 20 hour pretreatment 
prior to the addition of LPS. Despite this substantially longer pretreatment, 
however, dexamethasone was still found to be ineffective in inhibiting the 
increase in albumin transfer induced by a 24 hour incubation with LPS and 
was, additionally, also found to have no effect on the increase in albumin
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transfer induced by a 2 hour incubation with LPS. These results would 
therefore indicate that induction of an inducible isoform of nitric oxide 
synthase is not required in order to establish the effects of LPS on endothelial 
barrier function.
As with the findings for the nitric oxide synthase inhibitors tested in this 
study, these findings for the actions of dexamethasone would appear to be 
in conflict with previously reported effects of the glucocorticoid on both 
the hypotension and the hyporeactivity to vasoconstrictors induced by 
LPS. For instance, Rees et al. (1990) showed that the gradual loss of tone 
which was observed in rat aortic rings, and which they attributed to LPS 
present in the buffer in which the rings had been placed, was prevented 
by prior addition of dexamethasone. The hyporeactivity to U46619 observed 
in hearts obtained from LPS-treated rabbits was similarly prevented by 
prior treatment with dexamethasone (Smith et al., 1991), as was the 
hyporeactivity to noradrenaline observed in anaesthetised rats 6 0  minutes 
after treatment with LPS (Szabo et al., 1993). The hyporeactivity induced 
immediately following administration of LPS to anaesthetised rats was, 
however, unaffected by dexamethasone treatment suggesting that only the 
late phase of the hyporeactivity response is mediated by induction of an 
inducible isoform of nitric oxide synthase. Dexamethasone was also found 
to inhibit LPS-induced killing of porcine aortic endothelial cells (Palmer 
et al., 1 9 9 2 ) suggesting that induction of an inducible isoform of nitric 
oxide synthase is also involved in mediating the cytotoxic actions of LPS 
on the vascular endothelium.
Taking the results obtained in this study for the nitric oxide synthase 
inhibitors and dexamethasone together, it would seem clear that nitric 
oxide production does not mediate the endothelial barrier dysfunction 
which is induced by LPS. This would appear to be in contrast to LPS-
Page 195
M odulation o f  Endothelial Barrier Function Chapter 8
induced hypotension and hyporeactivity to vasoconstrictors, both of which 
have been shown to depend upon the production of nitric oxide. Moreover, 
LPS has been shown to stimulate the immediate release of nitric oxide 
from BAEC (Salvemini et al., 1990) and it is therefore likely that generation 
of nitric oxide through activation of a constitutive nitric oxide synthase in 
the vascular endothelium mediates the immediate phase of both the 
hypotension and the hyporeactivity to vasoconstrictors induced by LPS. 
LPS has also been shown to induce nitric oxide production through 
stimulation of an inducible nitric oxide synthase in the smooth muscle of 
the vascular wall (Fleming et al., 1990; Knowles et al., 1990) and therefore 
it is likely that this nitric oxide production mediates the dexamethasone- 
sensitive late, sustained phases of both the hypotension and the 
hyporeactivity to vasoconstrictors which are induced by LPS. Since the 
increases in albumin transfer across BAEC observed in this study were 
found, in contrast, to be unaffected by both nitric oxide synthase inhibitors 
and pretreatment with dexamethasone, it would appear that nitric oxide 
production, through either a constitutive or an inducible nitric oxide 
synthase, is not in any way responsible for the effects of LPS on endothelial 
barrier function. Furthermore, other work in this laboratory using a 
chemiluminescence technique to measure nitrite accumulation as an 
indicator of nitric oxide production, showed no evidence of the induction 
of nitric oxide synthase in BAEC following 24 hours’ incubation with LPS 
(Berman et al., 1993). LPS-induced endothelial barrier dysfunction would 
therefore appear to be mediated by a different mechanism from that which 
mediates both the hypotension and the hyporeactivity to vasoconstrictors 
which are also induced by LPS.
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8.1.3 Role of prostaglandins
Chapter 8
Prostaglandin release, particularly release of prostaglandin E2  and prostacyclin, has been observed in vivo during septic shock (Petrak 
et al., 1 9 8 9 ) and prostaglandins have been shown to contribute to the 
pathogenesis of septic shock (Parratt & Sturgess, 1975). Additionally, 
vasodilator prostaglandins including prostaglandins Ei, E2  and G2 have 
been shown in vivo to enhance both histamine- and bradykinin-induced 
plasma exudation in rabbit skin (Williams & Peck, 1977). This effect was 
linked to their vasodilator actions which result in an increased hydrostatic 
pressure and an increase in the area of vessel wall available for plasma 
exudation. Another cyclo-oxygenase product, thromboxane A2 ? has also 
been shown to increase endothelial permeability in vivo (Petrak et al., 
1989).
In order, therefore, to establish if prostaglandin production plays a role in 
mediating the increase in albumin transfer across BAEC induced by 24 
hours’ incubation with LPS, the effect of co-incubation of LPS with the 
cyclo-oxygenase inhibitor, flurbiprofen (30 //M), was investigated. 
Flurbiprofen was, however, found to have no effect on the increase in 
albumin transfer stimulated by LPS. This indicates that production of 
prostaglandins and other cyclo-oxygenase products is not responsible for 
mediating the effects of LPS on endothelial barrier function following a 
24 hour incubation with LPS.
8.1.4 Role of hydrogen peroxide
H ydrogen peroxide has been shown, in this study and in others (Wilson et al., 1990; Yamada et al., 1990b; Siflinger-Birnboim et al., 
1 9 9 2 ), to have the ability to induce endothelial barrier dysfunction as
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shown by an increase in macromolecular transport across endothelial 
monolayers. Additionally, it has been shown in this study to be a key 
mediator of the endothelial barrier dysfunction induced by both the 
hypoxanthine-xanthine oxidase system and the copper-catalysed oxidation 
of homocysteine. In order, therefore, to investigate the possibility that 
hydrogen peroxide is also the mediator of the endothelial barrier dysfunction 
induced by LPS, the effect of catalase on the LPS-stimulated increase in 
albumin transfer across monolayers of BAEC was investigated.
Catalase which was added at a concentration 1000 U m H  was found to 
have no effect on the increase in albumin transfer obtained following 
incubation of BAEC monolayers with LPS for 24 hours. This concentration 
of catalase had previously been found in this study to be sufficient to 
abolish the increase in albumin transfer induced by both the hypoxanthine- 
xanthine oxidase system and by either concentration (0.1 mM and 10 mM) 
of hydrogen peroxide tested. Therefore, it would appear that hydrogen 
peroxide is not responsible for mediating the observed effects of LPS on 
endothelial barrier function at the later time-point which was investigated 
in this study.
8.2 Effects of interferon-y (IFN-y)
Various cytokines including interleukins, TNF-a and IFN-y are released during septic shock (Bone, 1991a) and many of these have been 
observed to increase endothelial permeability both in vivo and in vitro. 
For example, interleukin-2 was found to increase albumin transfer across 
ovine aortic endothelial cells (Bechard et al., 1990), whilst interleukins-la 
and -lp  have been shown to increase albumin transfer across monolayers 
of both bovine pulmonary artery endothelial cells (Campbell et al., 1992) 
and human umbilical vein endothelial cells (Burke-Gaffney & Keenan,
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1993a). TNF-a has also been observed to increase albumin, inulin and 
sorbitol transfer across monolayers of BAEC (Brett et al., 1989) as well as 
albumin transfer across monolayers of bovine pulmonary artery (Goldblum 
& Sun, 1990; Wheatley et al., 1993) and human umbilical vein (Camussi 
et al., 1991; Burke-Gaffney & Keenan, 1993a; Burke-Gaffney & Keenan, 
1 9 9 3 b) endothelial cells.
IFN-y has been shown to alter cell shape and morphology when incubated 
with monolayers of human umbilical vein endothelial cells (Stolpen et al., 
1986). Additionally, LPS has been shown to induce an up-regulation of 
IFN-y expression in mice (Cockfield et al., 1993). Thus it is possible that 
IFN-y in fact mediates the endothelial barrier dysfunction which is induced 
by LPS and, hence, the effects of IFN-y on albumin transfer across 
monolayers of BAEC were investigated in this study.
When albumin transfer was measured across BAEC monolayers subsequent 
to 24 hours’ incubation with human recombinant IFN-y (0.75-75 U ml“l)  
no increase above control levels was, however, observed. This finding 
would seem to indicate, therefore, that IFN-y does not act directly on 
endothelial cell monolayers to induce endothelial barrier dysfunction.
Beynon et a l  (1993) similarly found that human recombinant IFN-y 
(125 U ml-1) did not induce endothelial barrier dysfunction using human 
umbilical vein endothelial cells across which the transfer of anti-FITC 
antibody was measured. However when IFN-y was subsequently added in 
combination with interleukin-4, which itself did not affect anti-FITC antibody 
transfer, a significant increase in transfer was found to result, thus showing 
that IFN-y can act synergistically with interleukin-4 to induce endothelial 
barrier dysfunction.
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In contrast to these findings, as well as those in this study, Burke-Gaffney 
& Keenan (1993a) demonstrated the ability of human recombinant IFN-y 
to stimulate an increase in albumin transfer across monolayers of human 
umbilical vein endothelial cells. This increase was attained following an 
incubation period with IFN-y of 20 hours and could be observed using an 
IFN-y concentration of 25 U ml~l which was within the concentration- 
range investigated in this study, i.e. 0.75-75 U ml-*. The only major 
difference between their study and this was the fact that they used human 
venous endothelial cell monolayers to assay the effects of human 
recombinant IFN-y, whereas in this study bovine arterial endothelial cell 
monolayers were employed to assay the effects of human recombinant 
IFN-y. Thus, it is possible that the reason for the failure of IFN-y to increase 
albumin transfer across BAEC monolayers in this study, was due to an 
insufficiency in species morphology between the human recombinant IFN-y 
and the bovine endothelial cells used. Alternatively, it is possible that 
IFN-y is only able to increase the albumin transfer across venous 
endothelium and not across arterial endothelium. More simply, this 
difference might occur because IFN-y receptors are present in human 
umbilical vein endothelial cells whilst they may be lacking in BAEC. These 
suggestions, however, do not explain the fact that Beynon et a l  (1993) 
failed to observe an ability of IFN-y to induce endothelial barrier dysfunction 
in human umbilical vein endothelial cell monolayers when added alone.
8.3 Conclusions
In conclusion, the ability of LPS to induce endothelial barrier dysfunction through a direct action on the vascular endothelium has been confirmed 
in this study by the ability of LPS to stimulate an increase in albumin 
transfer across monolayers of BAEC. This increase in albumin transfer was 
found to be concentration-dependent and exhibited a biphasic time-course
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which in many ways parallels the profiles of both the hypotension and the 
hyporeactivity to vasoconstrictors which have been demonstrated to be 
induced by LPS in both in vivo and in vitro models of septic shock.
Evidence now suggests that the early phases of both the hypotension and 
the hyporeactivity to vasoconstrictors which are induced by LPS are mediated 
by nitric oxide production through stimulation of a constitutive nitric oxide 
synthase in the vascular endothelium, whilst in both cases, the late phase 
would appear to be mediated by nitric oxide production through induction 
of an inducible nitric oxide synthase in the smooth muscle of the vascular 
wall. In contrast, no evidence was found in this study for the involvement 
of nitric oxide production in either the early or late phase of the endothelial 
barrier dysfunction induced by LPS in BAEC monolayers. This was 
demonstrated by the inability of three nitric oxide synthase inhibitors, as 
well as dexamethasone, to inhibit either phase of the LPS-induced 
endothelial barrier dysfunction. It would therefore, appear that this 
endothelial barrier dysfunction is mediated by a different mechanism from 
that which mediates both the hypotension and the hyporeactivity to 
vasoconstrictors which are induced by LPS.
Additionally, it was observed that the late phase of the endothelial barrier 
dysfunction induced by LPS was not mediated by either a cyclo-oxygenase 
product, or by hydrogen peroxide. This was indicated by the inability of 
both flurbiprofen and catalase to inhibit the LPS-induced endothelial barrier 
dysfunction which was obtained following 24 hours’ incubation with LPS.
It is also unlikely that the late phase of the response to LPS observed in 
this study is m ediated by IFN-y. W hen the effects of IFN-y were 
independently investigated, it was found to have no effect on the endothelial 
barrier function of BAEC monolayers following a 24 hour incubation.
Page 201
M odulation o f  Endothelial Barrier Function Chapter 8
In addition to IFN-y, many substances which may affect endothelial barrier 
function have been shown to be released during the sepsis cascade including 
TNF-a, interleukins, PAF, leukotrienes and thromboxane A2  (Bone, 1991a). 
Further investigation is therefore required in order to establish in any of 
these agents, or indeed any other agents, are involved in mediating the 
observed effects of LPS on endothelial barrier function and which may 
therefore be responsible for the production of the profound vascular leakage 
which is observed in septic shock.
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